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Post-infectious (PIH) and post-hemorrhagic (PHH) hydrocephalus occur as sequalae of neonatal 
sepsis or intraventricular hemorrhage (IVH) of prematurity, respectively. Together, PIH and PHH 
represent the most common form of infantile hydrocephalus, the most common indication for 
neurosurgery in children globally, and the leading cause of neurological morbidity and mortality 
worldwide. The lack of understanding of the pathophysiology of PIH and PHH, particularly with 
regards to the host central nervous system response to the antecedent infection and hemorrhage, 
perturbation of differentiating neural stems in the ventricular (VZ) and subventricular (SVZ) 
zones, and damage to periventricular white matter (PVWM) tracts carrying sensorimotor fibers, 
 xxi 
has hindered the identification of therapeutic targets to prevent these two debilitating conditions. 
To this end, we hypothesized that PIH and PHH share a common pathophysiological mechanism 
characterized by host immune response to infection or hemorrhage, activation of the 
metalloprotease ADAM10 and cleavage of the cell-junctional protein, N-cadherin, which results 
in impaired VZ/SVZ differentiation and PVWM damage. The studies presented in this dissertation 
collectively explore novel overarching lines of scientific inquiry - the concept that there are unique 
host immune responses to PIH and PHH, as well as ones that are common to both conditions that 
underlie their observed clinical similarities. 
 
To test the hypothesis, we leveraged the cerebrospinal fluid (CSF) of human PIH, PHH and 
matched non-infectious non-hemorrhagic hydrocephalic control infants. First, we defined the 
differentially expressed proteome and transcriptome of PIH using high throughput proteomics and 
RNA-seq, respectively. The integration of proteogenomic techniques defined critical gene 
networks and pathway level mechanisms of PIH pathophysiology. Second, our validated 
proteomics pipeline was used to identify the common and unique molecular pathways that underlie 
the pathophysiology of PIH and PHH. Third, our CSF findings were related to VZ/SVZ 
development and PVWM microstructural damage with diffusion MRI (dMRI) in PHH and control 
infants. Neurocytology of human postmortem brain tissues of PIH, PHH and controls was 
performed to correlate the dMRI findings. Fourth, we defined the mechanistic triggers underlying 
PIH and PHH pathogenesis utilizing a mouse in vitro cell culture model of periventricular VZ 
cells. Finally, we developed in vivo animal models of PIH (mice) and PHH (ferrets), to recapitulate 
our findings of VZ/SVZ disruption, neuroinflammation and PVWM injury in both PIH and PHH.  
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Through our comprehensive experiments, we determined the following: 1) human CSF profiles of 
PIH and PHH reflect similar alterations in gene-activated pathways related to neuroinflammation 
and cell-cell junction structure; 2) neuroinflammation-associated cell junction (VZ/SVZ) 
disruption and PVWM injury is a pathophysiological mechanism that is common to both PIH and 
PHH; 3) dMRI can non-invasively assess the VZ/SVZ region as well as differentiate and quantify 
tract-specific patterns of PVWM injury. Therefore, it can distinguish direct effects on 
axons/myelin from changes in the extracellular milieu to reflect neuroinflammation, axonal fiber 
loss, and dysmyelination; 4) VZ/SVZ disruption in PIH and PHH is mediated by metalloprotease 
(e.g., ADAM10) cleavage of cell junctional proteins (e.g., N-cadherin); and 5) pharmacologic 
inhibition of ADAM10-mediated N-cadherin cleavage represents a viable therapeutic approach to 
prevent PIH and PHH. 
 
These novel insights into the pathophysiology of PIH and PHH may enable investigation of 
ADAM10 inhibitors and other therapeutic strategies to minimize the developmental disability in 
PIH and PHH patients. The biomarkers we identified can be further investigated as diagnostic 
measures for monitoring and providing therapy to infants who develop neonatal sepsis or IVH to 
prevent PHH/PIH. Finally, the in vitro and in vivo experimental models we generated are poised 
for future preclinical and translational studies into the pathogenesis of these previously 
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all the ferrets and performed all data analyses presented in this chapter. Dr. Pat McAllister 
coordinated the day-to-day management of the ferret model. However, the ferret model was a 
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provided me with all the necessary resources at the Experimental Imaging Center and mentored 
me on this project. I had invaluable help from Dr. Ying Wu (who performed the mice 
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1.1 Hydrocephalus  
 
Hydrocephalus encompasses a heterogeneous group of complex neurological disorders 
characterized by brain injury in the context of cerebrospinal fluid (CSF) accumulation and 
abnormal dilatation of the cerebral ventricles. This can occur with or without an increase in 
intracranial pressure (ICP) that arises from an imbalance between CSF production and clearance1,2.  
 
1.1.1 Classification of hydrocephalus 
 
There are several approaches to classify the “syndrome” of hydrocephalus3-7. The classic, most 
common system dichotomizes hydrocephalus into communicating vs. non-communicating (or 
obstructive) subtypes based on the absence or presence of an identifiable obstruction in the CSF 
pathways, respectively3-8. An age-based classification stratifies hydrocephalus into neonatal, 
infantile, pediatric, juvenile, transitional, adult and elderly forms2,9. From an etiological standpoint, 
hydrocephalus may be classified as primary vs. secondary (or acquired), based on whether the 
cause is unknown or a result of an identifiable antecedent neurologic event3-7. Examples of 
secondary hydrocephalus include post-hemorrhagic hydrocephalus (PHH; occurs following 
intraventricular hemorrhage (IVH) in neonates)2,10, post-infectious hydrocephalus (PIH; due to 
perinatal sepsis)11,12, congenital hydrocephalus (caused by genetic aberrations)7,13-15, and spina-





1.1.2 Clinical presentation and diagnosis 
 
The presenting signs and symptoms of hydrocephalus are often non-specific and may include any 
combination of the following: tense fontanels, splaying of cranial sutures and irritability in infants 
and headaches, nausea, vomiting, papilledema, cranial nerve abnormalities, seizures, depressed 
level of consciousness, urinary incontinence and gait difficulties in all age groups2,19. The clinical 
diagnosis of hydrocephalus requires both the presence of related clinical signs/symptoms and 
confirmation of abnormal ventriculomegaly on neuroimaging defined by metrics such as the 
frontal-occipital horn ratio and Evan’s Index20. 
 
In preterm neonates, head ultrasounds are the most commonly used neuroimaging modality since 
they can be performed at the bedside and require minimal handling of the infants. Computed 
tomography (CT) scans may be utilized when feasible but their use in infants and children is 
limited, especially in well-resourced countries due to the risk of exposure to ionizing radiation, 
associated with developmental impairments and radiation-induced cancers later in life21. Magnetic 
resonance imaging (MRI) is the preferred neuroimaging modality in infants because it does not 
expose patients to this ionizing radiation. MRI is also ideal for identifying sites of obstruction to 
CSF flow and hemorrhage that could contribute to hydrocephalus symptoms28,55. However, 
standard MRIs have lengthy acquisition times and often require sedation or general anesthesia, 
especially in neonates and uncooperative children, which subjects them to risks of anesthesia-
related complications22,23. Recently, the United States Food and Drug Administration 
recommended against repeated elective exposure to anesthesia in young children24. Consequently, 
fast brain MRI protocols have been implemented since 2002 to circumvent the need for sedation 
in pediatric hydrocephalus patients. Fast brain MRIs utilize short pulse sequences to acquire MRI 
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images in 2-3 seconds per slice, which are adequate for making prompt clinical decisions in most 
pediatric hydrocephalus patients25,26. However, due to concerns of poor image quality and 
susceptibility to motion artifacts, indications for fast brain MRIs in hydrocephalus are typically 
limited to gross anatomical/structural and ventricular catheter placement assessments.  
 
In addition to initial diagnosis, hydrocephalus patients undergo serial neuroimaging for a wide 
range of indications, including assessment of response to treatment and workup for future 
treatment failures27. However, the conventional symptomatologic-radiologic approach to 
hydrocephalus often poses a diagnostic dilemma. The current metrics are neither sensitive nor 
specific, and they do not provide any information on the pathophysiology or natural history of the 
disease28.  
 
1.1.3 Global burden of hydrocephalus 
 
There is heterogeneity in the reported prevalence and incidence of hydrocephalus, often without 
reference to age or etiology29. The global prevalence of hydrocephalus is often estimated as 1 in 
500-1000 individuals2,30,31 with variations based on age, etiology, geography and economic 
strata1,7. We performed the first systematic review and metanalysis of population-based studies 
reporting prevalence of hydrocephalus in both pediatric and adult populations32. From a population 
of approximately 172 million extracted from 52 studies, we found that the overall global 
prevalence of hydrocephalus was 85 per 100 thousand [95% CI, 62-116]. The pooled prevalence 
of hydrocephalus in the pediatric population was 72 per 100 thousand [95% CI, 58-89] without, 
and 88 per 100 thousand [95% CI, 72-107] with spina bifida-associated hydrocephalus. The 
prevalence of pediatric hydrocephalus between continents was almost two-fold higher in Africa 
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(104 per 100 thousand [95% CI, 33-325]), compared to North America (56 per 100 thousand [95% 
CI, 41-75]) (Figure 1).  
 
Figure 1: Global prevalence of pediatric hydrocephalus.  
Assessment of the prevalence of pediatric hydrocephalus (HC)  with and without spina bifida (SB) 
stratified by continent shows majority of cases occur in continents with highest number of low-
income countries. 
 
To assess the incidence of pediatric hydrocephalus, we analyzed annual reports from the 
International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) database 
spanning the most recent 11 year period33. ICBDSR, a World Health Organization affiliate, 
collects data on birth defects including hydrocephalus and spina-bifida from 42 surveillance 
programs, spanning 36 countries. We identified that the mean annual incidence of pediatric 
hydrocephalus was 50 per 100 thousand [95% CI, 41-60] without and 81 per 100 thousand [95% 
CI, 69-96] with spina-bifida associated hydrocephalus. In addition, countries with a higher level 
of income were associated with a significantly lower mean incidence of hydrocephalus, 78 per 100 
thousand [95% CI 65-92], when compared to low- and middle-income countries combined, 106 
per100 thousand [95% CI, 76-148], p < 001 (Figure 2). 
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Figure 2: Incidence of pediatric hydrocephalus.  
The mean annual incidence of pediatric hydrocephalus (A) with or without spina bifida (SB) 
remained steady from 2003 to 2014. (B) Countries with low- to medium-income status had 
relatively higher annual incidences than those in the high-income stratum. 
 
Postnatally acquired hydrocephalus, including PIH and PHH, were not included in our 
hydrocephalus incidence analyses as those data are not reported to the ICBDSR. However, Dewan 
et al. performed a similar but limited systematic review on the incidence of pediatric hydrocephalus 
that included PIH and PHH populations34. Together, PIH and PHH represent the largest cause of 
infantile hydrocephalus worldwide with a majority of PIH cases in low- and middle-income 
countries34-37. As the largest single cause of childhood hydrocephalus and the need for neurological 
surgery in children worldwide, PIH afflicts 60%37 of the estimated 300,000 infants who develop 
hydrocephalus each year in low- to middle-income countries34. In sub-Saharan Africa alone, it is 
estimated that 1 in every 200 infants will develop PIH, resulting in >100,000 affected infants in 
that region each year38. On the other hand, PHH represents the most common cause of pediatric 
hydrocephalus in Europe and North America, affecting 1 in every 1000 newborns39,40. PHH occurs 
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in up to one half of infants who develop IVH39-41, the most frequent and severe neurological 
complication of preterm birth, occurring in nearly 20% of preterm infants42-44. PHH causes 
significant neurologic injury in patients. It is associated with some of the worst neurological 
outcomes in newborn medicine, with persisting cognitive deficits in >85% and cerebral palsy in 
70% of the affected infants41,42,44-46. Unfortunately, these alarmingly high reported global 
incidences of PIH and PHH are likely an underestimation because most affected infants, 
particularly in developing countries, die in early childhood without presenting to healthcare 
facilities; therefore they are omitted from neonatal mortality surveillance47.  
 
Hydrocephalus care results in a high financial burden for patients, their families, and healthcare 
infrastructure because of the diagnostic process, treatment, follow-up and long-term management. 
Inpatient care of pediatric hydrocephalus patients (predominantly PHH) is reported to cost 
approximately $2 billion per year in the United States alone48. While already substantial, this does 
not account for the considerable costs associated with out-of-hospital care48.  
 
1.2 Post-infectious hydrocephalus (PIH)  
 
PIH is a serious sequelae of neonatal sepsis and a major cause of morbidity with one million annual 
deaths worldwide36,47,49,50. The PIH phenotype is complex with brain calcifications, seizures, 
neurological injury and developmental impairments36, and a typical clinical picture of ventriculitis 
without prior meningitis (Figure 3).  
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Figure 3: Representative CT scans of post-infectious hydrocephalus.  
Axial images showing (A) the normal lateral ventricles (LV) in a healthy infant in comparison to 
(B & C) infants with post-infectious hydrocephalus who have severe ventriculomegaly with 
loculated abscesses (as indicated by the stars). 
 
PIH continues to be a major global health problem in spite of the recent clinical efforts to optimize 
treatment51. Strategies to prevent PIH have been thwarted for several reasons. First, there is a lack 
of identification of the key pathogens responsible for the underlying septic episodes that proceed 
to PIH. Moreover, the environmental factors that drive the incidences of PIH vary from one region 
to another12,52,53. For example, it is known that seasonal Neisseria meningitidis epidemics within 
the African meningitis belt can produce PIH54. However, there have been reports of a tendency 
toward gram negative coliform bacteria in infants in other Southern55 and Eastern12 African 
locations where Neisseria meningitidis is uncommon. Another major systemic problem impeding 
progress in the fight against PIH is the lack of diagnostic approaches. Whether lumbar puncture in 
infants, especially those without meningeal infection, could be a diagnostic tool during their 
neonatal sepsis evaluation is presently unknown. In addition, CSF cultures are difficult to employ 
due to limited armamentarium in low- and middle-income countries where PIH is most common38. 
Even in well-resourced regions where CSF analyses are readily available, the commonly tested 
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indices (e.g., glucose, protein, cell count and differential, and gram stain) are often not reliable in 
identifying an infection and cultures underappreciate the polymicrobial nature of PIH56. 
Alternatively, high throughput and unbiased pan-microbial approaches may be required to detect 
microbes in these complex PIH CSF samples, and to identify pathways toward more optimal 
treatment and prevention of the proximate neonatal infections. 
 
1.3 Post-hemorrhagic hydrocephalus (PHH)  
 
Infants who are born preterm (< 37 weeks gestational age) often sustain spontaneous intracranial 
hemorrhage within the germinal matrix44 which may extend into the cerebral ventricles to cause 
IVH 57,58. IVH, in premature infants, is classified into four grades of severity (grades I to IV)57,59 
(Figure 4). In grade I, the hemorrhage is restricted to the germinal matrix. The hemorrhage is 
considered to be grade II or III when it extends beyond the germinal matrix into the lateral 
ventricles and  covers less than 50% or greater than 50% of the ventricular volume with associated 
ventriculomegaly, respectively60,61. The severest form, grade IV, is defined as having the features 
of grade III in addition to intraparenchymal hemorrhage60,61. Grades III and IV are grouped into a 
“high grade IVH” category because they are associated with the most severe neuromotor and 
cognitive impairments of preterm birth62. In approximately half of the infants who develop high 
grade IVH, ventricular CSF dynamics are severely disrupted, which leads to the accumulation of 
CSF, raised intracranial pressures, and PHH2,42.  
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Figure 4: Representative cranial ultrasounds of intraventricular hemorrhage of prematurity.  
The coronal sections show (A) the appearance of normal lateral ventricles (LV) and temporal horn 
(TH) in a healthy infant in comparison to (B-D) preterm infants with IVH. (B) Grade I, (C) grade 
II and (D) grade IV. Hemorrhages are outlined or identified by stars. Scale bars = 1 cm. 
 
1.4 Current treatments of PIH and PHH 
 
Timely treatment of hydrocephalus, particularly for acute cases with raised ICP is critical because 
it is associated with progressive neurologic injury and high mortality rates ranging from 20 to 
87%30,31,45,63,64. With a primary goal of decreasing ventricular size, resolving raised ICP, mitigating 
patient symptoms and preventing further neurologic injury, the only effective treatment for 
hydrocephalus is surgical CSF diversion2. CSF diversion may be performed as a temporary or 
permanent intervention depending on the clinical indication51,65-68. Temporary procedures include 
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insertion of ventricular reservoirs or external ventricular drains69, which allow serial external CSF 
removal. However, the timing and volume of CSF removal are highly variable with little evidence-
based practice or guidelines. Patients who demonstrate a need for long term treatment typically 
undergo ventriculoperitoneal (VP)70,71 or ventriculoatrial (VA)72-74 shunt insertion, which divert 
CSF into the peritoneal cavity or right atrium of the heart, respectively74. Other extracranial 
compartments such as the lungs75 and gallbladder76, capable of absorbing CSF into systemic 
circulation may be used. 
 
Shunts have been the mainstay of hydrocephalus treatment for over 60 years77. However, their 
associated risks and complications remain unacceptably high, with 50% failing within the first two 
years of implantation71, subjecting patients to multiple revision surgeries and poor quality of life. 
An alternative approach to shunting is endoscopic third ventriculostomy (ETV), which establishes 
a CSF pathway between the ventricles and the subarachnoid space through a fenestration made in 
the floor of the third ventricle66,78,79. ETVs may be coupled with choroid plexus cauterization 
(CPC) to gain added benefits of decreasing CSF production and dampening the negative effects of 
choroid plexus pulsatility51,80-82. However, ETV with or without CPC have not been shown to be 
more efficacious than shunting51,83.  
 
Attempts at non-surgical treatment for hydrocephalus in humans have been unsuccessful, and there 
is no effective medical therapy yet84-88. Decorin, a transforming growth factor beta (TGF-β) 
inhibitor has been shown to prevent ventriculomegaly in rats with infantile communicating 
hydrocephalus89,90 and PHH91,92.  Magnesium sulfate has been shown to improve gait performance 
and lower reactive astrocytosis in hydrocephalic rats93. In rat models of congenital hydrocephalus, 
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intraperitoneal administration of minocycline reduced the markers of neuroinflammation and 
increased cortical mantle thickness94-96. Intraventricular infusion of nimodipine, a calcium channel 
antagonist has been shown to reduce white matter damage and improve sensorimotor function and 
spatial learning in juvenile hydrocephalic rats 97,98. However, all the pharmacologic agents tested 
to date have shown to be variable with limited short-term success, even in the animal models84-98, 
and none have translated into an efficacious human hydrocephalus treatment88. 
 
1.5 Current understanding of the pathophysiology of PIH/PHH 
 
Although significant positive strides have been made in the context of advances in infection 
control71,99, shunt hardware100,101, and surgical technique51,66,78-82,87,102-107, the outcomes of 
hydrocephalus remain dismal71. Unfortunately, hydrocephalus surgery early in life is largely 
palliative and at the time of diagnosis over 80% of the deleterious effects of hydrocephalus are 
already established and are irremediable. Therefore, the most significant global health impact on 
PIH and PHH will require directing efforts to defining disease pathophysiology to target both the 
underlying causes and mechanisms of neurological injury12,52,56. Characterizing the 
pathophysiology of PIH and PHH may also direct the discovery of biomarkers that will promote 
early identification and diagnosis, predict treatment efficacy, alert treatment failure in a timely 
fashion and facilitate the comparison of prevention strategies and treatment modalities in clinical 
trials. Furthermore, if PIH/PHH pathophysiology is better characterized and understood, emphasis 
could shift from palliation of CSF accumulation51 to prevention84,85,87.  
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1.5.1 Embryological overview of the cerebral ventricular system 
 
As mentioned above, characterization of the pathophysiology of PIH and PHH renders in the 
development of diagnosis, treatment and prevention strategies. Knowledge of the ventricular 
system, ependymal barrier, and choroid plexus, particularly in the context of the development of 
the central nervous system (CNS) is essential to understand the PIH and PHH pathophysiology.  
 
1.5.1.1 Ventricular development 
 
Human development originates from the three-layer primitive embryonic structure: ectoderm, 
mesoderm and endoderm. These are formed through purposeful cell movement and organization 
following fertilization108.  During neurulation, around the second week of embryonic development, 
the neural plate thickens and invaginates into a neural groove along its midline which then fuses 
into a rostro-caudal neural tube108,109. The neural tube momentarily remains in communication 
with the surrounding environment via its rostral (anterior) and caudal (posterior) neuropores, until 
they both eventually close off to form the ventricular system108 (Figure 5).  
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Figure 5: Embryological origins of ventricular development.  
During neurulation, the anterior and posterior neuropores close to isolate the ventricular system 
from its embryonic environment. Formation of the complex five-vesicle structure and differential 
expansion of regions around the neural tube flexures and the neural canal create the cerebral 
ventricles. 
  
Around the third week of embryonic development, the rostral end of the neural tube undergoes 
rapid morphogenetic movement and expansion to develop three symmetric primary swellings: the 
prosencephalon (forebrain), the mesencephalon (midbrain), and the rhombencephalon (hindbrain). 
This three-vesicle stage is facilitated by a symmetric folding of the neural tube rostrally along its 
lateral axis to form two flexures: the cephalic flexure which develops between the prosencephalon 
and mesencephalon, and the cervical flexure, which divides the rhombencephalon and the spinal 
cord108. Due to significantly restricted morphogenesis at the cephalic flexure in relation to the rest 
of the prosencephalon, two distinct structures develop: the rostral telencephalon and the caudal 
diencephalon. At approximately the sixth week, the pontine flexure develops to demarcate the 
rhombencephalon into the myelencephalon and the metencephalon. Thus, by the seventh week, 
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the three primary vesicles have developed into five secondary vesicles108, which are (from rostral 
to caudal): telencephalon (future cerebral hemispheres), diencephalon (future thalami, 
hypothalamic and optic cups) mesencephalon (future midbrain), metencephalon (future pons and 
cerebellum) and myelencephalon (future medulla oblongata)108 (Figure 5).  
 
Development of the ventricular system is a fascinating and clinically important topic in its own 
right and is integral to understanding the complexities of ventricular-associated pathologies, such 
as hydrocephalus. In the developed human brain, the ventricular system comprises of two lateral 
(telencephalic) ventricles that connect through the foramen of Monro to the third (diencephalic) 
ventricle, which in turn connects to the fourth (rhombencephalic) ventricle via the cerebral 
aqueduct. Although the ventricular system is continuous with the central canal of the spinal cord 
in development, and potentially thereafter, it communicates with the subarachnoid space through 
the foramen of Magendie and foramina of Lushka at the level of the pons. 
 
Embryonic ventricular development is heralded by the closure of the anterior and posterior 
neuropores, which are connected at the midline by a CSF-filled lumen lined by ependymal cells 
along the neural canal. Osmotic absorption of water by the cells lining the primitive ventricles and 
secretion of fluid into the ventricular cavity from the choroid plexus lead to physical forces during 
neural tube expansion. These forces and interactions mediate the development of the three-
dimensional ventricular structure from the primitive neural tube configuration. The segment of the 
neural canal that spans the telencephalon develops into the lateral ventricles. The lateral ventricles 
maintain a large inflated shape due to massive CSF production by the choroid plexus in those 
regions. The C-shaped configuration of the lateral ventricles occurs as a result of bilateral 
 17 
ventromedial expansion of the ganglionic eminence bilaterally108. During the sixth week of 
gestation, the initial slit-like communication between the diencephalon and bilateral telencephalon 
vesicles enlarges forming the foramen of Monro. While the cavity in the diencephalon forms the 
third ventricle, the cerebral aqueduct forms from the remnant of the neural canal at the level of the 
mesencephalon. The fourth ventricle develops from the splaying of the pontine flexure. Unlike the 
fourth ventricle, which enlarges during formation of the rostral neural tube structures, the cerebral 
aqueduct is relatively large during early embryological stages but later narrows. The remainder of 
the neural canal stretches inferiorly as the central canal of the spinal cord. Around weeks 10-12 
the lateral ventricles and the fornices are separated into the left and right by a thin membranous 
bridge; the septum pellucidum110. The septum pellucidum develops inextricably with the corpus 
callosum and the anterior and hippocampal commissures from the basal medial portion of the 
lamina terminalis known as the commissural plate110-112 (Figure 5). 
 
From a bulk flow perspective, CSF moves rostro-caudally from the lateral ventricles, propelled by 
the ependymal cilia, through the foramen of Monro into the third ventricle. It then moves through 
the cerebral aqueduct and enters the spinal subarachnoid space via the foramina of Luschka and 
Magendie. From the subarachnoid space, it has been traditionally thought that CSF is absorbed 
into systemic circulation exclusively at the arachnoid granulations113-116. However, other pathways 
including some cranial and dural routes113-116, and a glymphatic pathway117-121, have been recently 
described. The glymphatic pathway is a glia-based paravascular route for the clearance of soluble 




1.5.1.2 Ependymal layer development 
 
The inner perimeter of the cerebral ventricles is lined by the ependymal layer, a monolayer of 
multiciliated cuboidal to columnar epithelial cells122 held together near the apical surface by cell-
cell junctional proteins. Embryonically, the ependymal layer is derived from the ventricular zone 
(VZ), a single layer of monociliated neural stem cells (NSC) that populates the germinal matrix. 
The VZ and the subjacent sub-ventricular zone (SVZ) are also the primary sites of neurogenesis 
for the brain123. During fetal development, NSCs in the VZ migrate via radial glial cells123-126 to 
differentiate either into neurons of the cerebral cortex or glia127,128 (e.g., ependymal cells)127. The 
VZ spans the entire neural tube during neurulation. However, it is replaced by the ependymal layer 
as the brain matures, and stem cells are largely limited to specific areas of the SVZ. These stem 
cells retain restorative and repair capabilities; for example, they can regenerate neurons of the 
olfactory bulb and dentate gyrus via the rostral migratory stream129,130. One major role of the 
ependymal layer is to facilitate CSF flow through a highly coordinated beating of its apical cilia 
to move debris. Another major role is to serve as a protective barrier that shields the juxtaposed 
basal subependymal gray and white matter tissues from CSF toxins131. The predominant cell 
junction proteins that connect ependymal cells to maintain their structural integrity and function 
are adherens junctions (e.g., N-cadherin) and cell adhesion molecules (e.g., L1-CAM and NCAM-
1) (Figure 6). However, some gap junctional proteins, such as connexins132, and transitory 
expression of tight junctions during fetal development133 have been identified. However, the 
persistence of tight junctions in mature ependyma remains debatable. 
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Figure 6: Schematic representation of ependymal layer and choroid plexus.  
Mature multiciliated epithelial cells are structurally organized in a monolayer with intervening 
cell-cell adherens junctional proteins to form a partial CSF-brain barrier. The choroid plexus on 
the other hand comprises a monolayer of choroid plexus epithelial cells connected by tight 
junctions. 
 
1.5.1.3 Choroid plexus development 
 
As development of the neural tube progresses, a shallow sulcus limitans at the caudal end 
demarcates the roof and alar plates from the floor and basal plates. Further differentiation of non-
neural tissue at the roof plate forms the highly vascularized choroid plexus that is found within 
each cerebral ventricle134. After neural tube closure, the choroid plexus appears first in the fourth 
ventricle, followed by the lateral ventricles synchronously, and lastly by the third ventricle135. 
Despite their distinct appearance, the choroid plexuses in the lateral ventricles merge at the exit 
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levels of foramina of Monro and fuse with the third ventricle plexus to form a continuous choroid 
plexus structure135-137. The many functions of the choroid plexus, such as CSF secretion135,138, 
solute transport139, and immune system regulation140, have been extensively described in the 
literature. Histologically, the choroid plexus comprises a network of connective tissues and 
fenestrated capillaries, surrounded by cuboidal epithelial cells that are held together by tight and 
adherens junctions to form the blood-CSF barrier. A wide range of transporters, including 
aquaporins, Na+-K+-ATPase, Cl--HCO3, Na+-K+-Cl- and glucose transporter 1 have been identified 
as facilitators of the choroid plexus’ CSF production mechanism141. 
 
1.5.2 Hydrodynamic and pulsatility concepts of hydrocephalus  
 
The traditional pathophysiological perspective on hydrocephalus considers impairment of CSF 
flow dynamics, i.e. CSF overproduction and/or impaired uptake as the primary mechanisms1,142,143. 
CSF overproduction has been mainly attributed to hypersecretion due to alterations in choroid 
plexus physiology144-147. In an Escherichia coli acute septic ventriculitis mouse model, Cardia et 
al. reported ultrastructural changes of the choroid plexus epithelium that led to CSF overproduction 
and PIH144. In an experimental obstructive hydrocephalus model, Karimy et al. demonstrated that 
hydrocephalus was propagated by neuroinflammation-induced choroid plexus hypersecretion145. 
In terms of CSF absorption impairment, the main theory is that CSF egress pathways, such as the 
cerebral aqueduct and arachnoid granulations undergo gliosis and scarring that impair CSF flow 
leading to CSF accumulation within the ventricles121.  
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Once hydrocephalus is established, there are progressive effects on the biomechanical properties 
of the brain. Di Rocco et al. demonstrated that ventricular dilation is likely propagated by abnormal 
intracranial pulsatility148, which may be attributed to an increased cerebral capillary pulsatility 
and/or the loss of an endogenous vascular dampening mechanism149-152. Increased capillary 
pulsatility in hydrocephalus may have several pathophysiologic consequences, including the loss 
of parenchymal microvessels153-156 and compromise of the blood-brain barrier157-159. Both of these 
effects might explain the marked loss of cerebral perfusion that has been well documented in 
clinical160-162 and experimental163-165 hydrocephalus. Importantly, it has been shown that excessive 
pulsatile stress can impair hemodynamics through changes in endothelial cell homeostasis166 
mediated by nitric oxide167,168. These examples all provide a compelling case for the importance 
of CSF pulsatility in the pathogenesis of hydrocephalus.  
 
As additional details of the biological mechanisms of CSF hydrodynamics and pulsatility emerge, 
pharmacological targeting of these systems may be utilized to modulate CSF physiology in PIH 
and PHH. Nevertheless, imbalances in CSF flow are only a part of a much more complex 
pathophysiology of hydrocephalus. Indeed, recent experimental169-178 and clinical studies169,179-183 
have confirmed the pathophysiology of hydrocephalus is multifactorial, encompassing a complex 
interplay between neuroinflammation, edema, reactive gliosis, perturbations of the neurogenic 
niche and other neurodevelopmental processes, distortion of brain parenchyma, cerebral hypoxia 





1.5.3 Phenotypic similarities between PIH and PHH 
 
For the purposes of this work, it is critical to note that PIH and PHH have very similar features 
suggesting they may share common pathophysiological mechanisms. Clinically, the signs and 
symptoms associated with PIH and PHH after their respective antecedent event are 
indistinguishable. Radiologically, PIH and PHH are both classified as communicating 
hydrocephalus with features of diffuse grey and white matter injury, such as T2-weighted 
hyperintensities indicating tissue disruption191,192, susceptibility weighted imaging evidence of 
petechial hemorrhages193-195, restricted diffusion representing tissue ischemia193-195, and disrupted 
white matter water diffusivities on diffusion MRI (dMRI) suggesting PVWM damage. On gross 
pathology and histology, both PIH and PHH are characterized by many features of inflammation 
and basal cisterns fibrosis36,85-87,190,196,197. Interestingly, based on the many phenotypic similarities 
between PIH and PHH, a recent review by Karimy et al. classified them collectively as an 
“inflammatory hydrocephalus” subtype198. This is critical because the commonalities suggest that 
in response to the antecedent neonatal sepsis or hemorrhage, neuroinflammation pathways are 
activated to mediate similar patterns of brain injury seen in both PIH and PHH86,87,190,197. 
Furthermore, it is also possible that host-mediated neuroinflammation causes diffuse brain scarring 
and obstruction of CSF pathways, which results in hydrocephalus. 
 
1.5.4 Role of neuroinflammation in PIH/PHH pathogenesis 
 
Neuroinflammation, the host immune response to cues that threaten nervous tissue integrity, is a 
consistent finding in many forms of hydrocephalus and likely underlies the chronic problems that 
plague hydrocephalic patients due to glial scar formation199.  
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In PIH, the role of neuroinflammation may be well-defined in the case of a systemic infection. 
Typically, once a pathogen breaches a host’s epithelial barriers, innate immune mechanisms 
eliminate the microbe. Sepsis, a systemic inflammatory response, occurs when the pathogen is not 
effectively eliminated. With a persistent pathogenic material, multiple pathways including the 
Toll-like receptor (TLR)200, Janus kinase/signal transducers and activators of transcription 
(JAK/STAT)201,202 and NF-κB/TREM-1 signaling203 pathways are activated elevating 
inflammation. Systemic inflammation typically makes the blood-brain barrier permeable to 
microbes and other systemic inflammatory mediators that traverse into the subarachnoid space. 
This leads to the activation of neuroinflammatory cascades, production of nitric oxide metabolites, 
hypoxia, and decreased glucose metabolism in the brain and CSF204-206 culminating in brain injury 
and subsequent PIH.  
 
In PHH, the presence of blood and blood products in the CSF initiates TLR2 and complement 
activation resulting in a release of cytokines (e.g., interleukins (IL) and tumor necrosis factors 
(TNF)) and chemokines (e.g., Chemokines C-C (CCL) and C-X-C (CXCL)) that culminate in 
ependymal gliosis, arachnoiditis, and fibrotic blockage of CSF pathways to cause 
hydrocephalus85,196.  Our group recently showed that the CSF of PHH infants contains significantly 
higher levels of IL-1α, IL-4, IL-6, IL-12, TNF-α, CCL-3, CCL-19, and CXCL-10 compared to 
healthy control infants207. Several other investigators have utilized targeted assays to demonstrate 
strong associations between PHH and CSF inflammatory markers199,208-210.  
 
Therefore, it is important to characterize the nature of the host-immune response in PIH and PHH 
to understand the pathophysiology. This will allow us not only to address PIH and PHH as the 
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most prevalent variants of hydrocephalus, but also to gain further insights into other forms of 
hydrocephalus. 
 
1.5.5 Effect of PIH and PHH on neurodevelopment 
 
In humans, VZ/SVZ differentiation to form the ependymal layer continues into the third trimester 
and newborn period211. During these critical periods, any perturbations in the VZ/SVZ, particularly 
by IVH or infection, can have deleterious effects on brain development and CSF physiology. 
McAllister et al. reported that VZ/SVZ disruption is a key feature of IVH in preterm human 
infants197 and is characterized by alterations in NSCs, VZ/SVZ cell loss, neuroepithelial injury, 
and gliosis in the affected areas. Blood and blood products, including iron, have also been shown 
to elicit similar effects on neurogenesis in experimental models85,212-214. Yung and colleagues 
reported that lysophosphatidic acid (LPA), a blood component that also plays a major role in 
neurogenesis, neuronal differentiation, and apoptosis of neural progenitor cells, consistently 
causes hydrocephalus when injected into the lateral ventricles of fetal mice214. LPA induction of 
hydrocephalus depends strongly on expression of the LPA1 receptor by neural progenitor cells in 
the VZ. Increased levels of LPA promotes the transfer of Yes-associated protein (Yap), a 
transcriptional regulator involved in the maturation of ependymal cells, from the cytoplasm to the 
nucleus in VZ cells. Nuclear Yap is associated with agenesis of ependymal cells leading to VZ 
disruption and hydrocephalus215. VZ disruption in the pathogenesis of other forms of 
hydrocephalus has been demonstrated by a series of studies on mice with genetic defects171,175-
177,216-220.  
Accumulating evidence suggests that the VZ/SVZ disruption and loss of NSCs in many forms of 
hydrocephalus likely results from disruption of cell junctional proteins. For example, in congenital 
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hydrocephalus, mutations in genes encoding proteins involved in intracellular trafficking and cell 
junctional complexes have been identified169,172,176,215,221-224. In addition, many forms of human 
congenital hydrocephalus result from genetic alterations of cellular adhesion proteins such as N-
cadherin, connexin, and L1CAM169. A series of studies on hydrocephalus with hop gait (hyh) 
mice175,177,216-219, which develop perinatal aqueductal stenosis also support the presence of a 
genetic defect in cell junction complexes as an underlying cause of hydrocephalus. Furthermore, 
impairment of cell-cell junctional complexes has been implicated in the subcommissural organ 
alterations that lead to aqueductal stenosis170,225,226.  
 
ADAM10, a metalloprotease, cleaves a wide range of cell-cell junctional proteins and regulates 
cell-cell interaction227. For example, hyperactivity of ADAM10 induces disruption of lung 
epithelial cells through the loss of cadherin-dependent junctions228. Preliminary results from in 
vitro approaches (described in Chapter 4) provide strong support for a potential mechanistic role 
of ADAM10 in the VZ/SVZ disruption observed consistently in PIH and PHH. It is quite possible 
that cleavage of adherens junction proteins such as N-cadherin by ADAM10 could create 
downstream effects on the neurogenic niche, such as ependymal denudation, eruption of neural 
precursors into the CSF, and formation of heterotopia. However, whether this disruption stimulates 
further inflammatory responses from astrocytes and microglia is another key question to be 
answered. Overall, there is a critical association between genetic susceptibility, cell-cell junction 
regulatory molecules, and hydrocephalus; therefore, setting the stage for exploring therapies that 
can mitigate these processes.  
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1.5.6 Periventricular white matter (PVWM) injury in PIH/PHH 
 
One of the major effects of hydrocephalus is PVWM disruption. This disruption often presents as 
T2 hyperintensities on MRI, and is histologically characterized by rarefactions, edema, 
astrogliosis, dysmyelination, hemosiderin-laded macrophages, and decreased neurofilament 
proteins175,178,197,229,230. Anatomically, the VZ/SVZ layer is juxtaposed by a thin layer of white 
matter fibers medial to large bundles of PVWM tracts such as the corpus callosum, internal capsule 
and optic radiations. When the VZ/SVZ and immediate PVWM fibers, a region we have 
collectively termed as the lateral ventricular perimeter (LVP)231, are disrupted by 
hydrocephalus232,233, the larger bundle of PVWM tracts, which carries ascending and descending 
motor and sensory fibers, is at risk of injury by CSF toxins and neuroinflammation234. 
Hydrocephalus-related PVWM injury has been associated with neuromotor and cognitive 
developmental deficits in children131,187,235-239 and have been implicated in most of the debilitating 
neurological symptoms in affected infants240-242. Because the LVP can also be damaged by the 
expanding ventricles, PVWM tracts remain chronically vulnerable throughout the entire period of 
progressive hydrocephalus. Therefore, characterization of the LVP and large bundle PVWM tracts 
is indispensable for understanding PIH and PHH pathophysiology in addition to providing insights 
on the relationships between LVP injury and PVWM-related neurological function. 
 
1.6 Proposed strategies 
 
While important strides have been made in defining the pathophysiology of hydrocephalus, there 
remain unanswered questions in the field of PIH and PHH pathophysiology. Expert panelists at 
hydrocephalus research workshops coordinated by the National Institute of Health (NIH) have 
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outlined some of the significant gaps in hydrocephalus studies applicable to PIH and PHH 
research87,102. For example, how does ventriculitis or IVH cause CSF dysregulation? And what 
genetic mechanisms or pathology-induced epigenetic changes occur in the subset of patients who 
progress to develop PIH or PHH? Secondly, what are the reversible and irreversible cellular 
responses to inflammation and mechanical distortion by ventriculomegaly? Thirdly, which 
biomarkers are most useful for the diagnosis, prognosis, and monitoring of PIH and PHH infants? 
And can those biomarkers be used to predict hydrocephalus before it develops? Lastly, perhaps 
more importantly, what pharmacologic strategies might be effective in reducing the myriad of 
pathophysiologic changes or preventing the development of PIH and PHH?  
 
To address some of these questions, this dissertation utilizes genomics, proteomics, 
proteogenomics, dMRI, neurocytology and animal models as complementary approaches to 
characterize the pathophysiology of PIH and PHH and to examine potential therapeutic targets.  
 
1.6.1 CSF genomics and proteomics 
 
The molecular composition of CSF reflects the physiological status of the neural structures it 
bathes making it an indispensable medium for assessing changes that occur in the brain and for 
identifying genetic and proteomic footprints of disease pathogenesis. CSF also harbors molecular 
components necessary for neurodevelopment, neuromodulation and neurotransmission which may 
also be altered by pathological processes. In hydrocephalus, the initial injury, raised ICP, and 
ventricular stretch are all capable of initiating injurious cascades that can disrupt the CSF micro- 
and macro-environment39,87,102,185,187,189. Thus, the importance of CSF analyses in hydrocephalus 
cannot be overstated142,143,207,243-249. 
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There are several approaches to CSF analysis, including those done routinely to measure levels of 
clinical metabolites250,251 and targeted assays238,245-247,249,252,253 such as enzyme-linked 
immunosorbent assays (ELISAs) and western blots. While routine biochemical analyses and 
targeted assays are informative, they both have inherent limitations, such as lack of sensitivity and 
specificity, that preclude their utility for characterizing the multifactorial pathophysiology of and 
differentiating between PIH and PHH. We recently performed a retrospective review of the routine 
clinical lab CSF results of a cohort of 176 infants with CNS infections, IVH/PHH infants without 
infection, and controls with no known neurological injury. We found that the CSF profile of non-
infected PHH infants is indistinguishable from that of infants with bacterial CNS infections. Both 
conditions presented with higher leukocyte counts, higher protein but lower glucose concentrations 
relative to healthy controls. Recently, the use of targeted assays to analyze CSF in hydrocephalus 
has gained momentum. Morales et. al. utilized ELISAs to analyze CSF samples obtained from 
preterm IVH infants and control infants246. They reported an increase in amyloid precursor proteins 
(APP) and APP-related peptides in PHH246,249 and a correlation between ventricular size reduction 
and reduced levels of those markers245. Mounting evidence suggests that APP and its isoforms are 
associated with neurodevelopment and synaptogenesis254-256, and their disruption invariably leads 
to axonal injury257-259. As such, the elevated levels of APP and its isoforms in PHH may be 
attributed to a cascade of axonal disruption caused by the inciting hemorrhagic insult and the 
ventricular distension238,252. Presumably the reduction of APP levels following resolution of 
ventriculomegaly245 signals a reversal of the pathologic process. CSF targeted assays have also 
shown that infants with PHH have alterations in cell junction molecules including L1CAM, 
NCAM-1 and N-cadherin247,253. Despite their utility, targeted assays require a priori knowledge of 
which molecules to investigate, thus only permitting the isolation of a limited number of proteins 
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instead of exploring the large CSF proteome of hydrocephalus207,245,246. These limitations 
necessitate the need for using high throughput discovery-based strategies such as genomics and 
proteomics to comprehensively define the molecular hallmarks of PIH and PHH pathophysiology. 
 
A fundamental question in understanding any disease is the relationship between gene expression 
and biological function. Large scale genomic studies have already provided some insights into the 
role of genetics, especially those related to neurodevelopment in congenital hydrocephalus7,15. 
Harnessing this genomic approach, Schiff and colleagues’ recent work involving Sub-Saharan 
African infants with neonatal sepsis12,56 has offered evidence that genomics can be utilized to 
define PIH and PHH pathophysiology. However, the literature search did not reveal any studies to 
date that have used genomics to characterize the effect of hemorrhage, infection or PIH/PHH on 
the CSF genomic profile of infants.  
 
On the other hand, CSF proteomics has been utilized, mostly by our group, to explore candidate 
protein biomarkers of hydrocephalus247. These biomarkers were subsequently examined with 
targeted assays to outline their clinical implications as they pertain to ventricular size and 
intracranial pressure245. Using tandem mass tagging (TMT)-10 proteomics, Morales et al. 
identified over 400 human CSF proteins involved with various neurodevelopmental processes 
including cell adhesion molecules, synaptogenesis, extracellular matrix and oxidative 
metabolism247. However, these experiments were performed in a small cross-sectional cohort of 
PHH infants and such level of detailed analysis has not yet been applied to PIH.  
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1.6.2 Proteogenomics  
 
Proteomics and genomics are important strategies for defining the pathophysiology of disease and 
identifying biomarkers, individual genes, sets of genes and biologically functional proteins. 
However, these approaches in isolation cannot comprehensively explain the clinical phenotype of 
a disease260. Rather, disease pathogenesis involves the combinatorial interaction of regulatory 
elements within the proteome, transcriptome, and other environmental factors261. Proteogenomics 
is an emerging field that integrates deep-scale proteomics with next-generation genomic and 
transcriptomic data to define network and pathway level linkages to probe molecular mechanisms 
of disease262. Proteogenomic findings inform functional studies that lead to detailed insights into 
the biology of disease and, ultimately, new therapeutic approaches and novel drugs. The nucleotide 
sequencing data obtained from a proteogenomic study can be used to improve protein 
identification through comprehensive protein sequence database construction. Proteomic data can 
also be used to demonstrate the validity and functional relevance of novel findings based on large 
scale RNA-seq and novel coding transcripts262.  
 
Following proteogenomic integration, gene set enrichment analysis (GSEA) can be utilized to 
perform signaling pathway analyses on proteogenomic data to identify dynamic interactions 
among genes263-265. In GSEA, differentially expressed proteogenomes are layered atop knowledge-
based physical or biochemical interaction scaffold networks265. In PIH and PHH, these functional 
analyses can be carried out by ranking differentially expressed genes to calculate a score that 
reflects the degree to which a given pathway is represented at the extremes of the entire ranked 
list265. The significance of the gene set scores can be determined by using permutations of the 
samples266. It is important to note that like other existing pathways analyses, GSEA focuses on the 
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number of differentially expressed genes observed in a given pathway, but it is unable to either 
address topology or assess the impact of perturbations on gene-gene interactions. To address these 
important limitations, signaling pathway impact analysis (SPIA)267 may be used. SPIAs permit the 
calculation of a global pathway significance p value, which factors a perturbation p-value into the 
GSEA p-values to limit data noise in signaling pathways and increase their sensitivity and 
specificity to the pathology of interest. To identify interactions beyond direct protein-protein 
binding, differentially expressed genes in PIH and PHH can also be entered into the search tool 
for the retrieval of interacting genes/proteins (STRING) database to capture functional links, such 
as substrates that connect PIH/PHH-related proteins in a metabolic pathway or proteins that are 
involved in large multi-protein assemblies268.  
 
1.6.3 Diffusion magnetic resonance imaging (dMRI) 
 
CSF perturbations due to an infection or hemorrhage invariably culminate in brain injury. This 
injury can be seen on conventional MRI as global changes in grey and white matter, including 
loculations, calcifications, necrosis and infarcts. However, conventional MRI is unable to examine 
pathophysiologic, microstructural changes of brain tissue. In contrast, dMRI is capable of 
delineating white matter integrity by assessing the magnitude and directionality of water molecules 
within tissues269-271 to inform microstructure and detect aberrations in white matter tissues that 





1.6.3.1 Diffusion tensor imaging (DTI) 
 
Diffusion tensor imaging (DTI) is a commonly used dMRI technique, with many clinical and 
experimental applications. Standard DTI measures include: fractional anisotropy (FA), which 
quantifies water diffusion anisotropy; axial diffusivity (AD), which assesses the rate of water 
diffusion parallel to the direction of axons; radial diffusivity (RD), which assesses the rate of water 
diffusion orthogonal to the direction of axons; and mean diffusivity (MD), which is an average of 
AD and RD270,271,273. With FA, AD, RD and MD measurements, DTI can determine PVWM 
integrity 271,273,274 and structural changes associated with hydrocephalus through its imaging of the 
orientation-independent magnitude of water diffusion. DTI has been widely used to assess PVWM 
integrity in hydrocephalus238,239,270,271,273,275-287 which has been shown to correlate with 
neurodevelopmental outcomes in hydrocephalic children238,276,284,287,288. For example, Mangano et 
al. showed that motor scores negatively correlated with MD scores in the internal capsule of 
hydrocephalic patients, who also had significantly lower conceptual, practical, and social ABAS-
II composite scores than healthy controls284. Higher diffusivity values in the corpus callosum have 
also been associated with poor psychomotor development index scores at approximately two years 
following hydrocephalus diagnosis289.  
 
DTI measures have been shown to improve or normalize following shunt surgery284,287,290,291. For 
example, we recently reported a reduction in internal capsule and corpus callosum MD indices in 
PHH and congenital hydrocephalus infants to levels similar to controls following 15 months of 
shunt surgery for hydrocephalus treatment292. Tan et al. demonstrated that higher FA measures 
correlated with better clinical outcomes as assessed by the Headache Disability Inventory and the 
Hydrocephalus Outcome Questionnaire among 21 adolescent and young adult patients who had 
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been previously treated for hydrocephalus293. While these pieces of evidence suggest that serial 
DTI may have both diagnostic and prognostic value294, there is an ongoing debate regarding the 
utility of DTI as a clinical tool for managing hydrocephalus in patients. This is because of the 
complete reliance on conventional high-resolution multi-sequence MRIs, which require long 
acquisition times up to 60 minutes per scan. However, we recently developed a fast brain MRI 
protocol that has an average entire brain acquisition time of approximately six minutes, from which 
MD can be calculated. With our protocol, the diffusion tensor is computed by averaging the 
diffusion measurement in three axial directions derived from the conservation of the trace of the 
diffusion tensor under rotational transforms. We tested the feasibility of this protocol in 40 infants 
with PHH or congenital hydrocephalus alongside healthy controls. The results demonstrated that 
fast brain MRIs can be extended beyond anatomical assessments to evaluate the integrity of 
PVWM in pediatric hydrocephalus patients, limiting the need for sedation for dMRI analyses292.  
 
Despite its utility and many advantages, DTI has inherent limitations that make it challenging to 
delineate white matter pathology with adequate sensitivity and specificity295-297. For example, DTI 
is not capable of resolving crossing fibers296,298,299 or quantifying axonal density299,300.This is in 
part because DTI utilizes a single tensor model in which the white matter fibers in a voxel are 
represented as a single population, despite the fact that 60%-90% of white matter voxels contain a 
more complex configuration of white matter fibers, including crossing fibers. Secondly, in multi-
faceted white matter pathologies such as PIH and PHH, each voxel may contain water populations 
representing myelinated, dysmyelinated or unmyelinated axons. Moreover, DTI has been shown 
to lack the sensitivity to quantify myelination under similar circumstances299,300. Furthermore, 
neuroinflammation, which is a major pathophysiology in PIH and PHH, leads to multiple water 
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compartments, including varying cell densities and morphologies due to reactive astrogliosis, 
edema, and axonal loss207,208,230. There are alternative dMRI approaches296,297,301-308, such as 
diffusion basis spectrum imaging (DBSI)307-312, that can address some of DTI’s limitations; 
however, they have yet to be utilized for PIH, PHH or other forms of hydrocephalus.  
 
1.6.3.2 Diffusion basis spectrum imaging (DBSI) 
 
Diffusion basis spectrum imaging (DBSI) is a relatively new dMRI technique best suited for 
examining complex multicompartmental cellular processes in the white matter. Unlike DTI, water 
displacements in DBSI are represented as multiple diffusion tensors each representing different 
water compartments. This allows separation of crossing fibers and estimation of crossing angles, 
directional diffusivity of individual crossing fibers, and axonal loss307-313. In addition to anisotropic 
diffusion compartments, DBSI includes isotropic tensors, which reflect water compartments in 
inflammatory cells and edema water307,311,313. DBSI has been validated in clinical308-311 and 
preclinical/phantom studies307,309,314-316 of multiple sclerosis307-309,311,314, epilepsy315, spinal cord 
injury317, and cervical spondylotic myelopathy310. The extended capabilities of DBSI suggest that 
it may provide more informative biomarkers than DTI for the differentiation and quantification of 
PVWM integrity in hydrocephalus. There are several benefits of utilizing DBSI for the assessment 
of hydrocephalus-related PVWM injury. First, DBSI may provide parameters that more directly 
reflect underlying tissue microstructural changes. Second, DBSI may provide an opportunity to 
comprehensively investigate complex aspects of structural brain development in hydrocephalus 
and track their association with neurodevelopmental outcome. Third, DBSI may be used to 
delineate the relationship between ventricular volume, which is readily modified with current 
standard-of-care neurosurgical hydrocephalus treatments, and therapeutic response following 
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surgical treatment of hydrocephalus. Lastly, DBSI may be used to inform clinical trials that assess 




Immunohistochemistry is perhaps the most definitive modality for assessing the effects of 
hydrocephalus on brain microstructure. General cellular structure is often assessed with 
hematoxylin and eosin (H&E) stains. With a focus on neurodevelopment, neuroinflammation and 
PVWM injury, single- and double-labeling immunohistochemistry with antibodies specific to cell 
adhesion molecules, neural stem cells, ependymal cells, and glial activity are valuable tools that 
can be leveraged to evaluate the effects of PIH/PHH on these processes.  For example, anti-βIV 
tubulin can be used to evaluate multiciliated ependymal cells and undifferentiated monociliated 
cells, anti-N-cadherin for adherens junctions, anti-ADAM10 for metalloprotease activity, anti-
GFAP for immature ependymal cells and reactive astrocytes, and anti-Iba1 as a surrogate for 
microglia-related products. Following staining, epifluorescence or confocal microscopy are 
commonly used to visually examine cellular structure. VZ/SVZ damage are histologically 
characterized by disrupted adherens junctions, reduced number of multiciliated (mature) 
ependymal cells, radial glial cell disorganization, astrocytic proliferation, and ependymal rosette 
formation142,197. PVWM damage is typically observed as rarefactions, edema, astrocytosis, gliosis, 
dysmyelination, hemosiderin-laden macrophages, and decreased neurofilament proteins197,230,242. 
Our group recently developed an in-house script that utilizes ImageJⓇ to quantify the numbers, 
length, area, volume, intensity, shape, and texture of cells318. Immunohistochemistry can also be 
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utilized to assess the brain regions of interests across species (i.e., humans vs. experimental 
models). 
 
1.6.5 Experimental models of hydrocephalus 
 
Animal models offer an environment that is amenable to manipulations of biological, cellular, and 
physiological processes to best understand the mechanisms of pathogenesis in human diseases and 
trial therapeutic strategies87,102. In vitro models, which involve the isolation and cultivation of cells 
or organ systems in specially formulated media provide micro-environments that can be precisely 
controlled to focus on mechanisms of action in disease pathogenesis. To date, only a few studies 
have utilized tissue cultures to investigate cellular processes involved in hydrocephalus. For 
example, Smith et al. utilized tissue culture chambers to examine the effects of increased pressure 
and to potentially slow stretch on ependymal and glial cells319. Other groups have examined 
explanted shunt catheters in tissue culture media to assess growth as well as specific responses to 
compression, stretch, and hypoxia. In several studies, Harris et al. have utilized a bioreactor to 
demonstrate the immediate deposition of protein biofilms that form a substrate for macrophage 
and glial cell attachment and provided evidence for cell surface modifications that reduce cell 
adhesion on silicone catheters320-324.  
 
A major drawback of tissue culture systems is that they cannot mimic all the physiologic conditions 
of living organisms, necessitating the need for in vivo models. There is currently a plethora of in 
vivo models of several forms of hydrocephalus. Mouse knockout models such as the hydrocephalus 
with hop gait (hyh)176,216,217,219, hydrocephalus-3 (hy3)325-327, those with ciliopathies328-336 and mice 
with mutations in SUMS/NP 337,338, TGF-β1339-341, FGF-2342,343, L1-CAM344,345, Rnd-3346, and 
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AQP-4 347,348 have provided valuable insights into the genetic basis of congenital 
hydrocephalus15,338,349-351. In rats, the H-Tx352-356 and LEW/Jms357-360 models, which develop 
aqueductal stenosis, have been widely used to investigate the pathophysiology of obstructive 
hydrocephalus and, recently, to explore VZ/SVZ disruption, and the potential to transplant 
neurospheres for replacement therapy169,170,361,362. Acquired hydrocephalus models on the other 
hand, have mostly been achieved by an intraventricular injection of the substances depending on 
the variant of hydrocephalus of interest. The most popular injected substance is kaolin. The inert 
silicate is injected into the cisterna magna or the basal cisterns, to induce obstructive and 
communicating hydrocephalus, respectively151,363-369.  
 
The vast majority of the existing animal models of hydrocephalus are mice370,371 and rats84,372,373, 
likely because of their reduced costs, ease of handling and availability of transgenic 
models133,170,220,359,374,375. However, these small animals are phylogenetically less advanced, 
usually develop severe ventriculomegaly rapidly and have a limited life span. Additionally, their 
lissencephalic cerebral cortex often presents challenges when translating research results to 
humans376. Recently, there has been an increasing focus on animals with gyrencephalic brains such 
as ferrets, dogs, sheep and piglets377-380 since they are more similar to human brains. 
 
In PHH models, IVH has historically been induced with intraventricular injections of blood (whole 
or lysed) and blood products such as hemoglobin, iron and LPA85,212,213,223,242,372,381,382. 
Ventriculomegaly in IVH models is believed to be related to mechanisms of neuroinflammation 
and damage to the VZ/SVZ. However, it is worth noting that up to 50% of control animals, 
typically injected with PBS intraventricularly, develop ventriculomegaly suggesting that the 
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intraventricular injection itself can produce collateral tissue damage91,383. Other studies have 
induced IVH and PHH via intraperitoneal injection of glycerol384, hemodynamic dysregulation and 
asphyxia378,385 and endovascular perforation of subarachnoid vessels386 with limited success.  
 
In terms of CNS infections, there is extensive knowledge and documentation on several animal 
models387-391. However, the majority of these experiments were designed to study the virulence of 
pathogens, passive immunization and the efficacy of antimicrobial therapy392-395; and none have 
focused on PIH. A PIH model may be induced through inoculation of live bacteria or bacterial 
toxins via several routes including intraperitoneal, intranasal, oral and intraventricular387-389,391-
393,396-398. However, achieving meningitis/ventriculitis from bacteremia in animals is extremely 
challenging and is associated with unacceptably high risks of mortality from septic shock and 
multi-organ failure. Alternatively, direct intraventricular injection of toxins to cause ventriculitis 
may be more feasible, with the caveat that it bypasses the primary routes of human neonatal 
sepsis397,399-401. 
 




With the long-term goal to improve patient outcomes by identifying targetable pathways to prevent 
the development of PIH and PHH, this dissertation leverages a complementary, yet comprehensive 
scientific approach that encompasses: 1) High throughput discovery-based analyses of human 
infant CSF to identify differentially expressed genes and proteins in PIH and PHH; 2) 
Proteogenomic integration of proteomic and transcriptomic data to define network and pathway 
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level linkages to probe molecular mechanisms underlying PIH and PHH; 3) Characterization of 
the effects of hydrocephalus on the VZ, SVZ and PVWM using dMRI modalities that complement 
human hydrocephalus neurocytology; 4) Generation of experimental models of hydrocephalus to 
mimic the human condition and characterize hydrocephalus-associated neurobiology; and 5) 
examine the role of metalloprotease inhibition as a therapeutic strategy for abrogating PIH and 
PHH pathology.  
 
1.7.2 Central hypothesis 
 
We hypothesized that VZ/SVZ disruption in PIH and PHH is caused by ADAM10-mediated N-
cadherin cleavage. CSF protein profiling from PIH and PHH infants will demonstrate alterations 
in gene-activated pathways in immune-response, cell-cell junction adhesion, and 
neurodevelopment-neural injury. Pharmacologic inhibition of ADAM10 will represent a viable 
therapeutic approach to preventing these disabling diseases.  
 
1.7.3 Specific Aims 
 
1.7.3.1 Specific Aim 1 
 
Determine the gene-pathway alterations that are common and unique to PIH and PHH.  
Working hypothesis: Expressomes and specific pathways define the immune responses and 
dysregulation of neurodevelopmental mechanisms in PIH and PHH  
Sub Aim 1: Quantify the PIH and PHH CSF expressome using high throughput mass spectrometry 
(MS)/MS proteomics and RNA-seq transcriptomics 
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Sub Aim 2: Identify differentially expressed genes and proteins in the CSF of human PIH and 
PHH infants using deep scale proteomics and define activated pathways relative to controls 
 
1.7.3.2 Specific Aim 2 
 
Define PIH and PHH related microstructural VZ and PVWM injury in human infants using 
advanced dMRI and immunohistochemistry. 
Working hypothesis: VZ histopathology and abnormal diffusion metrics are associated with 
neuroinflammation in the PVWM of PIH/PHH human infants 
Sub Aim 1: Quantify VZ and PVWM diffusion properties in PHH infants and age-matched control 
infants with dMRI. 
Sub Aim 2: Determine the relationships between immune-associated PVWM microstructural 
histopathology and VZ disruption in human PIH/PHH postmortem tissues using 
immunohistochemistry 
 
1.7.3.3 Specific Aim 3 
 
Evaluate N-cadherin expression as a marker of ADAM10 activity and VZ disruption in vitro and 
examine the effect of ADAM-10 modulation on N-cadherin expression.  
Working hypothesis: In vitro ADAM10-mediated cleavage of N-cadherin is associated with VZ 
disruption, and pharmacological inhibition of ADAM10 will ameliorate VZ disruption 
Approach: Quantify N-cadherin disruption in vitro by exposing VZ cells to alpha-toxin (PIH) or 
whole blood (PHH). Then determine if treatment with the ADAM10 inhibitor G1254023X will 
preserve N-cadherin expression 
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1.7.3.4 Specific Aim 4 
 
Evaluate hydrocephalus associated VZ disruption and PVWM injury in vivo using PIH mouse and 
PHH ferret models. 
Working hypothesis: N-cadherin is associated with VZ disruption and PVWM damage in the 
pathogenesis of PIH and PHH  
Approach: Develop PIH mouse and PHH ferret hydrocephalus models and utilize MRI and 
immunohistochemistry to determine the relationships between N-cadherin expression, 
neuroinflammation and VZ and PVWM microstructure.  
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2 Chapter 2: Proteogenomics and the PIH-PHH Cerebrospinal Fluid Expressomes 
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PIH and PHH are both likely propagated through analogous, yet poorly characterized host-genome 
interactions. While there is anecdotal understanding of their pathophysiology, there has been no 
systematic exploration of the regulatory pathways that drive the disease phenotype87. This has 
limited previous efforts in PIH and PHH research to develop biomarkers for the clinical 
management and comparative effectiveness studies, in turn hindering progress in diagnosis, 
monitoring of therapeutic efficacy, and providing information regarding long-term neurological 
outcomes. With a working hypothesis that expressomes and specific pathways define the host 
responses in PIH and PHH, the primary objectives of the experiments presented in this chapter 
were to identify key causative activated gene regulatory pathways and related functional protein 
products involved in the pathophysiology of PIH and PHH. To achieve this goal, we carried out 
two major studies examining the CSF of a cross-sectional cohort of infants with PIH, PHH and 
non-infectious non-hemorrhagic hydrocephalic controls. The first study examined the CSF 
proteogenomic expressomes of PIH, utilizing concurrent high throughput deep-scale proteomics 
and next-generation transcriptomics. Our proteogenomics pipeline (Figure 7), which leverages 
message-passing strategies to integrate gene expression and protein-protein interactions was 
utilized. The second study utilized isobaric labelling proteomics to define the proteome of PIH, 
PHH and matched control infants to determine pathway alterations that are common to both 
conditions and those that are specific to each.  
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Figure 7. Schematic of proteogenomics experimental and data analysis workflow.  
Output data from concurrent proteomics and RNA-Seq on the same samples were processed, 
normalized, batch-controlled and explored independently. Differentially expressed transcriptomic 
and proteomic data were integrated following dimension reduction and feature selection. Gene 
ontology enrichment was evaluated and common reactome pathways were visualized to identify 
prominent molecular pathways implicated in the pathophysiology of post-infectious 
hydrocephalus. 
 
2.2 Results  
 
2.2.1 Concordant proteome and transcriptome of host immune response in PIH 
 
In this study, ventricular CSF samples of 100 infants ≤ 3 months of age with PIH (n=64) and non-
post-infectious hydrocephalus, NPIH (n=36) were concurrently analyzed with TMT-10 proteomics 
and Illumina-based RNA-Seq transcriptomics. Gene expression and protein abundance data were 
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analyzed for functional enrichment. Downstream analysis of proteomics and RNA-Seq data 
included dimension reduction, feature selection, gene ontology enrichment and reactome over-
representation pathway analyses of the differentially expressed proteins and genes.  
 
2.2.1.1 Pathogen identification 
 
Prior to this study, we had identified a strain of Paenibacillus spp. in the CSF of our PIH infants 
in a background of cytomegalovirus infection (CMV)402, utilizing an extensive pathogen detection 
approach including Sanger sequencing, next generation sequencing, quantitative polymerase chain 
reaction (PCR), and VirCapSeq® 403.  The Paenibacillus spp. strain we identified (which has been 
since named the “Mbale strain”) had a 99% identity and a whole-genome average nucleotide 
identity value of 97% to a known Paenibacillus thiaminolyticus strain NRRL B-4156T (=JCM 
8360T, GenBank accession CP041405 – “Reference strain”)404. In our cohort, presence of the 
Mbale strain in CSF inversely correlated with age and was associated with poorer clinical signs 
including seizures febrile episodes, and worse neuroimaging metrics assessing the presence of 
brain abscesses, calcifications loculations and debris on cranial CT scans. In 21-28-day old 
C57BL/6J mice, intraperitoneal inoculation of the Mbale strain lead to a 93% mortality rate, and 
was associated with acute tubular necrosis in the kidneys, bone marrow myeloid hyperplasia, and 
lymphocyte apoptosis in the splenic periarteriolar sheaths. There were no significant lesions in the 
brains or hydrocephalus402. Similar inoculation with the Reference strain was associated with no 
adverse effects402. We are presently working on characterizing the pathogenicity of the Mbale 
strain, utilizing RNA-Seq and label-free data-dependent acquisition proteomics.  
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2.2.1.2 Patient characteristics  
 
Informed by our findings of Paenibacillus spp. and CMV in the CSF of our cohort402, patients 
were sub-categorized as “Paeni-positive” or “Paeni-negative”, and “CMV-positive” or “CMV-
negative”, respectively. Comparison of baseline characteristics between Paeni-positive and Paeni-
negative patients: Paeni-positive patients had higher peripheral (p=0.002), and CSF (p<.001), 
white blood cell (WBC) counts, and lower hemoglobin (p=0.039) compared with Paeni-negative 
patients. There were no significant differences in age and gender between the groups. (Table 1).  







 NPIH; n=36 PIH; n=26 
 
Age in days, mean (SD) 57 (24) 43 (27) 75 (11) 59 (17) 
Sex  
   
   Male (%) 51 (51) 16 (44) 14 (54) 21 (55) 
   Female (%) 49 (49) 20 (56) 12 (46) 17 (45) 
CSF CMV Status, + (-) 8 (92) 0 (36) 2 (24) 6 (32) 
CSF WBC [1.0 x 103]/µL, mean (SD)  30 (62) 5 (0.5) 5 (0.0) 72 (86.0) 
Peripheral blood  
WBC [1.0 x 103]/µL, mean (SD) 
10.3 (3.6) 8.8 (2.6) 9.8 (3.0) 11.9 (4.1) 
Hemoglobin g/dl, mean (SD) 11.5 (2.2) 13.0 (2.8) 10.5 (1.3) 10.8 (1.3) 
Hematocrit %, mean (SD) 36.8 (7.4) 41.6 (9.3) 33.6 (4.2) 34.4 (4.1) 
SD: Standard deviation, CSF: Cerebrospinal fluid, CMV: Cytomegalovirus; PIH: post-infectious 
hydrocephalus; NPIH: non-post-infectious hydrocephalus; Paeni-positive: Cerebrospinal fluid (CSF) 




Supplementary Figure 1. Patient baseline characteristics  
Composite of CT scans from all patients grouped by post-infectious hydrocephalus (PIH, upper 
groupings) and non-post-infectious (NPIH, lower group) hydrocephalus. The PIH group is further 
clustered by Paenibacillus spp. negative (left) and positive (right). Yellow and red stars indicate 
if a patient was PCR positive for cytomegalovirus (CMV) in the CSF and blood respectively. Two 
other patients met criteria for a bacterial identification for a putative pathogen, indicated as group 
B Streptococcus (GBS) in a case that was also Paenibacillus spp. positive, and one case with 
Bacillus sp. in the NPIH group. Two patients in the NPIH group were positive for Paenibacillus 
spp. (Paeni) using V1-V2 analysis. Note that no patient in the NPIH group that was CMV positive 
in the blood had CMV detected in the CSF. 
 
2.2.1.3 Proteomics demonstrate neuroinflammation and cell junction disruption in PIH  
 
Multi-dimensional scaling of proteomic data demonstrated clustering of PIH and NPIH infants and 
distinguished Paeni-positive from Paeni-negative patients. Of 616 proteins identified, 292 were 
differentially expressed based on Paenibacillus spp. status, with 144 upregulated and 148 proteins 
downregulated in the Paeni-positive group, respectively. Adjusting for CMV status did not change 
the differentially abundant proteins. (Figure 8).  
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Figure 8. Proteomic profile of PIH and NPIH infants 
The proteomics profiles of infants with (PIH) and without (NPIH) post-infectious hydrocephalus 
are based on 16s rRNA-determined Paenibacillus spp. status. (A) Multi-dimensional scaling 
(MDS) of normalized protein abundances demonstrating clustering of Paenibacillus spp. positive 
(Paeni-positive) infants from the remaining groups. The axes of the scatter plot of individual 
participants represent the first and second components. Each oval (not drawn to scale) encircles 
majority of patients belonging to the color-matched group, with orange as infants in the NPIH 
group, green as Paeni-negative PIH infants (Non-Paeni PIH), and purple as Paeni-positive infants 
(Paeni PIH). (B & C) Volcano plots demonstrating differential expression of genes between Paeni-
positive and Paeni-negative infants. The vertical dashed lines demarcate fold changes of 1 and -1 
respectively, and the horizontal dashed line represents an alpha significance level of 0.05. Each 
point represents a differentially expressed protein and those with an absolute fold change greater 
than 1 that met the significance level (red points) were selected for gene set enrichment analyses. 
(B) Differential expression of proteins based on Paenibacillus spp. status was similar with or 
without adjusting for CMV status (B). (C) There were no differentially expressed proteins based 
on CMV status alone that met fold change (blue points) and statistical significance (grey points) 
criteria.  
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Gene set enrichment analysis of the differentially expressed proteins demonstrated the most 
predominantly enriched functional gene sets identified were neuroinflammation related, 
particularly neutrophil-mediated inflammation, and negative regulation of proteolysis and 
peptidase activity, and modulation of extracellular matrix and structure (Figure 9). 
 
Figure 9. Gene ontology analyses based on cerebrospinal fluid assay. 
Differentially expressed (A) proteins and (B) RNA transcripts between infants with post-infectious 
hydrocephalus (PIH) and those without (NPIH) is based on 16s rRNA-determined Paenibacillus 
spp. status. In both proteomics and RNA-Seq, there was enrichment for functions associated with 
neuroinflammation, extracellular matrix structure and cell-cell adhesion. The abscissae of the dot 
plots correspond to the number of proteins/genes per total number of genes (gene ratio), and the 
size of each circle reflects the relative number of proteins/genes expressed that are enriched for the 





2.2.1.4 RNA-Seq demonstrates neuroinflammation and cell junction disruption in PIH  
 
Principal component analysis (PCA) of genes identified with RNA-Seq demonstrated clustering 
of PIH and NPIH infants. Of the 11,114 genes expressed in the cohort, 2,161 were differentially 
expressed, and hierarchical clustering of those genes distinguished a subset of Paeni-positive from 
Paeni-negative patients (Figure 10). Gene ontology analysis of the differentially expressed genes 
based on Paenibacillus spp. status demonstrated an enrichment for genes related to response to 
bacteria, host immune regulation, and cell motility, migration and adhesion (Figure 9).  
 
Figure 10. Transcriptomic profile of PIH and NPIH infants 
The transcriptomic profiles of infants with post-infectious hydrocephalus (PIH) and those without 
(NPIH) based on 16s rRNA-determined Paenibacillus spp. status. (A) Principal component 
analysis of normalized protein abundances demonstrating clustering of PIH from NPIH. The axes 
of the scatter plot of individual participants represent the first and second components. Each oval 
(not drawn to scale) encircles majority of patients belonging to the color-matched group, with 
green as infants in the NPIH group, and blue PIH infants. (B) Heatmap of the 500 most 
differentially expressed genes, with the dendrogram demonstrating hierarchical clustering on 




Adjusting for CMV status did not significantly alter the gene ontology enrichment based on 
Paenibacillus spp. status. Sixty-four genes were differentially expressed based on CMV status, 
and those genes were enriched for functions related to host response to virus. PCA using RNA 
abundance of all genes was not able to separate samples based on CMV status. (Supplementary 
Figure 2) 
 
Supplementary Figure 2: Transcriptome profile of patients with CMV infection. 
Role of CMV infection on the genomic profile of infants with post-infectious hydrocephalus (PIH) 
and those without (NPIH), based on 16s rRNA-determined Paenibacillus spp. status.  There were 
64 differentially expressed genes between Paeni-positive and Paeni-negative infants based on 
CMV status, and (A) those genes were enriched for functions related to host response to virus 
demonstrated on the interactome. Genes are represented by grey circles and interactions are noted 
by lines between genes, clustered by their respective labelled gene ontology biological processes 
(cantaloupe circles). (B) However, there was no clustering of patients based on CMV status as 
shown on the PCA plot, where the axes of the scatter plot of individual participants represent the 




2.2.1.5 Clinical traits correlate with CSF gene expression in PIH 
 
Using weighted correlation network analysis (WGCNA), 2 gene sets (Modules 1-2) were identified 
within a subset of 33 patients clustered by expression of differentially expressed genes between 
the Paeni-positive and Paeni-negative cohorts. These modules were assessed for correlation with 
5 clinical variables: WBC counts and Paenibacillus spp. status in both CSF and peripheral blood, 
and, CSF CMV status in CSF (Figure 11). Module 1 contained all but 11 of the genes differentially 
expressed with Paenibacillus spp. status and was positively correlated with CSF cell count, and 
negatively correlated with Paenibacillus spp. status. Module 2 was positively correlated with 
Paenibacillus spp. status, but those 11 genes were not enriched for any gene ontologies, indicating 
no specific functional enrichment for the small number of genes within this module. 
 
Figure 11. Weighted correlation network analysis (WGCNA) of gene modules 
WGNCA gene modules identified within RNA-Seq data for post-infectious (PIH) and non-post-
infectious (NPIH) hydrocephalus cohorts demonstrate Module 2 (A) was positively correlated 
with CSF cell count and negatively correlated with age and (B) was enriched for host immune 
responses, including leukocyte and neutrophil functions. 
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2.2.1.6 Proteogenomic expressome of host immune response in PIH 
 
Unsupervised gene ontology analyses of concatenated differentially expressed proteins and genes 
assayed from proteomics and RNA-Seq respectively, recapitulated enrichment for the immune 
system, metabolism, response to oxidative stress, cell-cell junction interactions and extracellular 
matrix structure in association with peptidase activity. (Figure 12). 
 
Figure 12. Prominent Gene Ontological (GO) functions and interactions.  
The Alluvial plot demonstrate GO functions enriched for the pathophysiology of post-infectious 
hydrocephalus (PIH) between Paenibacillus spp. positive and Paenibacillus spp. negative infants. 
Each ontological clustering occupies a column in the diagram and is horizontally connected to 
preceding and succeeding significance clustering by stream fields, representing similar gene 
involvement. Each stacked bar is color-coded based on the assay being assessed, with blue 
representing RNA-Seq data, orange for proteomics and green for genes common to both RNA-Seq 




There were 33 genes that were common to both proteomics and RNA-Seq. Pathway enrichment 
analysis of those genes demonstrated an enrichment for functions predominantly associated with 
the immune system, particularly interleukin (IL)-4, IL-12, IL-13, interferon signalling, and genes 
involved with neutrophil activity and the Janus kinase/signal transducers and activators of 
transcription (JAK-STAT) pathway. In addition, there was enrichment for processes involved with 
response to platelet activating factors and host recognition of microbes including antigen 
presentation and Class I MHC antigen processing (Figure 13). 
 
Figure 13. Pathway analysis of differentially expressed markers in RNA-seq and proteomics 
Post-infectious and non-post-infectious hydrocephalus infants are stratified by cerebrospinal fluid 
16s rRNA Paenibacillus spp. status. Corresponding pairs of upregulated (red boxes) and 
downregulated (green boxes) proteins (blue columns) and genes (purple columns) in the 
Paenibacillus spp. positive group that were identified with proteomics and RNA-Seq respectively 
are listed on the x-axis. The 33 common genes demonstrated predominant involvement of the 
immune system, particularly the innate system and those associated with neutrophil-mediated 
activity, interleukins, interferon and the Janus kinase/signal transducers and activators of 
transcription (JAK-STAT) pathway (y-axis). Differential expression was defined as log2 fold 




Interactome analysis405 demonstrated these 33 proteins had high physical protein-protein 
interactions with regards to their chromosome neighborhood, gene fusion, phylogenetic co-
occurrence, homology, co-expression, experimentally determined interactions, database 
annotation and automated text mining405 (Figure 14).  
 
Figure 14. Interactome analysis of cross-omic differentially expressed markers.  
Comparing the CSF profiles of Paenibacillus spp. positive post-infectious hydrocephalus infants 
compared to Paenibacillus spp. negative infants, the network nodes represent proteins produced 
by a single, protein-coding gene locus and first shell of interactors. Filled and empty nodes imply 
the 3D structure of the protein is known or unknown, respectively. Edges represent protein-protein 
associations determined from known interactions (curated and experimentally determined), 
predicted interactions (related to gene neighborhood, fusions and co-occurrence) and other 
interactions including text mining, co-expression and protein homology. The colors of edges, as 
demonstrated on the key, reflects the interactions. Shaded regions depict groupings into their 
predominant gene ontology function with grey, purple and orange regions representing those 
involved with the immune system, cytokine-mediated immune response and factors associated 
with platelet activity.  
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2.2.2 Activated gene pathways in PIH and PHH  
 
Integration of RNA-Seq and proteomics was a useful approach to characterize PIH 
pathophysiologic mechanisms. Neuroinflammation and extracellular organization are critical 
processes in the pathophysiology of PIH and may also play a role in development of PHH. This 
study focused on parsing activated gene networks that are common to PHH and PIH, and just as 
importantly, those that are unique to each condition. We utilized our existing proteomics pipeline 
to assess ventricular CSF samples from PIH, PHH and non-infectious, non-hemorrhagic 
hydrocephalic infants (Controls). 
 
2.2.2.1 Patient characteristics  
 
There were 125 participants, which included 64 PIH, 17 PHH and 44 control infants. Parents of 
all participants provided informed consent. Among the PIH group, 38 were Paenibacillus spp. 
positive (Paeni-pos PIH) and 26 were Paenibacillus spp. negative (Paeni-neg PIH). The PHH and 
8 control samples were obtained from infants from North America, whereas the PIH and 36 control 
samples were from Sub-Saharan Africa; regions where the conditions are most prevalent, 






2.2.2.2 Protein expression patterns in PIH and PHH 
 
A z-log protein expression score was calculated as a ratio of the measured expression level to that 
of the common reference pool. These scores were then normalized, including batch correction and 
quantile normalization of z-log protein expression scores for each of 2,841 proteins identified. 
Multi-dimensional scaling of proteomic data demonstrated clustering of patients based on groups. 
As we identified in the previous experiments, controls clustered with Paeni-neg PIH, while Paeni-
pos PIH clustered with PHH. To assess for differential expression of proteins between groups, we 
performed a linear modelling that included three sets of comparisons: PIH vs. controls; PHH vs. 
controls; and PIH vs. PHH. 1,832 proteins (64%) were differentially expressed between groups. 
(Figure 15). 
 
Figure 15. Proteomic profiles of infants with PIH, PHH and non-PHH non-PIH controls 
The proteomic profiles of post-infectious (PIH) and post-hemorrhagic (PHH) hydrocephalus and 
those with non-infectious non-hemorrhagic hydrocephalus (Controls). Panel A is a multi-
dimensional Scaling of normalized protein abundances demonstrating clustering of Controls and 
Paenibacillus spp. negative (Paeni-neg PIH) from Paenibacillus spp. positive (Paeni-pos PIH) 
infants. The abscissa and ordinate of the scatter plot of individual participants represent the first 
and second components, respectively. Each oval (not drawn to scale) encircles majority of patients 
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belonging to the color-matched group. Panel B is a Euler diagram demonstrating counts of 
differentially expressed proteins among infants with PIH, PHH and Controls. Each branch (circle) 
is proportional to the number of proteins differentially expressed between the labelled pair-wise 
comparisons, with each intersection isolating proteins exclusive to the respective subgroup 
comparisons. Upregulated (↑) and downregulated (↓) counts of proteins are color-coded with red 
and blue, respectively.   
 
Directed by our objective to identify activated pathways that are common or unique to PIH and 
PHH, the following specific protein clusters from the linear model were selected for downstream 
analyses: 1) the proteins that were differentially expressed between PIH and PHH but not 
differentially expressed independently with controls (PIH-PHH group; n=84); 2) the proteins that 
were differentially expressed between PHH and controls (PHH-Control group; n=143) and those 
between PIH and controls (PIH-Control; n=59), respectively, but not differentially expressed 
between PIH and PHH. The former evaluated common pathways between PIH and PHH while the 
latter evaluated pathways that are uniquely activated in each condition. The nested F-test 
approach406 was utilized to achieve consistency between all related contrasts while ensuring 
proteins that were expressed in equal proportions between pairs of samples (log2 fold change of 0) 
were not excluded. (Figure 16). At all levels of the model, unsupervised hierarchical clustering of 
the differentially expressed proteins resulted in groups with PHH generally clustering separately 
from other groups. Two separate PIH populations also emerged, one of which is distinct from other 
groups, while the second shows some overlap control participants (Figure 16; Supplementary 
Figures 3 and 4).  
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Figure 16. Differentially expressed proteins between PIH, PHH and control infants  
Protein expression profiles between post-infectious hydrocephalus (PIH), and post-hemorrhagic 
(PHH) hydrocephalus and control infants. (A) Heatmap demonstrating hierarchical clustering on 
Euclidean distance of proteins identified in the respective conditions. (B) Volcano plot 
demonstrating differential expression of proteins uniquely expressed in PIH and PHH infants, and 
not differentially expressed between either and controls. The vertical lines demarcate fold changes 
of 1 and -1, and the horizontal line represents an alpha significance level of 0.05. 
 
Supplementary Figure 3. Differentially expressed proteins between PIH and control infants 
Proteomic profile of infants with post-infectious hydrocephalus (PIH) and control infants with 
non-infectious non-hemorrhagic hydrocephalus (control). (A) Heatmap demonstrating hierarchical 
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clustering on Euclidean distance of proteins identified in the respective conditions. (B) Volcano 
plot demonstrating differential expression of proteins uniquely expressed in PIH and Control, and 
not differentially expressed between PHH and post-hemorrhagic hydrocephalus. The vertical lines 
demarcate fold changes of 1 and -1, and the horizontal line represents an alpha significance level 
of 0.05.  
 
Supplementary Figure 4. Differentially expressed proteins between PHH and control infants 
Proteomic profile of infants with post-hemorrhagic hydrocephalus (PHH) and control infants with 
non-infectious non-hemorrhagic hydrocephalus (Control). Panel A is a heatmap demonstrating 
hierarchical clustering on Euclidean distance of proteins identified in the respective conditions. 
Panel B is a volcano plot demonstrating differential expression of proteins uniquely expressed in 
PHH and Control, and not differentially expressed between PHH and post-infectious 
hydrocephalus. The vertical lines crossing the positive and negative abscissae demarcate fold 
changes of 1 and -1, and the horizontal line represents an alpha significance level of 0.05. 
 
2.2.2.3 The independent proteomes of PIH and PHH  
 
Gene set enrichment analysis of the differentially expressed proteins in the PIH-control and PHH-
control groups independently demonstrated that inflammation and processes associated with 
extracellular structure, in association with protein metabolism, were predominantly enriched with 
minor variations. In PHH, expression markers of enrichment for inflammation was limited to acute 
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immune responses including neutrophil activity and platelet degranulation. Extracellular 
organization gene enrichment was associated with regulation of peptidases and hydrolases. As 
expected, there was also enrichment for factors related to blood coagulation and hemostasis. 
(Figure 17).   
 
Figure 17. Proteins unique to PHH and controls  
Proteins uniquely expressed between post-hemorrhagic hydrocephalus (PHH) and controls. (A) 
Volcano plot demonstrating the differentially expressed proteins between infants with PHH and 
controls, that are not differentially expressed in post-infectious hydrocephalus. The vertical lines 
demarcate fold changes of 1 and -1, and the horizontal line represent an alpha significance level 
of 0.05. (B) Interactome of the differentially expressed proteins that met criteria (Panel A, red dots) 
demonstrating enrichment for processes predominantly involved with inflammation, extracellular 
organization, coagulation and wound healing. The size of each circle reflects the relative number 
of proteins expressed that are enriched for the corresponding function. 
 
Similar to PHH, inflammatory responses enriched in PIH included those related to neutrophil 
activity and platelet degranulation. However, complement activation was also enriched. 
Enrichment for extracellular organization processes occurred in the context of proteolysis, as well 
as in response to wound and wound healing (Figure 18).  
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Figure 18. Proteins unique to PIH and controls  
Analysis of proteins that are differentially expressed between infants with post-hemorrhagic (PIH) 
and controls, that are not differentially expressed in post-hemorrhagic hydrocephalus. (A) Volcano 
plot demonstrating differential expression of proteins. The vertical lines demarcate fold changes 
of 1 and -1, and the horizontal line represent an alpha significance level of 0.05. (B) Dot plot from 
gene set enrichment analysis of the differentially expressed proteins that met criteria (Panel A, red 
dots) demonstrating enrichment for processes predominantly involved with inflammation, 
extracellular organization, and wound healing. Each dot corresponds to the number of proteins per 
total number of proteins (gene ratio), and its size reflects the relative number of proteins expressed 
that are enriched for the corresponding function. 
 
2.2.2.4 Neuroinflammation is a common process in PIH and PHH pathophysiology 
 
Proteins that were uniquely differentially expressed in PIH or PHH were subjected to downstream 
analyses. Gene set enrichment analysis demonstrated that those proteins were also predominantly 
enriched for inflammation, but included both acute and humoral immune responses, complement 
activation and platelet degranulation. Neuroinflammation occurred in association with 
extracellular structure organization processes, which occurred in the context of protein activation 
cascades. (Figure 19). 
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Figure 19. Gene ontology interactome of proteins common to PIH and PHH 
Differentially expressed proteins that are common to infants with post-infectious (PIH) and post-
hemorrhagic (PHH) hydrocephalus, but not differentially expressed in non-hemorrhagic non-
infectious hydrocephalic infants were analyzed. Each point on the interactome represents a 
differentially expressed protein with an absolute fold change greater than 1. There is enrichment 
for functions associated with neuroinflammation and extracellular organization, occurring in the 
context of protein activation cascades. The size of each circle reflects the relative number of 
proteins expressed that are enriched for the corresponding function. 
 
Having established neuroinflammation and extracellular organization as processes that are central 
to the pathophysiology of PIH and PHH, reactome analysis407 was performed to identify 
potentially targetable markers. Markers common to both the innate and adaptive systems that had 
a concomitant effect on cellular organization were of particular interest. Of 32 inflammation-
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related proteins, five (CDC42, PSMB10, LGMN, NCF2 and TOM1) were common to both 
immune systems. CDC42 and PSMB10 are downstream markers involved with cytokine signaling 
(Figure 20). KEGG pathway analyses408 (not shown) were performed independently on CDC42, 
PSMB10, LGMN, NFC2, and TOM1 to identify their interactors. All but TOM1 were involved in 
various protein cascades reflecting their potential effects on extracellular organization. 
 
Figure 20. Reactome pathway analyses of proteins common to PIH and PHH 
Differentially expressed inflammation related proteins unique to post-infectious (PIH) and post-
hemorrhagic (PHH) hydrocephalus when compared to non-infectious non-hemorrhagic 
hydrocephalic controls were subjected to reactome analyses. CDC42, PSMB10, LGMN, NCF2 
and TOM1 were found to common to the innate and adaptive systems. CDC42 and PSMB10, 
DDX58 and PRPS1 are involved with cytokine signalling in the immune system.  
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2.3 Discussion  
 
2.3.1 Summary of findings 
 
PIH and PHH are the most debilitating neurological sequelae of neonatal sepsis and 
intraventricular hemorrhage, respectively.35,36,42,409 The overarching goal of the many experiments 
presented in this chapter was to identify critical genes involved in the pathophysiology of PIH and 
PHH and map those genes onto their activation pathways to define the common and unique 
pathophysiological mechanisms underlying both conditions. To circumvent some of the major 
independent limitations of proteomics and RNA-Seq, proteogenomics was utilized to integrate 
protein and gene data. Hierarchical clustering identified that PIH and PHH patients had differential 
expression of genes or proteins involved in neuroinflammation and extracellular matrix 
organization. Differential expression of host immune response genes and proteins in PIH (those 
with Paenibacillus spp. in CSF) was predominantly related to the innate immune system (i.e., 
neutrophil activity, IL-4, IL-12, IL-13 and interferon signaling, the JAK-STAT pathway, and 
platelet response/activating factors) when compared to controls. In addition, there was enrichment 
for processes involved with host recognition of microbes including Class I MHC antigen 
presenting complex in PIH. Similarly, host immune response in PHH was predominantly 
associated with enrichment of processes involving neutrophil activity and platelet degranulation. 
However, gene sets involved in complement activation were enriched in PHH, as well as those 
involved in blood coagulation and hemostasis. In both PIH and PHH, protein cascades and 
processes such as proteolysis and hydrolysis were enriched, all within the context of extracellular 
matrix and cellular structural organization.  
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2.3.2 Proteogenomics as an approach for defining PIH and PHH pathophysiology 
 
Large scale proteomics and genomics studies have been instrumental in the discovery of important 
biomarkers and have provided insights to the pathophysiology of central nervous system disease. 
CSF proteomics have previously identified clinically useful protein biomarkers such as amyloid 
precursor protein and cell adhesion molecules in PHH.245,247 RNA-Seq of CSF has been widely 
used to study infectious diseases.410,411 Disease pathogenesis involves the combinatorial 
interaction of elements within the proteome, transcriptome, and environmental factors.260,412 
Therefore, integrative methods that combine proteomic and genomic data into a network model 
are essential for understanding human disease.262 Our group is the first to utilize proteogenomics 
to characterize gene regulatory networks involved in PIH and PHH. Here we utilized clustering, 
reactome and interactome pathways, and gene ontology enrichment methodologies at the RNA 
and protein levels to unravel the underlying mechanisms involved in host response to PIH and 
PHH. Through this effort we have identified the putative genes and pathway responses in the host 
involved in the pathophysiology of PIH due to Paenibacillus spp. Important future work will test 
the generalizability of host response observed in this study to other pathogens and other variants 
of hydrocephalus.  
 
2.3.3 Host-immune responses in PIH and PHH 
 
In addition to ventriculomegaly, both the PIH and PHH phenotype is characterized by granular 
ependymitis, ependymal gliosis, arachnoiditis, calcifications, and multi-loculated infiltrates36 
suggesting that severe inflammation occurs locally during the antecedent neonatal sepsis or 
hemorrhage. Indeed, infants with PIH due to Paenibacillus spp. had ten-fold more calcifications, 
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abscesses, loculations and debris on head CT402. Collectively, these findings underscore the 
importance of characterizing the nature of the host-immune response in PIH and PHH.  
 
Typically, once a pathogen breaches a host’s epithelial barriers, immune mechanisms are activated. 
Although there is rapid progression of immunologic competence after birth, the innate immune 
system is the primary active defense against pathogens in infants less than 3 months of age since 
they lack the antigenic exposure required to develop acquired immunity. Consequently, the host 
immune response to microbial pathogens, mounted by the infants involved in this study, involved 
antigen-independent immune components such as neutrophils, phagocytes, natural killer and 
antigen presenting cells.201,413-416 However, complement activation, which has crossover with the 
adaptive immune system is a major mediator of host response to infection. Thus, it was not 
surprising to find that our PIH cohort had differential expression of proteins involved with the 
complement system.  Immune response to non-infectious triggers such as hemorrhage in PHH 
would also involve activation of the innate immune system in response to endogenously released 
markers of cellular damage. 
 
Our results support the role of the immune response in PIH and PHH pathophysiology. Persistent 
inflammation in the CSF of infants in our study may be pathologic rather than physiologic as they 
were remote from the original infection or hemorrhage and were already clinically well for surgery. 
While host-immune response is necessary for clearing pathogens or non-infectious toxins, 
prolonged or overstimulated immune activation may be detrimental to the host.417 In terms of PIH 
and PHH, it is likely that the same host immune activity that clears pathogens also causes 
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hydrocephalus by damaging local tissues. Of the three cytokines we identified in PIH, IL-12 is the 
most diverse and is typically involved in augmentation of CD8+ T cell cytotoxicity. Upregulation 
of MHC Class I in our PIH cohort could be an indication of presentation to cytotoxic CD8+ cells 
and IL-12 activity.418 Further, IL-4 and IL-13 typically work synergistically to decrease 
inflammation and counteract the IL-12 activity, and thus may be upregulated in response to IL-12 
upregulation. IL-4 has also been associated with Staphylococcus aureus infections, which like 
Paenibacillus spp. is gram-positive. One hypothesis is that the balance of IL-12 and IL-4/IL-13 
within the CSF contributes to risk of developing PIH. In Chapters 4 and 5, we present further 
evidence that inoculation of a gram-positive bacterial toxin in vitro and in vivo in experimental 
models is associated with neuroinflammation and disruption of the ependymal CSF-brain barrier, 
likely as an antecedent process to developing hydrocephalus.  
 
2.3.4 Inflammation and barrier integrity in PIH and PHH 
 
The activated immune pathways found in PIH and PHH support the perspective that neonatal 
immune response to toxins such as infection or hemorrhage inadvertently causes hydrocephalus 
through ependymal denudation, scarring of CSF conduits and disruption of CSF physiology to 
cause hydrocephalus. Our finding of differential abundance of RNA and protein involved in cell-
cell integrity in PIH and PHH infants is also consistent with recent evidence from both 
experimental170,172,175-177,419 and clinical181-183,419 studies. In those studies, immune response is 
associated with ependymal cell-cell junction protein disruption as a critical pathogenetic 
mechanism of hydrocephalus. In a human postmortem histological study, McAllister et al. 
attributed the diffuse ependymal damage they identified in PHH infants to disruption of cell-cell 
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junctional proteins, which had occurred in the context of GFAP over-expression, a non-specific 
surrogate marker of neuroinflammation and glial scarring.197 Together, our findings and these 
evidences underscore the critical interplay between neuroinflammation and ependymal cellular 




Limitations to this study include small cohort size for subset analyses such as in the case of the 
CMV positive participants, low RNA abundance in the control samples, and reduced availability 
of clinical covariates to assess for correlation with gene abundance patterns. Identifying CMV in 
some of the infants in our cohort402 raises the important question of whether the host-immune 
response we observed was at least in part attributable to CMV. While there were differentially 
expressed transcripts at the genome level in response to viruses, we did not detect any functional 
proteins associated with CMV, nor was there any effect of CMV status on the differential 
expression of host-immune markers at the gene or protein level. It is possible that our inability to 
detect a CMV-related host-immune response was limited by having only a few (8/100) CMV-
positive infants. Another possibility is that CMV tend to cycle through dormant and active state in 
affected individuals420, thus point sampling of CSF may not have captured an active state. 
Therefore, it remains unknown whether CMV was a risk factor for developing Paenibacillus spp. 
infection or PIH in the first place, whether CMV can be implicated in the persistent host-immune 
response we observed, and whether it will have any long-term effects in these infants. 
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2.4 Materials and Methods 
 
2.4.1 Patients and recruitment 
 
PIH and NPIH infants were recruited at the CURE Children's Hospital of Uganda (CCHU), a 
pediatric neurosurgery hospital that serves as the largest referral center for patients with 
hydrocephalus in Uganda. Ethics oversight for those patients was provided by the CCHU 
Institutional Review Board (IRB), Mbarara University of Science and Technology Research Ethics 
Committee, the Ugandan National Council on Science and Technology, and the Pennsylvania State 
University (PSU) IRB. A United States Centers for Disease Control permit for importation of 
infectious materials covered the transfer of specimens from CCHU to PSU. PHH and NPHH 
infants were recruited from the St. Louis Children’s Hospital (SLCH), a large tertiary pediatric 
hospital in St. Louis, Missouri. Ethics oversight for the PHH and NPHH infants was provided by 
the Washington University Human Research Protection Office (HRPO #s 201101887 and 
201203126). Verbal informed consent was obtained from the parent(s) of each subject. 
 
Each PIH infant had a history of febrile illness and/or seizures preceding the onset of 
hydrocephalus and/or ventriculitis, as detected by physical examination, endoscopy, or 
neuroimaging. No PIH infants had hydrocephalus at birth. NPIH infants were selected based on 
need for neurosurgical intervention of congenital hydrocephalus due to an obstructive aqueduct 
lesion, Dandy-Walker cyst, or other congenital malformation of the nervous system.  
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The PHH group included preterm infants (age < 35 weeks estimated gestational age) admitted to 
the SLCH Neonatal Intensive Care Unit who sustained IVH which was diagnosed with head 
ultrasound within the first month of life. Patients underwent weekly head ultrasounds for 
monitoring of ventricular size and were eventually deemed to require implantation of a ventricular 
access device (VAD). Well-established Hydrocephalus Clinical Research Network criteria were 
applied for the diagnosis of PHH and need for and timing of hydrocephalus interventions421. All 
PHH infants included in this study underwent permanent CSF diversion surgery (ETV +/- CPC or 
VP shunt). The NPHH group included age and gender matched infants who needed neurosurgical 
intervention congenital or aqueductal stenosis hydrocephalus who had no evidence of 
intraparenchymal or intraventricular hemorrhage on their head ultrasound.  
 
Inclusion criteria for all patients were age less than 3 months and weight greater than 2.5 kg at 
time of CSF sampling. Exclusion criteria for all subjects were prior surgery on the nervous system 
or evidence of communication of nervous system with skin. Additionally, PHH patients with a 
history of systemic infection were excluded. Clinical patient information including demographics, 
computed tomography (CT) neuroimaging, CSF cell counts, and CSF culture results were obtained 
from review of the medical records.  
 
2.4.2 CSF Samples 
 
Sterile CSF samples were acquired directly from the cerebral ventricles of all patients at the time 
of surgery for treatment of hydrocephalus. After collection, samples were RNA shielded (Zymo 
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Research, Irvine CA) to preserve nucleic acid and protein contents when possible, then rapidly 
frozen and maintained in liquid nitrogen prior to shipment for final -80℃ storage until proteomics 
and/or RNA-Seq was performed. In all cases, the CSF microbiological cultures sent at the time of 
collection remained sterile. Any NPIH, PHH or NPHH that had gram stain or microbial cultures 




2.4.3.1 RNA Extraction 
 
All reagents and consumables required for RNA extraction were UV-treated in a polymerase chain 
reaction (PCR) workstation for 15 minutes. A TRIzol™ LS Reagent and Direct-zol™ RNA 
MiniPrep Plus kit was used for all extractions. Each batch of extraction included a water control 
in which 500 μL of elution buffer was put through all extraction steps. CSF samples thawed at 
room temperature were processed with two aliquots of 250 μL mixed with 750 μL of TRIzol™ LS 
Reagent. After bead lysis, 200 μL of chloroform was added, incubated at room temperature for 15 
minutes then centrifuged at 12,000g for 15 minutes at 4oC. Once separated the aqueous layers from 
the two aliquots were put into the same tube. Then each organic layer was re-suspended in 400 μL 
of water and centrifuged again for 5 minutes. The 1.6 mL of aqueous phases were combined with 
1.6 mL of 100% ethanol and put through the Zymo-Spin™ IC Column twice and proceeded per 
manufacturer’s protocol.  
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2.4.3.2 RNA Sequencing 
 
Following RNA extraction, Illumina® TruSeq® Stranded RNA Sequencing kit was used for rRNA 
depletion and fragmentation, first strand cDNA synthesis, second strand cDNA synthesis, 
adenylate 3’ ends, adapters ligation, and DNA fragment enrichment following the manufacturer’s 
protocol. It was expected that due to the nature of low cell counts in CSF, varying concentrations 
of RNA would be extracted. Indeed, in our samples, majority of the RNA concentrations fell below 
the recommended input of 100 ng so a standard 10 ul of total RNA was used for input ranging 
from 10-150 ng of RNA. Using biotinylated, target-specific oligos combined with Ribo-Zero 
ribosomal RNA (rRNA) removal beads of divalent cations and high temperatures (60 – 100oC). 
Ribosomal RNA was then depleted from the total RNA and the remaining RNA was purified, 
fragmented, and primed for cDNA synthesis. The cleaved RNA fragments were then copied into 
first strand cDNA using reverse transcriptase (Part # 18064-014) and random hexamers. A second 
strand cDNA synthesis was obtained by removing the RNA template, synthesizing a replacement 
strand, and incorporating dUTP in place of dTTP to generate the ds (double stranded) cDNA, using 
DNA Polymerase I and RNaseH. A single 'A' nucleotide was then added to the 3' ends of the blunt 
fragments and a corresponding single 'T' nucleotide was added on the 3' end of the adapter. 
Multiple indexing adapters were then ligated to the ends of the ds cDNA fragments to prepare 
them for hybridization. Polymerase chain reaction (PCR) was used to enrich the DNA fragments 
which was done without dUTP to ensure only the first strand was enriched. The libraries were 
quantified by fluorometry and size and quality checked on an Agilent Technologies 2100 
Bioanalyzer. Libraries were then pooled to 4 nM, diluted and sequenced on the NovaSeq 6000 
using the S2 flowcell with 2x100 reads aiming for 25 million reads per sample.  
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2.4.3.3 Data Analysis 
 
All RNA-Seq data analyses were performed with R v.3.5TM (http://www.R-project.org) utilizing 
the following packages: clusterProfiler422, edgeR423, RSEM424, STAR425, YARN426. Pair-end RNA-
Seq were first mapped to the human reference genome hg38 using STAR425. Then RSEM424 was 
used for estimating gene and isoform expression levels from mapped RNA-Seq data. Gene read 
counts from all samples were combined into matrix for further analysis. YARN426 was used to 
create normalized gene expression sets from the RNA-Seq matrix data. edgeR423 was used to 
calculate differential expression between groups using a Genewise Negative Binomial Generalized 
Linear Model. Differentially expressed genes were selected based on Benjamini-Hochberg 
adjusted p-value cutoff of 0.05 and absolute log fold change of 1 and were mapped to Gene 
ontology terms and assessed for enrichment using clusterProfiler422. Pathway enrichment analysis 
was performed utilizing Reactome Pathway Enrichment analysis and Database for Annotation, 




2.4.4.1 Sample preparation and mass spectrometry 
 
A standard validated proteomics workflow was utilized428. Briefly, the top six most abundant 
proteins in CSF (albumin, IgG, antitrypsin, IgA, transferrin and haptoglobin) were removed using 
a reproducible affinity method247. Samples were then enzymatically digested with trypsin, and 
peptides were isobarically labeled using a ten-channel peptide mass tagging (TMT-10) robotic 
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solid phase extraction system429,430. Labeled peptides were analyzed by high-resolution liquid 
chromatography-mass spectrometry (LC-MS) using a Q-Exactive Plus instrument coupled to an 
EASY-nanoLC 1000 system (Thermo-Fisher Scientific). The pooled samples in batches of ten 
were loaded onto a 75 µm i.d. × 25 cm Acclaim® PepMap 100 RP column (Thermo-Fisher 
Scientific). Peptide separations were started with 95% mobile phase A (0.1% FA) for 5 min and 
increased to 30% B (100% ACN, 0.1% FA) over 180 min, followed by a 25-min gradient to 45% 
B, a 5-min gradient to 95% B and washed at 90% B for 7 min, with a flow rate of 300 nL/min. 
Full-scan mass spectra were then acquired using the Orbitrap mass analyzer in the mass-to-charge 
ratio (m/z) of 375 to 1400 and with a mass resolving power set to 70,000. Fifteen data-dependent 
high-energy collisional dissociation (HCD) were performed with a mass resolving power set to 
35,000, a fixed first m/z 100, an isolation width of 0.7 m/z, and the normalized collision energy 
setting of 32. The maximum injection time was 50 ms for parent-ion analysis and 105 ms for 
product-ion analysis. Target ions already selected for mass spectrometry (MS)/MS were 
dynamically excluded for 30 s. An automatic gain control target value of 3 x 106 ions was used for 
full MS scans and 1 x105 ions for MS/MS scans. Peptide ions with charge states of one or greater 
than six were excluded from MS/MS interrogation. 
 
2.4.4.2 Protein identification  
 
MS raw data were converted to peak lists using Proteome Discoverer (version 2.1.0.81, Thermo-
Fischer Scientific) with the integration of reporter-ion intensities of TMT-10-plex at a mass 
tolerance of ±3.15 mDa431. MS/MS spectra with charges +2, +3 and +4 were analyzed using 
Mascot search engine432 (Matrix Science, London, UK; version 2.6.2). Mascot was set up to search 
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against a SwissProt database of human (version June 2016, 20,237 entries) and common 
contaminant proteins (cRAP, version 1.0, 116 entries). With trypsin as the digestion enzyme, four 
was the maximum allowed missed cleavages. The searches were performed with a fragment ion 
mass tolerance of 0.02 Da and a parent ion tolerance of 20 ppm. Carbamidomethylation of cysteine 
was specified in Mascot as a fixed modification. Deamidation of asparagine, formation of pyro-
glutamic acid from N-terminal glutamine, acetylation of protein N-terminus, oxidation of 
methionine, and pyro-carbamidomethylation of N-terminal cysteine were specified as variable 
modifications. Peptide spectrum matches (PSM) were filtered at 1% false-discovery rate (FDR) 
by searching against a reversed database and the ascribed peptide identities were accepted.  The 
uniqueness of peptide sequences among the database entries was determined using the principal 
of parsimony. Protein identities were inferred using a greedy set cover algorithm from Mascot and 
the identities containing ³ 2 Occam’s razor peptides were accepted433.  
 
2.4.4.3 Protein quantification 
 
All protein quantification and data analyses were performed with R v.3.5TM (http://www.R-
project.org) utilizing the following packages: clusterProfiler422, Limma434, mixtools435. The 
processing, quality assurance and analysis of TMT data were performed with our tidyverse-
based436 in-house pipeline, ProteoQ (version 1.0.0.0). Briefly, reporter-ion intensities under 10-
plex TMT-10 channels were first obtained from Mascot®, followed by the removal of PSM entries 
from shared peptides or with intensity values lower than 1E3. Intensity of PSMs were converted 
to logarithmic ratios at base two, relative to the average intensity of reference samples within a 10-
plex TMT.  Under each TMT channel, Dixon’s437 outlier removals were carried out recursively for 
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peptides with greater than two identifying PSMs. The median of the ratios of PSM that can be 
assigned to the same peptide was first taken to represent the ratios of the incumbent peptide.  The 
median of the ratios of peptides were then taken to represent the ratios of the incumbent protein. 
To align protein ratios under different TMT channels, likelihood functions were first estimated for 
the log-ratios of proteins using finite mixture modelling, assuming two-component Gaussian 
mixtures using the mixtools435. The ratio distributions were then aligned in that the maximum 
likelihood of the log-ratios are centered at zero for each sample.  Scaling normalization was 
performed to standardize the log-ratios of proteins across samples. To discount the influence of 
outliers from either log-ratios or reporter-ion intensities, the values between the 5th and 95th 
percentile of log-ratios and 5th and 95th percentile of intensity were used in the calculations of the 
standard deviations. 
 
2.4.4.4 Data analysis 
 
All proteomics data analyses were performed with R v.3.5TM utilizing the following packages: 
clusterProfiler422, edgeR423, and YARN426. Batch differences were visualized with MDS and 
Principal Component Analyses (PCA) of the protein z-log ratios. YARN426 was then used to filter 
genes and correct for batch effects, while preserving group specificity. The data was then quantile 
normalized in a group-aware manner, accounting for global differences in protein distribution. 
(Supplementary Figure 5). Next, empirical Bayes moderation were carried out to ensure variances 
were no longer dependent on mean protein expression levels438 Log fold change values of the 
protein abundances between groups were calculated by comparing mean expression levels using 
the Limma. The number of differentially expressed proteins were examined with significance set 
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at a Benjamini-Hochberg adjusted p-value cutoff of 0.05. Proteins that were differentially 
expressed in multiple comparisons were extracted and examined from smallest to largest adjusted 
p-value with their associated protein log fold changes. For assessing differentially expressed 
proteins common and unique to PIH and PHH, the nested F-test approach was used, and log fold 
change cut-off was set to zero in order to achieve better consistency between related contrasts 
while preserving proteins that were expressed at similar levels between groups. ClusterProfiler422 
was then used to map differentially expressed proteins to their respective Gene ontology terms to 
assess for enrichment. Proteins enriched for similar and closely overlapping biological processes 




Supplementary Figure 5. Proteomics and RNA-Seq data preprocessing and quality control 
Representative (A and C) multi-dimensional scaling and (B and D) protein density plots grouped 
by tandem mass tagging (TMT)-10 batches of proteomics experiments. The z-log normalized data 
had batch effects demonstrated as sparse patient samples in (A) first and second components and 
heterogeneity (“noise”) on the (B) density plot. After filtration of poor-quality samples, quantile 
normalization and correction for batch effects, (C) sparsity and (D) noise are reduced, while 
preserving group specificity. Each circle and spike represent a patient sample color-coded by the 
TMT-10 batch. Batch pos and Batch neg were CSF samples obtained from infants not in this study, 
whose CSF was used to bookmark all TMT-10 batches to act as batch controls, and to which each 
TMT-plex was normalized to obtain the z-log scores. The Batch pos samples were combined from 
a PIH and a PHH patient and Batch neg was from a non-infectious non-hemorrhagic control infant. 




Integration of proteomics and transcriptomics data was performed following dimension reduction 
and feature selection of differentially expressed proteins and genes. Gene ontology enrichment 
using DAVID427 and reactome over-representation pathway analysis were performed by 
concatenating differentially expressed proteins and genes with a set Log fold change of < -1 and > 
1 and a false discovery rate < 1 at an alpha of 0.05. In-house parsing scripts for data visualization 
and gene/pathway/GO enrichment commonality analyses were performed on the integrated data. 
Physical and functional protein-protein interactions of the genes common to both proteomics and 
RNA-Seq were assessed using the STRING405 online tools. Gene-gene relationships between 
differentially expressed genes were quantified by assigning a composite score to each pairwise 
comparison. Between each pair of genes, the composite score reflected their chromosome 
neighborhood, gene fusion, phylogenetic co-occurrence, homology, co-expression, experimentally 
determined interactions, database annotation and automated text mining405. The higher the 
composite score (i.e. closer to 1), the stronger the predicted gene-gene relationship405.  
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In the previous chapter, we leveraged human CSF to establish that the pathophysiology of post-
infectious (PIH) and post-hemorrhagic (PHH) hydrocephalus are similar, in that they are both 
propagated by inflammation-related disruption of the ependymal barrier. However, it is important 
to note that the infection and hemorrhage that herald PIH and PHH typically occur at a neonatal 
age when neural stem cells in the VZ and SVZ are actively differentiating to form the ependymal 
barrier. Therefore, to gain further insights into the pathophysiology of PIH and PHH, it is 
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imperative to characterize the ventricular zone (VZ) and subventricular zone (SVZ) in PIH/PHH 
infants. There is considerable histological evidence from human post-mortem tissues and animal 
models to support our CSF findings that the VZ and SVZ are critical regions in hydrocephalus 
pathophysiology133,175,197,318. However, there are presently no human studies that have been able 
to examine those regions in vivo. The ability to examine the VZ/SVZ non-invasively, would 
advance the diagnosis, care, monitoring, and prognostication of infants who develop perinatal 
infections and IVH. Additionally, non-invasive characterization of the VZ/SVZ will afford a 
foundation for future studies of therapeutic interventions which address the effects of 
hydrocephalus on those regions.  
 
While diffusion tensor imaging (DTI) offers a unique opportunity to assess the VZ and SVZ 
regions in granular detail, it has not been utilized to date for characterizing those regions. Perhaps 
the biggest hurdle to utilizing any neuroimaging modality for these purposes has been the 
seemingly insurmountable challenge of overcoming volume averaging effects at the margin of the 
ventricle where the VZ and SVZ reside.  
 
In this chapter, we present two major studies. The first study presents a novel semi-automated 
dMRI segmentation algorithm, which we developed, that can delineate the VZ, SVZ, and thin layer 
of PVWM to a high precision of 1.2 mm3 voxels (a region we have since named the Lateral 
Ventricular Perimeter, LVP). We established the feasibility of our algorithm in human preterm 
infants who developed PHH or non-hydrocephalic IVH in comparison to preterm and full-term 
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infants with no brain injury. DTI characterization of the LVP helped gain further insights into the 
pathophysiology and deleterious effects of hydrocephalus on ependymal CSF-brain barrier.  
 
There is evidence that disruption of the LVP exposes the subjacent large bundle PVWM to injury 
by toxin-laden CSF. PVWM injury, especially in tracts such as corpus callosum (CC), 
corticospinal tracts (CST), and optic radiations (OPRA), has been implicated in the majority of the 
debilitating neurological impairments seen in hydrocephalic infants. Therefore, our second study 
focused on assessing the effect of PHH on the CC, CST, and OPRA of our patient cohort. In that 
study, we used diffusion basis spectrum imaging (DBSI) instead of DTI for three principal reasons. 
First, DTI has been extensively used by our group and others to study PVWM in various forms of 
hydrocephalus. Second, unlike DTI, DBSI can separate anisotropic tensors to model and resolve 
crossing fibers, assess injured axons and demyelination, and parse the isotropic tensor spectrum 
into components to reflect cellularity and edema. Third, DBSI related dMRI findings to histology, 
which not only helped to co-validate the dMRI findings but also provided further evidence for the 
associations between LVP disruption and PVWM injury.  
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3.2 Results  
 
3.2.1 Segmentation of the lateral ventricular perimeter (LVP) on diffusion MRI  
 
3.2.1.1 Segmentation requires minimal user input 
 
Here we detail the semi-automated delineation of the LVP in infants whose DTI data were 
extracted from LVP to elucidate the role of VZ/SVZ disruption in the pathophysiology of PHH. 
In MATLAB, the algorithm was set up to first read standard processed DTI files. Images showing 
mean diffusivity (MD) were then sequentially displayed to allowed us to select slices centered on 
the foramen of Monro. Once the central slice was determined, the algorithm automatically selected 
three total axial slices (one rostral and one caudal to the center slice) for further analysis. The MD 
image was used since it provides a sharp demarcation between the brain parenchyma and the CSF. 
The script then displayed a bimodal histogram of the MD values with the lower peak representing 
MD values in the brain parenchyma, and the higher peak representing CSF spaces. Based on the 
histogram, we determined a threshold value that best separated the parenchyma and CSF MD 
values. Following this, the script produced an image showing voxels with MD values above the 
threshold. Through automated sequential erode and dilate steps, the selected regions were 
smoothed, and small extraneous spaces were removed. 
 
The algorithm was capable of automatically calculating the number of objects in each slice and the 
area of each object (blob analysis), then displaying the information. A predetermined minimum 
size (we used 10 voxels) was applied to display only areas likely to be involved in the ventricular 
system. The script also determined the center of mass of each object, with the assumption that true 
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ventricular objects will be close to the center of the brain. At this stage, the number of objects to 
be further processed was selected, including all objects that represent ventricular spaces. An image 
of all objects greater than the minimum size was then produced by the script, allowing us to click 
near the center of mass of each object to be included in the final selection. Once the relevant objects 
were selected, they were automatically saved, and extraneous objects were removed from further 
analysis. This process was repeated for each of the three contiguous slices automatically. 
 
3.2.1.2 The frontal and occipital horns of the lateral ventricle can be independently assessed 
 
In our cohort, we independently segmented the anterior (frontal) and posterior (occipital) horns of 
the lateral ventricle. To select only the frontal and occipital horns (FOHP), the previously 
segmented LVP objects were modified as follows: 1) The center point of the LVP in the anterior-
posterior (A-P) direction was calculated, dividing the brain into an anterior and posterior segment; 
2) The algorithm then located the most anterior and most posterior voxels that were already 
included in the LVP, to select all voxels that were within a predetermined A-P distance from the 
most extreme points for inclusion in the frontal and occipital horn perimeters. 
 
3.2.1.3 Semi-automated algorithm strongly corelates with manually segmented LVP  
 
With minimal user input as previously described, the algorithm automatically isolates 
periventricular voxels by performing two sequential dilation steps, incorporating voxels that are 
one and two spaces away from the ventricles and then subtracting the original ventricle objects 
from the dilated objects (Figure 21). Extraction of DTI data from the LVP was performed by 
applying numerical thresholds to MD maps to isolate the lateral ventricles as being central 
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structures with high MD values. To assess for potential differences between the algorithm and 
manually placed ROIs, dMRI of 20 neonates of varying ventricular morphologies were selected 
and manual ROIs were placed by an independent expert rater. Pearson correlation analyses 
between dMRI measures from both approaches indicated a strong positive association between the 
automated and manual segmentations fractional anisotropy (r (20) = .91, p <.001) and MD (r(20) 
= .89, p <.001) measures. 
 
Figure 21: Segmentation of Regions of Interest (ROIs)  
Representative contiguous axial mean diffusivity maps of infants with variable ventricular 
morphologies demonstrating segmentation of the lateral ventricular perimeter (top row) and 
frontal and occipital horn perimeter (bottom row). 
 
3.2.2 Region-specific dMRI-derived LVP disruption underlies PHH pathophysiology  
 
3.2.2.1 Patient characteristics  
 
This study leveraged a large cohort of prospectively recruited very preterm infants with/without 
IVH/PHH and full-term healthy control infants in order to assess the effects of PHH on LVP. The 
first group included infants born ≤30 weeks gestational age with no or low-grade IVH (very 
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preterm, VPT group). The second group (high-grade intraventricular hemorrhage, HG-IVH 
group), was comprised of age-matched VPT infants who developed grade III/IV IVH identified on 
cranial ultrasound within the first month of life. The third group (post-hemorrhagic hydrocephalus, 
PHH group), was comprised of VPT infants who sustained grade III/IV IVH identified on cranial 
ultrasound within the first month of life and required neurosurgical treatment for hydrocephalus. 
The fourth group (full-term, FT group) were healthy infants born at 38–42 weeks gestational age, 
who were identified from a larger cohort undergoing neonatal neuroimaging scans as part of a 
contemporaneous fetal monitoring study. All patients underwent dMRI at term equivalent age.  
 
A total of 206 infants (FT=76, VPT=91, HG-IVH=20, PHH=19) with DTI data were screened for 
possible inclusion in the study. Reasons for study exclusion across the groups included: acidosis 
(FT=8), positive maternal urine drug screen (FT=5, VPT=1, HG-IVH=1), atypical pattern of brain 
injury/abnormal MRI finding (FT=2, VPT=2). (Figure 22). 
 
Figure 22: Flowchart of subjects screening and enrolment for study 
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Of the 158 infants (77 males and 81 females) included in the final study cohort, there were 56 FT, 
72 VPT, 17 HG-IVH, and 13 PHH infants. Median frontal-occipital horn ratios were higher in 
PHH (0.50 ± 0.06) > HG-IVH (0.41 ± 0.04) = VPT (0.41 ± 0.02) > FT (0.37 ± 0.02) (Table 2; 
Figure 23). All 13 PHH infants had undergone reservoir placement prior to their study MRI, with 
6 of these infants also undergoing shunt placement prior to their MRI scan. There were no 
significant differences in MD or FA values either in the FOHP or LVP between PHH infants who 
underwent their shunt surgery before vs. after their MRI scan. Of the 13 PHH infants, 12 had 
reservoirs and 2 had subgaleal shunts placed prior to VP shunt or ETV surgery. For permanent 
hydrocephalus treatment, 10 infants had VP shunts placed and 2 underwent ETV surgery. As 
expected, the median ventricular size of the ETV infants was larger (0.60±0.01) than that of the 
VP shunt infants (0.49±0.05) (p=0.008). Nevertheless, in this limited cohort, there was no 
difference in dMRI measures between infants who underwent ETV vs. VP shunt in both the LVP 
and FOHP regions. One infant underwent treatments for hydrocephalus with a reservoir but did 
not require permanent CSF diversion.  
 
Table 2: Characteristics of 158 infants in a prospective study to assess the effects of IVH/PHH on 
dMRI measures of the lateral ventricular layer 
 FT VPT HG-IVH PHH 
# of patients 56 (35.4%) 72 (45.6%) 17 (10.8%) 13 (8.2%) 
Sex (# of Male/Female) 27 /29 30 /42 7/9 13/0 
Birth gestational age (weeks) 39.0±1.2 27.0±1.7 25.0±2.0 24.0±2.1 
Term age equivalent (weeks) 39.0±1.2 37.0±1.5 38.0±2.1 39.0±1.1 
Birth weight (g) 3229.50±461.14 940±257.67 735±266.50 780±216.27 
Clinical risk index score 0.00±0.00 1.00±1.87 3.00±1.69 3.00±2.33 
Frontal-occipital horn ratio 0.37±0.02 0.41±0.02 0.41±0.04 0.50±0.06 




Figure 23: Assessment of ventricular size  
Ventricular size was determined by the frontal and occipital horn ratio. Axial T2W image of a 
normal neonate (left) and an infant with hydrocephalus (right). Ventricular size is determined by 
the frontal and occipital horn ratio which was calculated as (𝛼 + β)/2𝛿 or by the Evan’s Index 
calculated as (α/ 𝛿). Box and whisker diagram demonstrating the PHH group had the largest 
frontal-occipital horn ratio among 158 infants (p <.001, ***). There was no difference in 
ventricular size between the VPT and HG-IVH infants, although both groups had median 
ventricular sizes that were larger than that of the FT control infants.  
 
3.2.2.2 PHH is associated with segmental aberration of dMRI measures in the LVP  
 
In the LVP, family-wise comparisons with Benjamini-Hochberg correction revealed that PHH had 
consistently lower fractional anisotropy (FA) and higher mean (MD) and radial (RD) diffusivities 
than FT and VPT infants (p<.050). While PHH FA was lower, and PHH RD was higher than that 
of HG-IVH (p<.050) in the LVP, the MD and AD values did not differ (Tables 3 and 4; Figure 
24). In the FOHP, Benjamini-Hochberg corrected family-wise comparisons revealed PHH infants 
had lower FA and higher RD than FT and VPT infants in the FOHP (p<.010) (Tables 3 and 4; 
Figure 25). Similar to the LVP, PHH FA was lower than that of HG-IVH (p<.001) in the FOHP. 
Except for MD and RD in the LVP region, there were no differences in dMRI measures between 
the HG-IVH and VPT infants. Among the PHH group, there was no difference in dMRI measures 
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between the ETV and VP shunt treated infants (p>.050) in both the LVP and FOHP regions. While 
the magnitude of PHH AD was consistently less than AD measures in the other groups, in both the 
LVP and FOHP pairwise comparisons were not significant (p>.050). Comparison of LVP/FOHP 
dMRI measures to those of adjacent CST and OPRA revealed tract-specific associations between 
dMRI measures. Among the HG-IVH infants, dMRI metrics in both the LVP and FOHP were 
associated with OPRA microstructure, but no associations were found with the CST. In contrast, 
few associations were found for the PHH group. 
 
Table 3: Median dMRI measures among 157 full- and pre-term infants with/or without IVH/PHH 
 
FT VPT HG-IVH PHH Sig. 
Lateral ventricular perimeter 
FA 0.27±0.05 0.23±0.04 0.21±0.04 0.16±0.05 <0.001* 
MD (μm2/s) 1.46±0.09 1.47±0.08 1.55±0.11 1.58±0.15 <0.001* 
AD (μm2/s) 1.88±0.12 1.85±0.15 1.93±0.18 1.82±0.25 0.031* 
RD (μm2/s) 1.24±0.15 1.29±0.12 1.38±0.10 1.48±0.15 <0.001* 
Frontal-occipital horn perimeter 
FA 0.29±0.07 0.22±0.06 0.20±0.05 0.13±0.04 <0.001* 
MD (μm2/s) 1.59±0.11 1.66±0.19 1.73±0.14 1.77±0.24 <0.001* 
AD (μm2/s) 2.13±0.14 2.09±0.27 2.11±0.21 1.94±0.32 0.173 
RD (μm2/s) 1.33±0.17 1.45±0.18 1.56±0.15 1.66±0.24 <0.001* 
All measures within the respective groups are medians ± standard deviations where necessary; One-way 
ANOVA was performed with Kruskall-Wallis test (Sig.). All p-values are Benjamini-Hochberg corrected 
with alpha level set at p <0.050 (*).  FA = fractional anisotropy; MD = mean diffusivity; AD = axial 
diffusivity; RD = Radial diffusivity; PHH = post hemorrhagic hydrocephalus; HG-IVH = high grade 







Table 4: Groupwise comparisons between 157 full- and pre-term infants with/or without IVH/PHH 
 
FT:VPT FT:HG-IVH FT:PHH VPT:HG-IVH VPT:PHH HG-IVH:PHH 
Lateral ventricular perimeter 
FA <0.001* <0.001* <0.001* 0.100 <0.001* 0.004* 
MD (μm2/s) 1.000 0.011* 0.027* 0.008* 0.034* 1.000 
AD (μm2/s) 0.299 1.000 1.000 0.055 1.000 0.869 
RD (μm2/s) 0.057 0.003* <0.001* 0.014* <0.001* 0.048* 
Frontal-occipital horn perimeter 
FA <0.001* <0.001* <0.001* 0.349 <0.001* <0.001* 
MD (μm2/s) 0.022* 0.003* 0.102 0.213 0.700 1.000 
AD (μm2/s) 1.000 1.000 0.281 1.000 1.000 0.567 
RD (μm2/s) 0.002* <0.001* 0.007* 0.118 0.007* 0.869 
All groupwise comparisons performed by Wilcoxon signed rank family-wise comparisons. All p-values are 
Benjamini-Hochberg corrected with alpha level set at p <0.050 (*).  FA = fractional anisotropy; MD = 
mean diffusivity; AD = axial diffusivity; RD = Radial diffusivity; PHH = post hemorrhagic hydrocephalus; 
HG-IVH = high grade intraventricular hemorrhage; VPT = very preterm; FT = full term 
 
 
Figure 24: dMRI measures of the lateral ventricular perimeter (LVP)  
The LVP demonstrated increasing severity of brain injury corresponds with decreasing fractional 
anisotropy (FA) and increasing mean (MD) and radial (RD) diffusivities. No significant changes 
were observed in axial diffusivity (AD) measures between groups.  
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Figure 25: dMRI measures of the frontal occipital horn perimeter (FOHP)  
The FOHP demonstrated increasing severity of brain injury corresponds with decreasing fractional 
anisotropy (FA) and increasing mean (MD) and radial (RD) diffusivities. No significant 
differences were observed in axial diffusivity (AD) measures between groups. 
3.2.2.3 The FOHP region is more severely injured than the rest of the LVP 
 
A linear mixed effects model, adjusted for term equivalent age at scan, revealed regional FA and 
RD differences between the FOHP and LVP [F (3,153) = (FA (19.46), MD (0.98), AD (1.88), RD 
(3.16); p<.001)]. In the FT infants, FA, MD, AD and RD measures in the FOHP were higher than 
the LVP, which reflects baseline differences between the two regions among healthy infants in this 
cohort. However, in the PHH group, while MD, RD and AD measures in the FOHP were higher 
than the LVP, FOHP FA was less than the LVP, directly opposite to the observed findings in the 
healthy infants. (Table 5; Figure 26). Nevertheless, directionality of the principal eigenvectors in 
both LVP and FOHP generally did not differ between groups (Figure 27). 
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Table 5: Region-specific dMRI measures examining between-group differences among 158 infants  
 
Lateral ventricular perimeter Frontal occipital horn perimeter Mean difference 
(LVP-FOHP) 
 
Estimate Lower Upper Estimate Lower Upper 
Fractional anisotropy 
FT 0.26 0.24 0.27 0.29 0.27 0.30 -0.03 
VPT 0.22 0.21 0.24 0.22 0.21 0.23 0.00 
HG-IVH 0.20 0.18 0.23 0.20 0.17 0.23 0.00 
PHH 0.15 0.12 0.18 0.12 0.09 0.15 0.03 
Mean diffusivity(μm2/s) 
FT 1.46 1.42 1.50 1.60 1.56 1.63 -0.13 
VPT 1.47 1.44 1.51 1.63 1.60 1.67 -0.16 
HG-IVH 1.55 1.49 1.62 1.73 1.66 1.80 -0.17 
PHH 1.58 1.51 1.66 1.73 1.65 1.81 -0.15 
Axial diffusivity(μm2/s) 
FT 1.88 1.82 1.93 2.11 2.05 2.16 -0.23 
VPT 1.82 1.77 1.86 2.02 1.97 2.07 -0.20 
HG-IVH 1.90 1.80 2.00 2.10 2.00 2.20 -0.20 
PHH 1.77 1.66 1.88 1.92 1.81 2.03 -0.15 
Radial diffusivity(μm2/s) 
FT 1.26 1.22 1.31 1.35 1.31 1.39 -0.09 
VPT 1.31 1.27 1.35 1.45 1.41 1.49 -0.14 
HG-IVH 1.38 1.30 1.46 1.54 1.46 1.62 -0.16 
PHH 1.51 1.42 1.60 1.65 1.56 1.74 -0.14 
Summary of least square means from a linear mixed effects model. PHH = post hemorrhagic 
hydrocephalus; HG-IVH = high grade intraventricular hemorrhage; VPT = very preterm; FT = full term. 
Lower and upper values are confident intervals 
 
 
Figure 26: Effects of region of segmentation on dMRI measures  
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Between groups the FOHP in PHH infants had higher MD, AD and RD as well as lower FA 
measures than the LVP, an indication the FOHP is more disrupted than the LVP. Error bars are 
standard error means. 
 
 
Figure 27: Representative principal eigenvector maps of white matter orientation 
The eigen vector analyses of the periventricular white matter in healthy full-term (FT) and post 
hemorrhagic hydrocephalus (PHH) infants demonstrated orientation of the direction of maximum 
water displacements (arrows) along the perimeter of the ventricles (V) was generally preserved 
between groups in spite of the reduced anisotropy in the PHH group. 
3.2.2.4 Ventricular size correlates with dMRI measures in the LVP and FOHP  
 
Spearman’s rho revealed that frontal-occipital horn ratio correlated with dMRI measures in the 
LVP. Ventricular size had negative correlation with FA (rs=-0.41 p<.001), with anticipated 
positive correlations with MD (rs=0.26, p=.005) and RD (rs=0.36, p<.001) in the LVP (Figure 28). 
Relatively stronger relationships were found in the FOHP in that ventricular size was negatively 
correlated with FA (rs=-0.47, p<.001) and positively correlated with MD (rs=0.35, p<.001) and 
RD (rs=0.42, p<.001) (Fig. 29). AD measures did not correlate with ventricular size in either the 
LVP or FOHP segmentation analyses (rs=-0.05, p=1.000). 
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Figure 28: dMRI-ventricular size correlations in the LVP  
Spearman correlation analyses demonstrated that larger ventricular size was associated with higher 
MD and RD and lower FA, suggesting ventricular enlargement is associated with dMRI-measured 
LVP disruption. 
 
Figure 29: dMRI-ventricular size correlations in the FOHP 
Spearman correlation analyses demonstrated larger ventricular size was associated with higher 




3.2.3 DBSI differentiates PVWM pathology in PHH  
 
3.2.3.1 Subject characteristics  
 
Prospectively recruited infants assessed between May 2007 and August 2016 were categorized 
into four groups: full term (FT), very preterm (VPT), intraventricular hemorrhage (IVH) and post-
hemorrhagic hydrocephalus (PHH). A total of 206 infants (FT=76, VPT=91, IVH=20, PHH=19) 
with dMRI data were assessed for possible inclusion. Sixty-six patients did not meet inclusion 
criteria for the reasons outlined in Figure 30, which included having a positive maternal urine drug 
screen, atypical pattern of brain injury/abnormal MRI finding that precluded accurate 
segmentation of ROIs, and dMRI data that could not be fitted with DBSI due to having less than 
25 diffusion-encoding directions and/or b-values. 
 
Figure 30: Flowchart of patient enrolment and selection for study inclusion 
 
 97 
Among 140 infants (70 males, 70 females) who underwent dMRI, 45 FT, 68 VPT, 15 IVH and 12 
PHH infants were included in the analyses. The median term age equivalent of dMRI acquisition 
was 38±2 weeks. By definition, the PHH group had larger ventricles than the remaining groups 
(median frontal-occipital horn ratio of 0.52±.10 vs. 0.40±.04). The median clinical risk scores of 
IVH and PHH infants were similar and significantly higher than that of the VPT and FT infants. 
(Table 6; Figure 31). Prior to their dMRI scan, all PHH infants (n=12) had undergone a temporary 
ventricular access device placement for serial CSF removal, with 10 of these infants eventually 
undergoing permanent shunt placement and two undergoing ETV to treat hydrocephalus. There 
were no differences between the shunt- and ETV-treated infants on all measures.  
Table 6: Characteristics of infants in a prospective study to assess DBSI indices in PVWM 
 
Full term Very preterm IVH PHH 
# of patients 45 68 15 12 
Sex 
    
# of male infants 22 29 7 12 
# of female infants 23 39 8 0 
GA at birth (weeks) 39.0±2.0 27.0±2.8 25.0±3.0 24.5±4.0 
TEA at dMRI acquisition (weeks) 39.0±2.0 37.0±1.0 38.0±4.0 39.0±1.0 
Birth weight (g) 3195±714.0 932.5±350.0 740.0±330.0 807.5±304.5 
Frontal-occipital horn ratio 0.36±0.03 0.41±0.03 0.41±0.04 0.52±0.10 
Clinical risk score 0±0 1±3 3±2 3±4 
All continuous variables are reported as median ± interquartile range within the respective groups. IVH = 




Figure 31: Ventricular size measurement and regions of interest segmentation 
Representative axial T2W of a preterm infant with post-hemorrhagic hydrocephalus (PHH) (top 
row). Ventricular size was determined by the frontal-occipital horn ratio which was calculated as 
(a + c)/2b 20. The Box and whisker diagram demonstrate the PHH group had the largest ventricular 
size among 140 infants (p<.001, ***). There was no difference in ventricular size between the 
VPT and IVH infants, although both groups had median ventricular sizes that were larger than that 
of the FT control infants. Bottom row demonstrates representative contiguous axial fractional 
anisotropy maps of infants with demarcation of the segments of the white matter bundles of interest 
within the corpus callosum, bilateral corticospinal tracts and bilateral optic radiations. 
 
3.2.3.2 Neuroinflammation and reduced fiber density in the corpus callosum 
 
In the CC, PHH infants had the lowest FA and highest RD (p<.001), suggesting they had more 
severe white matter disruption than non-PHH infants. Quantification of fiber density demonstrated 
that the PHH group had 71%, 70% and 53% less white matter fiber density than the FT, VPT and 
IVH groups, respectively (p<.001). However, the IVH group also had lower FA, higher RD and 
32% and 38% lower fiber density in comparison to the FT and VPT infants, respectively (p<.01). 
This indicates hemorrhage had an independent detrimental effect on white matter integrity, albeit 
exacerbated by hydrocephalus. Isotropic diffusion metrics revealed the PHH group had the highest 
restricted fraction, suggesting cellular infiltration when compared to the non-PHH groups 
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(p<.001). Hypercellularity would be expected to be associated with reduced FA and AD measures, 
and, indeed, fiber level analyses confirmed the PHH group had the lowest FFA and FAD (p<.001). 
FRD and the non-restricted fraction (a marker of edema) did not differ between groups (Figure 
32). Across tracts, dMRI measures and p values for one-way and groupwise comparisons are 
presented in Tables 7 and 8, respectively. 
Table 7: dMRI measures of PVWM in full term and preterm infants with/or without IVH/PHH and 
their frontal-occipital horn ratio-dMRI correlations  
  Measures Ventricular size-dMRI  
 PHH IVH VPT FT Rho P-value 
CC 
FA 0.11 ± 0.11 0.34 ± 0.40 0.42 ± 0.44 0.43 ± 0.57 -0.34 <0.001* 
AD 2.02 ± 1.48 2.25 ± 1.03 2.18 ± 0.94 2.15 ± 1.61 -0.06 0.474 
RD 1.61 ± 1.39 1.20 ± 0.89 1.08 ± 1.03 1.01 ± 1.59 0.28 0.001* 
MD 1.73 ± 1.42 1.56 ± 0.77 1.43 ± 0.81 1.38 ± 1.29 0.22 0.011* 
FFA 0.46 ± 0.32 0.70 ± 0.48 0.71 ± 0.29 0.69 ± 0.50 -0.14 0.106 
FAD 1.80 ± 1.30 2.42 ± 1.19 2.21 ± 1.19 2.18 ± 1.27 -0.20 0.018* 
FRD 0.71 ± 0.59 0.57 ± 0.38 0.56 ± 0.59 0.58 ± 0.61 -0.02 0.847 
FF 0.17 ± 0.30 0.36 ± 0.47 0.53 ± 0.66 0.58 ± 0.77 -0.28 0.001* 
RF 0.53 ± 0.56 0.34 ± 0.74 0.28 ± 0.72 0.22 ± 0.71 0.32 <0.001* 
NRF 0.28 ± 0.80 0.29 ± 0.80 0.16 ± 0.58 0.18 ± 0.75 0.05 0.547 
CST 
FA 0.39 ± 0.34 0.51 ± 0.36 0.51 ± 0.22 0.56 ± 0.40 -0.10 0.236 
AD 1.58 ± 0.55 1.77 ± 0.62 1.75 ± 0.25 1.76 ± 0.52 0.16 0.054 
RD 0.84 ± 1.02 0.69 ± 0.84 0.72 ± 0.35 0.66 ± 0.40 0.14 0.109 
MD 1.13 ± 0.87 1.05 ± 0.68 1.03 ± 0.28 1.02 ± 0.17 0.14 0.109 
FFA 0.65 ± 0.40 0.71 ± 0.57 0.71 ± 0.38 0.76 ± 0.31 -0.25 0.003* 
FAD 1.45 ± 0.86 1.92 ± 1.11 1.96 ± 0.42 1.87 ± 0.49 0.21 0.011* 
FRD 0.66 ± 0.22 0.42 ± 0.44 0.48 ± 0.61 0.42 ± 0.37 0.21 0.011* 
FF 0.49 ± 0.52 0.59 ± 0.65 0.62 ± 0.44 0.65 ± 0.56 -0.09 0.273 
RF 0.39 ± 0.44 0.29 ± 0.42 0.25 ± 0.43 0.27 ± 0.57 0.00 0.973 
NRF 0.05 ± 0.73 0.03 ± 0.23 0.02 ± 0.10 0.03 ± 0.19 0.06 0.493 
OPRA 
FA 0.24 ± 0.68 0.36 ± 0.32 0.37 ± 0.22 0.38 ± 0.23 -0.18 0.032 
AD 2.04 ± 1.03 1.91 ± 0.91 1.95 ± 0.35 1.81 ± 0.72 0.48 <0.001* 
RD 1.41 ± 1.41 1.21 ± 0.60 1.21 ± 0.54 1.20 ± 0.60 0.16 0.056 
MD 1.65 ± 1.04 1.48 ± 0.55 1.45 ± 0.42 1.39 ± 0.61 0.29 0.001* 
FFA 0.63 ± 0.32 0.68 ± 0.28 0.67 ± 0.25 0.72 ± 0.26 -0.18 0.031* 
FAD 2.53 ± 0.62 2.18 ± 0.92 2.22 ± 0.54 2.01 ± 0.54 0.47 <0.001* 
FRD 0.74 ± 0.72 0.76 ± 0.45 0.74 ± 0.47 0.65 ± 0.33 0.28 0.001* 
FF 0.36 ± 0.41 0.51 ± 0.33 0.53 ± 0.33 0.45 ± 0.38 -0.02 0.798 
RF 0.53 ± 0.66 0.40 ± 0.44 0.41 ± 0.34 0.41 ± 0.44 -0.03 0.700 
NRF 0.10 ± 0.28 0.04 ± 0.34 0.03 ± 0.24 0.05 ± 0.24 0.13 0.135 
All continuous variables are reported as median ± standard deviation within the respective groups. IVH = 
intraventricular hemorrhage; PHH= post-hemorrhagic hydrocephalus; Groupwise comparisons were 
done with the Wilcoxon signed rank test. Ventricular size- diffusion MRI (dMRI) correlations were assessed 
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with Spearman Rho correlations. All p-values were Bonferroni corrected and significant p-values (p<.050) 
are asterisked (*). 
Table 8: Levels of significance for one-way and groupwise comparisons of dMRI measures in full 
term and preterm infants with/or without IVH/PHH  

















FA <.001 <.001 <0.001* <0.001* <0.001* 0.004* 0.002* 0.462 
AD 0.489 0.278 0.394 0.314 0.196 0.379 0.235 0.854 
RD <.001 <.001 <0.001* <0.001* 0.026* 0.003* 0.001* 0.313 
MD 0.002 0.023 0.024* 0.018* 0.428 0.005* 0.005* 0.192 
FFA <.001 <.001 <0.001* <0.001* <0.001* 0.612 0.867 0.221 
FAD <.001 <.001 <0.001* <0.001* <0.001* 0.158 0.240 0.377 
FRD 0.480 0.160 0.213 0.152 0.367 0.973 0.606 0.522 
FF <.001 <.001 <0.001* <0.001* 0.002* 0.003* 0.001* 0.585 
RF <.001 <.001 <0.001* <0.001* 0.016* 0.002* 0.035* 0.010* 
NRF 0.127 0.145 0.305 0.070 0.683 0.446 0.086 0.208 
CST 
FA <.001 <.001 0.002* <0.001* <0.001* 0.102 0.438 0.114 
AD <.001 <.001 0.001* <0.001* <0.001* 0.919 0.745 1.000 
RD <.001 <.001 <0.001* <0.001* <0.001* 0.543 0.069 0.022* 
MD <.001 <.001 <0.001* <0.001* 0.003* 0.117 0.504 0.114 
FFA <.001 <.001 <0.001* <0.001* 0.025* 0.163 0.864 <0.001* 
FAD <.001 <.001 <0.001* <0.001* <0.001* 0.139 0.329 <0.001* 
FRD <.001 <.001 <0.001* <0.001* <0.001* 0.407 0.372 <0.001* 
FF <.001 <.001 0.004* <0.001* 0.002* 0.488 0.623 0.483 
RF 0.001 <.001 0.038* <0.001* 0.012* 0.906 0.179 0.344 
NRF <.001 0.005 0.080 <0.001* 0.152 0.879 0.047* 0.001* 
OPRA 
FA 0.004 0.001 0.001* 0.001* 0.015* 0.397 0.692 0.092 
AD <.001 0.037 0.009 0.135 0.069 0.242 0.042* <0.001* 
RD 0.139 0.029 0.066 0.026* 0.109 0.477 0.489 0.498 
MD 0.005 0.016 0.018* 0.019* 0.134 0.060 0.582 0.007* 
FFA <.001 0.012 0.005* 0.025* 0.121 0.028* 0.701 <0.001* 
FAD <.001 <.001 <0.001* <0.001* 0.001* 0.005* 0.674 <0.001* 
FRD <.001 0.307 0.031* 0.729 0.959 <0.001* 0.854 <0.001* 
FF <.001 <.001 0.022* <0.001* 0.003* 0.417 0.295 0.009* 
RF 0.025 0.004 0.018* 0.003* 0.024* 0.467 0.799 0.338 
NRF <.001 0.001 0.042* <0.001* 0.027* 0.761 0.154 0.008* 
All continuous variables are reported as median ± standard deviation within the respective groups. IVH = 
intraventricular hemorrhage; PHH= post-hemorrhagic hydrocephalus; Groupwise comparisons were 
done with the Wilcoxon signed rank test. All p-values were Bonferroni corrected and significant p-values 





Figure 32: dMRI measures of the corpus callosum (CC)  
The CC dMRI metrics demonstrated PHH infants had the most severe white matter disruption, 
which was marked by having the lowest fiber level FA and AD indices when compared to IVH, 
VPT and FT infants. PHH was also associated with a reduced white matter fiber density (Fiber 
Fraction), and the relatively highest measures of cellular infiltration (Restricted Fraction) in the 
CC. No differences were observed in fiber RD and markers of edema (Non-restricted Fraction) 
between groups. ***represents p-value<.001; FT=full term; VPT= very preterm; 
IVH=intraventricular hemorrhage; PHH=post-hemorrhagic hydrocephalus; FA= fractional 
anisotropy; AD=axial diffusivity; RD=radial Diffusivity. 
 
3.2.3.3 Neuroinflammation, reduced fiber density, and demyelination in corticospinal tracts 
 
In the CST, the PHH group again had the lowest FA, lowest AD and highest RD, implying more 
severe white matter disruption than in PHH compared to non-PHH infants (p<.001). Fiber-specific 
metrics demonstrated PHH had the lowest FFA and FAD, and the highest FRD when compared to 
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the non-PHH groups (p<.001). White matter fiber density quantification showed the PHH group 
had 25%, 21% and 17% less fibers than the FT (p=.004), VPT (p<.001) and IVH (p=.002) groups, 
respectively. The PHH group also had the highest measures of restricted fraction, suggesting a 
higher cellular infiltration than in the non-PHH groups (p<.001). Non-restriction fraction, a marker 
of edema, only differed between the PHH and VPT groups (p<.001). (Figure 33).  
 
Figure 33: dMRI measures of the corticospinal tracts (CST)  
The CST dMRI metrics demonstrated PHH infants had the most severe white matter disruption, 
which was marked by having the lowest fiber level FA and AD indices, as well as highest measures 
of RD when compared to IVH, VPT and FT infants. PHH was also associated with reduced white 
matter fiber density and the highest measures of cellular infiltration in the. No between group 
differences were observed in non-restricted fraction, a marker of vasogenic edema. ***, ** and * 
represents p-value <.001, <.01 and <.05, respectively; FT=full term; VPT= very preterm; 
IVH=intraventricular hemorrhage; PHH=post-hemorrhagic hydrocephalus; FA= fractional 
anisotropy; AD=axial diffusivity; RD=radial Diffusivity. 
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3.2.3.4 Neuroinflammation, reduced fiber density, and edema in optic radiations 
 
The OPRA in the PHH group also demonstrated disruption when compared to the non-PHH 
groups. However, the pattern differed from that of the CC and CST. Specifically, while the PHH 
group had the lowest FA values (p=.001), their AD and RD measures did not differ from the non-
PHH groups. Fiber level analysis showed that FFA in the PHH group was lower than that of the 
FT (p=.005) and VPT (p=.025) but did not differ from the IVH group (p=.12). FFA of the IVH 
and VPT groups were lower than that of the FT group (p=.028 and p<.001, respectively), but did 
not differ from each other (p=.70). Fiber level RD was lower in FT than very preterm infants: PHH 
(p=.03), IVH (p<.001), and VPT (p<.001). Together, these findings suggest hemorrhage and 
preterm birth were independent contributing factors to impaired white matter disruption in the 
OPRA. White matter fiber density quantification demonstrated the PHH infants had 20%, 32% 
and 29% less fibers than the FT (p=.02), VPT (p<.001) and IVH (p=.003) infants, and the PHH 
group had the highest measures of fiber level AD (p<.001). Isotropic tensor analyses demonstrated 
evidence of inflammation in the OPRA of PHH infants, given their increased measures of white 




Figure 34: dMRI measures of the optic radiations (OPRA)  
The OPRA dMRI metrics demonstrated PHH infants had the most severe white matter disruption, 
which was marked by having the lowest fiber level FA when compared to IVH, VPT and FT 
infants. PHH was also associated with reduced white matter fiber density (Fiber Fraction) and the 
highest measures of fiber level AD. In addition, the PHH group demonstrated evidence of severe 
inflammation marked by the highest measures of vasogenic edema (Non-restricted Fraction) and 
cellular infiltration (Restricted Fraction). ***, ** and *represents p-value <.001, <.01 and <.05, 
respectively; FT=full term; VPT= very preterm; IVH=intraventricular hemorrhage; PHH=post-
hemorrhagic hydrocephalus; FA= fractional anisotropy; AD=axial diffusivity; RD=radial 
diffusivity. 
 
3.2.3.5 Ventricular size correlates with magnitude of PVWM disruption  
 
Across all three white matter bundles, greater ventricular size demonstrated varying correlation 
strength with poorer dMRI measures with variable patterns. In the CC, ventricular size related 
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negatively with FA (p<.001) and fiber density (p=.001) and positively with RD (p<.001) and 
cellular infiltration (p<.001). In the CC, FAD negatively correlated with ventricular size (p=.018), 
while in the CST (p=.01) and OPRA (p<.001) positive correlations were observed. This likely 
reflects differences between the CC and CST/OPRA at this developmental stage including 
myelination and compactness of the respective white matter fiber bundles. (Figure 35). 
 
Figure 35: Ventricular size-dMRI correlations  
Spearman correlation analyses demonstrated increase in ventricular size was correlated with 
poorer dMRI measures, but in variable patterns across the corpus callosum (CC), corticospinal 
tracts (CST) and optic radiations (OPRA). In the CC, as ventricular size increases, a decrease in 
fiber AD and white matter fiber density and an increase in cellular infiltration are observed. 
However, in both the CST and OPRA, increases in ventricular size were associated with decreases 
in fiber FA and AD and increases in fiber RD. Ventricular size was obtained with frontal occipital 
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horn ratio approach20. Significant correlations are represented by bold image borders where ***, 
** and * represents p-value <.001, <.010 and <.050 respectively; FT=full term; VPT= very 
preterm; IVH=intraventricular hemorrhage; PHH=post-hemorrhagic hydrocephalus. 
 
3.2.3.6 Postmortem tissue neurocytology relates DBSI metrics to VZ disruption 
 
Immunohistochemical analyses of the CC from postmortem tissues validated the dMRI findings. 
In comparison to controls, PHH infants demonstrated white matter tracts with relatively higher 
cellularity, reflecting their high restricted fractions seen on dMRI. In addition, the PHH infants 
had decreased synaptophysin staining suggesting decreased neuropil and synaptic processes, 
which reflects their low fiber fractions on dMRI. While variable amount of cytoplasmic 
vacuolation suggesting edema was seen on histology, the dMRI correlate, non-restricted fractions 
did not differ between PHH and non-PHH groups, presumably the non-restricted fractions reflect 
interstitial or extracellular edema (Figure 36).  
 
Figure 36. Representative neurocytology of post-mortem PVWM tissue  
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Representative histological staining of post-mortem tissue from corpus callosum (CC) of preterm 
infants. (A & B) H&E and (C & D) synaptophysin of preterm infants (A & C) without or (B & D) 
with PHH. PHH infants had relatively increased cellular infiltration (B & D) and vacuolation of 
their cytoplasm to suggest edema (B). Decreased axonal staining in PHH (D) suggests a relatively 
decreased fiber density in comparison to controls (C). The CC is not myelinated at term equivalent. 
 
Analyses of the VZ/SVZ and adjoining PVWM demonstrated that IVH, and to a greater extent 
PHH, were associated with hemorrhage as well as VZ/SVZ disorganization, as characterized by 
variable granular ependymitis on H&E staining. IVH/PHH was associated with a 20-30% relative 
increase in VZ disruption when compared with (p=.016) and FT infants (p=.011). In addition, 
IVH/PHH was associated with disruption of radial glial cells in the VZ, characterized by loss of 
their basal projections and VZ lattice. Furthermore, there was relatively increased expression of 
GFAP and IBA1, representing reactive astrocytosis and microglia/macrophage-associated 
inflammation in the VZ/SVZ regions of IVH/PHH when compared to FT infants. (Figure 37). 
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Figure 37. Representative immunohistochemistry of postmortem brain tissue  
In the full term, FT (A, E, H, K), very preterm, VPT (B, F and I) and infants with intraventricular 
hemorrhage or post-hemorrhagic hydrocephalus, IVH/PHH (C, G, J, and L), the H&E images (A-
C) demonstrate an intact ventricular zone (VZ) with normal multiciliated ependymal cells (A), a 
region undergoing early VZ disruption with protrusion of the VZ toward the ventricular space with 
preserved cilia (B) and an established VZ disruption with denuded ependyma that has no cilia (C). 
(D) Percent VZ disruption, quantified as the cumulative length of the disrupted ependymal regions 
as a factor of the entire length of VZ available on the same slide, demonstrate IVH/PHH is 
associated with the severest VZ damage than VPT and FT infants (p<.05). Adjacent slides of the 
same infant’s double-labeled with anti-GFAP and anti-dapi demonstrates the characteristic shape 
of radial glial cells (E) with basal projections undergoing progressive changes in the pattern of 





3.3 Discussion  
 
3.3.1 The LVP is a critical region in PHH pathophysiology 
 
Many of the debilitating symptoms of IVH and PHH have been attributed to PVWM injury 
241,242,439,440. As such, the anatomical, physiological and molecular relationships between the LVP 
and PVWM have several critical research and clinical implications133,175,197,318. First, IVH/PHH in 
preterm infants typically occurs during a critical developmental period of VZ/SVZ differentiation, 
interfering with neural stem cell maturation and ependymal layer formation. Impairment in 
ependymogenesis leads to denuded regions that expose PVWM to injury from CSF contents, 
ciliopathy that impairs CSF circulation and overall dysregulation of cerebral homeostasis, 
immunologic response to injury and other normal cellular processes 232,233. In addition, the 
irritation effects of blood, ferritin and reactive oxidative species likely propagates injurious 
mechanisms of neuroinflammation, hypoxia and ischemia 131,197 that further compromises the LVP 
barrier and damages PVWM 122,133,184. Thus, examining LVP with dMRI in PHH patients may help 
focus future research on strategies that enhance LVP barrier properties in preterm infants to avert 
PVWM injury and its neurological sequalae. Second, in PHH, the ventricular dilatation exerts 
mechanical pressure on both the LVP and PVWM 39,185, which may exacerbate ependymal 
denudation and axonal dysfunction due to direct axonal stretch and/or compression. Further, from 
a hydrocephalus treatment standpoint, CSF diversion surgery is typically performed to relieve the 
mechanical pressure, thereby preventing further damage and permitting recovery 284,287,291. 
Therefore, using dMRI metrics to assess the relationships between ventricular size and LVP 
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integrity in IVH patients with or without PHH may help define the compounding effect of PHH 
on PVWM on top of IVH, and the role of therapeutic ventricular decompression.  
 
3.3.2 Delineating the LVP for dMRI analyses 
 
There are numerous technical challenges to using dMRI in neonates and high-risk clinical 
populations. From an acquisition perspective, specialized medical facilities, equipment, protocols 
and staff who are experienced in handling neonates and performing population-specific procedures 
implemented for collection of high-quality dMRI data are imperative 441,442. Moreover, since the 
majority of neonatal MRIs are acquired without sedation, there can be excessive motion leading 
to severe signal dropouts that compromise dMRI anisotropy. Furthermore, the relative differences 
in infant head sizes, cortical gyrification, and anatomical heterogeneity resulting from different 
forms/severities of brain injury also pose significant challenges to image acquisition and analyses 
441. Thus, standard dMRI analysis pipelines (usually for adults) will typically fail when applied to 
neonatal data, compelling development of tailored pipelines that are able to account for those 
factors. 
 
The LVP has been challenging to study with dMRI because of partial volume effects that may 
occur when adjacent or surrounding structures are included in the segmentation. This is because, 
in addition to being in close proximity to ventricular CSF and other tissues of varying signal 
intensities, the thickness of the LVP is only a few cell layers. Indeed, the ependymal layer is a 
single layer of epithelial cells (~5μm thickness), and the VZ/SVZ comprise a mix of radial glial 
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and neuroblast cells,123,133 which makes it technically challenging to segment a homogeneous ROI 
for the LVP. In this study, we developed a novel MATLAB-based algorithm capable of 
segmenting the innermost layer of the LVP and its adjoining PVWM with a spatial resolution of 
1.2 mm3. This voxel size is larger than the SVZ. As a result, the ROIs likely contain a mixture of 
SVZ and subjacent white matter. The ROIs had nonzero diffusion anisotropy, and evaluation of 
Eigen vector maps (Fig. 26) showed fiber orientation parallel to the walls of the lateral ventricles, 
consistent with the orientation of white matter in these areas. In contrast, the SVZ would be 
expected to have isotropic diffusion or a primary orientation of maximum water displacements 
orthogonal to the walls of the lateral ventricles. Thus, the measured diffusion parameters likely 
reflect those of white matter, and injury to the SVZ was inferred through evidence of injury to the 
adjacent white matter. Further, the ROIs were generated with an automated algorithm, which 
helped eliminate manual and inter-/intra-rater related errors. In addition, the ROIs were averaged 
from three contiguous axial slices to increase signal to noise and to reduce through-plane partial 
volume averaging effects.  
 
3.3.3 Cellular basis of dMRI-measured LVP injury in PHH 
 
During typical white matter development, PVWM FA increases, while MD, RD and AD decrease 
in a time-dependent fashion 443,444. Our finding of lower FA and higher MD and RD in VPT 
compared to FT infants is consistent with previous studies showing that preterm birth is associated 
with dMRI-measured tissue abnormalities 445-447 and poor neurological outcomes, which have been 
attributed to disrupted neuronal proliferation, migration and synaptogenesis 448. In HG-IVH and 
PHH the premature brain’s sensitivity to perturbations in normal cellular processes by hemorrhage 
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and hydrocephalus contributes significantly to their poorer neurological outcomes when compared 
to non-IVH preterm infants and healthy full term controls  439,440,449. Our finding of more prominent 
abnormalities in FA, MD and RD in HG-IVH and PHH infants recapitulates the patterns of 
IVH/PHH-associated tissue injury that have been previously reported by dMRI studies of large 
bundle PVWM tracts such as the corpus callosum and internal capsules 272,284,450-452. In Chapter 4 
we propose a molecular mechanism for LVP injury in the setting of IVH. Using cell cultures of 
VZ cells from the LVP to demonstrate VZ disruption occurs as a result of cleavage of adherens 
junctions proteins 318, thereby exposing the PVWM to severe inflammation and gliosis 197,318. 
Several other histopathological studies have shown that IVH is associated with LVP tissue 
damage, which is characterized by ependymal denudation, heterotopia and rosette formation, 
radial glial cell disorganization, and astrocytic proliferation in the VZ and SVZ 175,178,197.  
 
3.3.4 PHH-associated myelin injury  
 
Diffusion anisotropy data in white matter are typically interpreted in terms of changes to myelin, 
with an increase in RD thought to represent injury to myelin with relative sparing of axons. In the 
present context, this interpretation is complicated by the fact that most of PVWM is not myelinated 
at term equivalent 453. While white matter tracts associated with primary motor and sensory areas, 
particularly CST and OPRA, are myelinated at term equivalent and do show greater values for 
diffusion anisotropy than unmyelinated areas 443, the majority of PVWM is unmyelinated at this 
stage of development 453. Thus, for this study, the relative increase in RD compared with AD 
suggests greater spacing of axons, possibly related to transependymal migration of CSF, and/or an 
increase in axonal membrane permeability, perhaps related to stretching and injury 454-456. The 
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influence of these unmyelinated axons on the diffusion measurement is supported by the finding 
that the orientation of the direction of maximum water displacements (which indicates the 
orientation of white matter fiber tracts) was generally preserved in spite of the reduced anisotropy, 
suggesting that the axons were still present (Figure 26). Nevertheless, disruption of the LVP may 
be associated with subsequent abnormalities of myelination through injury to oligodendrocyte 
progenitor cells that are present in this region at term equivalent. Indeed studies of the CC of older 
hydrocephalic children after myelination 238,450 show MD changes driven by changes to RD rather 
than to AD, indicating myelin disruption. Other studies have identified morphological defects in 
oligodendrocytes, which occur as a result of hemorrhage and other multifactorial mechanisms 
including neuroinflammation and ischemia-induced excitotoxity 457-462. In addition, PHH likely 
compounds oligodendrocyte disruption and PVWM dysmyelination through its compressive 
effects on oligodendrocyte progenitor cells in the LVP 457,458,461. 
 
3.3.5 FOHP sustains a greater magnitude of injury than the rest of the LVP  
 
Across the LVP, there are regional differences in the cytoarchitecture of the VZ and organization 
of neural stem cells within the subjacent SVZ 133,197,463. While radial glial cells are sequentially 
replaced by ependymal cells along the LVP during fetal development, the lateral wall of the frontal 
horn is the only region that retains these stem cells into infancy 463, which may contribute to 
adverse neurodevelopmental outcomes when those regions are damaged by PHH. Indeed, in our 
cohort, the FOHP demonstrated more prominent evidence of injury than the LVP. These findings 
are consistent with the more prominent patterns of FOHP than LVP injury seen on conventional 
MRI scans of hydrocephalus patients, which is characterized by T2W periventricular 
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hyperintensities 449,464, petechial hemorrhages on susceptibility weighted imaging 193-195 and 
restricted diffusion on diffusion weighted imaging 465. There is also a disproportionate distribution 
of stress and strain on the stem cell rich FOHP in patients with hydrocephalus 466-468. For example, 
relative to the LVP, the FOHP region is subjected to higher stress and strain in the setting of 
hydrocephalus because of its concave geometry and acute anterolateral angles, which in turn 
expands the extracellular spaces in the FOHP and facilitates water extravasation and tissue edema 
466-468. It is important to note however, that in this study, all PHH infants had undergone 
intervention for hydrocephalus, and their intracranial pressure was expected to have normalized at 
the time of dMRI acquisition. Nevertheless, we suspect the dMRI disruptions seen in the PHH 
group may reflect complex pathology from the initial IVH, injury from raised intracranial pressure 
sustained prior to their shunt/ETV treatment, and the subsequent associated secondary injury. 
 
Several clinical and experimental studies have shown that PHH is strongly associated with 
significant neurological disabilities, which are mediated in part by impaired cerebral white 
matter289,469-475. Conventional dMRI has been widely employed to characterize alterations in 
cerebral development45,476 and to assess white matter disruptions in PHH, but the microstructural 
basis underlying the reported diffusion changes are not resolved307,309,311. DBSI, an innovative 
analysis technique uniquely capable of simultaneously modeling anisotropic and isotropic 
tensors307,309,311 was utilized in this study to quantify and differentiate white matter pathologies in 
prospectively collected dMRI data obtained at term equivalent age of preterm infants with PHH, 
those who sustained IVH but did not develop PHH and those who had no identifiable neurologic 
events (VPT), and full term healthy infants (FT). DBSI anisotropic diffusion tensors resolved 
fibers to assess axonal and myelin injury as well as white matter fiber density, while isotropic 
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tensor analyses reflected cellularity and edema. Three clinically relevant white matter tracts, the 
CC, OPRA and CST were assessed. Correlations between ventricular volume and DBSI measures 
were assessed. It is important to emphasize that the dMRI images in this cohort were acquired at 
term equivalent age, when some but not all white matter tracts are expected to have been 
myelinated, therefore, the findings are interpreted in the context of whether the assessed white 
matter is myelinated (CST and OPRA) or unmyelinated (CC).  
 
3.3.6 DBSI extends dMRI capabilities to delineate white matter cellular pathology  
 
Several clinical and experimental studies have shown that PHH exhibits multifactorial white 
matter disruption that encompasses a mix of axonal and myelin disruption, as well as multi-
compartmental microstructural processes such as inflammation, hypercellularity and edema. These 
nuances are beyond the capabilities of DTI to accurately parse out. Advanced post-processing 
computational methods such as DBSI address some of DTI limitations without need for 
dramatically changing data acquisition307-312. DBSI utilizes standard high-resolution dMRI data 
(with 25 diffusion encodings or more) and extracts multiple diffusion tensors across 
microstructural compartments307-313. These diffusion tensors then enable the separation of crossing 
fibers, estimation of crossing angles, recovery of directional diffusivity of individual crossing 
fibers, assessment of axonal loss, distinction of myelinated, dysmyelinated, or unmyelinated 
axons, and modelling crossing fibers, extra-axonal inflammation, cellularity and 
edema307,308,311,313,314. DBSI has been validated experimentally in preclinical mouse models of 
white matter injury307,309,314,315,477 and used to investigate white matter pathology across clinical 
populations in adults308-311. It lends itself as a uniquely powerful, non-invasive neuroimaging tool 
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with high sensitivity for delineating white matter alterations in the developing brain, both normal 
and in PHH pathology. 
 
Beyond the LVP, the white matter aberrations we identified in the CC, CST and OPRA with DBSI 
in PHH infants are all factors that have been associated with impaired neuromotor and cognitive 
development. This is likely because PHH disturbs processes that underlie early white matter 
development, engendering local and widespread effects through direct cellular mechanisms and 
disruption of subsequent cerebral development240,478-482. Collectively, LVP injury, characterized 
by the loss of progenitor cells and impaired neuroblast migration215,223,318,325,483, further impacted 
by pressure-related structural deformation, ischemia, oxidative stress, inflammation, and other 
phenomena86,185, has brain-wide effects, impacting both cortical and subcortical regions and the 
development of critical white matter tracts123-126.  
 
3.3.7 dMRI variability of white matter structure and development  
 
Across all fibers examined with DBSI, both conventional FA and fiber level FA were lower in the 
PHH group, indicating white matter injury. However, when assessing white matter integrity in 
infants, especially in PHH, variabilities in the stages of white matter development, as well as their 
response to injury must be taken into consideration. This is particularly important for this study 
because in conventional dMRI, RD is typically regarded as a marker of myelin integrity and the 
higher the RD, the worse the myelin injury. Yet, in this study, there was significant variability in 
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RD indices, which were subject to different interpretations in the presence or absence of myelin in 
the fiber tracts of interest.  
 
In large bundle tracts, myelination begins and ends at variable ages among different white matter 
bundles. In general, myelination in the CST and OPRA starts at 38- and 40-weeks’ gestation, 
respectively484, whereas myelination in the CC does not begin until after 2 months 
postnatally484,485. Kinney et. al.485 examined human postmortem tissues obtained less than 24 hours 
after expiration using immunohistochemistry and biochemical measurements of different lipids 
and observed that sphingomyelin, cerebroside, and sulfatide were not detectable until early infancy 
and myelin basic protein staining was not detectable until the 2nd postnatal month485 in the CC, 
similar to Sarnat et al.’s observations484. DTI RD in the unmyelinated CC of PHH infants in this 
study was significantly higher than non-PHH infants, but fiber level RD, while still highest in 
PHH, was not statistically significantly different. This suggests that the higher RD detected with 
DTI was related to increased fiber spacing rather than direct axonal injury, which is consistent 
with the roughly 70% reduction in fiber density found with DBSI and supported by histology. In 
contrast, the myelinated CST consistently demonstrated higher RD in the PHH than non-PHH 
group, suggesting myelin disruption/injury. For the myelinated OPRA, on the other hand, RD 
findings were not consistently different between groups. This may be attributed to intrinsic 
variabilities in myelination of segments within the OPRA that were not detected with dMRI. To 
complicate matters further, there is variability in the effects of PHH on different segments of the 
PVWM, even along the uniform lateral ventricular perimeter. Using a segmentation algorithm that 
quantified dMRI measures in the 1 mm layer subjacent to the ventricular wall along the lateral 
ventricular perimeter, Isaacs et al. demonstrated that the frontal and occipital horns of the lateral 
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ventricle had the worst dMRI-measured PVWM injury231. Anatomically, the OPRAs are in very 
close proximity to the occipital horns, which are subjected to the highest mechanical pressures and 
transependymal flow injury in PHH, leading to significant water extravasation and tissue edema 
in those regions.466-468 (Figure 38) 
 
Figure 38: Schematic rendering of postulated pathology underlying different PVWM bundles 
Diffusion MRI voxels from healthy myelinated and unmyelinated white matter are shown in the 
top row. Bottom row shows voxels from the corpus callosum (CC), corticospinal tracts (CST) and 
optic radiations (OPRA) of PHH infants, drawn to same scale as the healthy voxels, to demonstrate 
relative fiber density, inflammatory cells, and estimated inter-axonal spacing. The CC is not 
myelinated at this developmental stage76,77, depicted by the lack of myelin sheath. Relative to 
healthy white matter, there was significantly reduced fiber fraction and increased cellularity in the 
CC, CST and OPRA of PHH infants in comparison to healthy white matter. In the CST, increased 
radial diffusivity suggests likely myelin injury, which is represented as reddish sleeves around the 
axons.  
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3.3.8 Ventricular size correlates with magnitude LVP and large bundle PVWM injury 
 
Although ventricular size appears to be a central risk factor for neurodevelopmental impairment 
in PHH, and early surgical decompression may improve outcomes, little is known regarding the 
link between ventricular size and white matter integrity. Collectively, the tensile and compressive 
forces of enlarged ventricles in PHH on the LVP and distant PVWM such as the CC, CST and 
OPRA leads to impairment of arterial blood flow and venous stasis, which may cause axonal 
disruption and dysmyelination that sets off a cascade of ischemia-induced white matter injury 
458,486,487. These findings beg the question whether ventricular size can be used as a surrogate 
marker for disease severity in PHH patients. In assessing the LVP/FOHP, ventricular size 
correlated negatively with FA and positively with MD and RD, suggesting that expanded 
ventricular size likely has a negative effect on dMRI-measured LVP/FOHP tissue integrity.  
In the CC, CST and OPRA, DBSI parsed the relationships between ventricular size and white 
matter at the cellular level. In the CC, increases in ventricular size correlated with increases in 
hypercellularity and reduction fiber density, which may have been secondary to reactive cellular 
infiltration extracellularly and axonal loss, respectively. In PHH, the mechanical pressure from the 
large ventricles distorts PVWM fiber organization, decreases cerebral perfusion, and initiates an 
inflammatory cascade, which likely mediates axonal injury and loss185,210,242. These findings have 
critical clinical implications as several studies have shown that progressive ventricular distension 
in PHH is associated with higher rates of neurological disability. In a prospective study of 118 
children, including 54 with hydrocephalus, Mangano et al. showed that changes in FA in the CC 
and CST correlated with conceptual, general adaptive, and motor skills284. Strahle et al. found that 
larger ventricular size was associated with impaired hippocampal development and worse 
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cognitive scores at age 2 years in infants with PHH488. The findings of this study and the existing 
literature demonstrate the deleterious impact of PHH and ventricular enlargement on white matter 
integrity, brain development and its persistent neurodevelopmental effects. We also provide strong 
support for utilizing DBSI to investigating the role of ventricular size – a readily modifiable factor 




A primary limitation of this study is the small sample size in the PHH and, to a lesser extent, IVH 
cohorts which may have limited our ability to observe subtle differences in dMRI parameters. 
Notably, all PHH patients were male, which may have introduced a sex bias in the PHH group, 
although there is a male preponderance in IVH reported in the literature 489,490. In addition, while 
we were able to establish similarities between PHH and PIH in terms of VZ, SVZ and PVWM 
disruption on postmortem neurocytology, we did not have any PIH subjects with dMRI data to 
correlate to cytology. To minimize the effect of age on brain development, all scans were acquired 
cross-sectionally at term-equivalent age, which precludes assessment of the relationships between 
dMRI parameters and brain development over time. Almost all PHH infants had shunts in situ at 
the time of dMRI acquisition, which may have caused through plane distortions and susceptibility 
artifacts due to signal and geometric distortions. Critical steps and modifications to the imaging 
pipeline such as aligning the relative frequency encoding directions to the shunt catheters, using 
wider receiver bandwidths and reducing echo times may be helpful for decreasing geometric 
distortions and minimize signal loss441,491. In the OPRA AD and RD measures did not consistently 
differ between the PHH and non-PHH groups. While it is possible that the inflammation, edema, 
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decreased fiber density and increased axonal spacing could have affected AD and RD measures, 
the OPRA has relatively small tracts that in close proximity to many structures of varying signal 
intensities. These signals may have inadvertently been included in OPRA segmentation, thereby 
affecting the AD and RD measures due to partial volume artifacts. Due to the relative novelty of 
the analysis techniques employed in this dissertation and the lack of concomitant histological 
specimens in the same infants who underwent dMRI scans, our ability to directly link dMRI and 
immunochemistry results limits the interpretability of some key findings (i.e., as neurobiological 
or technical), such as the diffusivity measures in the OPRA. Another limitation is that our study 
contained only term-equivalent scans with a cross-sectional design. Thus, we were unable to make 
direct comparisons of measures in subjects with hydrocephalus studied during both the days before 
and after neurosurgical intervention; information critical for evaluating what these approaches add 
to our understanding of the reversible effects of neonatal hydrocephalus and optimal timing of 
neurosurgical interventions. A longitudinal study including multiple scans at predetermined time-
points for each subject would allow more detailed evaluation of relationships between dMRI 
parameters, frontal occipital horn ratio, and neurobehavioral correlates over time. In addition, the 
neuroimaging measures from the LVP and DBSI analyses have not been related to 
neurodevelopmental outcomes, limiting the interpretation of the clinical significance of our key 
findings. Successfully linking the brain and behavioral measures in this high-risk population would 
enhance the clinical relevance of our work and contribute to their validation as a biomarker. We 
are planning future  studies to investigate prospective associations between dMRI measures (DTI 
and DBSI) in the LVP, FOHP and PVWM with subsequent neurodevelopmental outcomes to 
elucidate the neurological mechanisms underlying impairment in high-risk VPT infants, as well as 
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to potentially identify VPT infants in need of early referral to intervention services and longer-
term follow-up care. 
 




All patients were recruited after written informed consent was obtained from at least one parent of 
every infant. Institutional Review Board approval for this study was obtained from the Washington 
University Human Research Protection office. The FT infants were identified from a larger cohort 
of infants undergoing neonatal neuroimaging scans as part of an existing contemporaneous fetal 
monitoring study conducted at an adjoining maternity hospital. All VPT, HG-IVH/IVH and PHH 
patients were recruited from a Level III Neonatal Intensive Care Unit. IVH diagnosis was made 
within the first month of life by cranial ultrasound and graded using the Papile classification 
system59. Well-established Hydrocephalus Clinical Research Network criteria were applied for the 
diagnosis of PHH and the timing of neurosurgical treatment421, which included a reservoir or sub-
galeal shunt placement for temporary ventricular access, or permanent treatment with endoscopic 
third ventriculostomy (ETV) or ventriculoperitoneal (VP) shunt. To ensure the FT group had no 
confounding health issues at birth, additional exclusion criteria included acidosis (pH < 7.20) on 
cord blood gas or blood gas obtained during the first hour of life or evidence of in utero illicit 
substance exposure. Exclusion criteria for all four groups included inability to obtain informed 
consent from an infant’s parent, presence of chromosomal abnormalities and/or proven congenital 
infections (e.g., cytomegalovirus, toxoplasma, rubella).  
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3.4.2 Perinatal Clinical Variables 
 
To account for differences in medical status between groups, perinatal clinical information 
obtained for each infant was used to calculate their clinical risk index score 470. The presence or 
absence of each of 10 factors were scored as 1 or 0 respectively. There were 9 patient-related 
factors, which included: 1) small for gestational age at birth or intrauterine growth restriction; 2) 
received oxygen therapy at 36 weeks; 3) received postnatal steroids; 4) developed necrotizing 
enterocolitis; 5) had a patent ductus arteriosus requiring indomethacin or ibuprofen therapy; 6) had 
retinopathy of prematurity; 7) developed culture-positive neonatal sepsis; 8) weight-for-
height/length ratio at the time of term equivalent MRI acquisition >3 standard deviations below 
the measured ratio at birth; and 9) duration receiving total parenteral nutrition above the 75th 
percentile. A point was also scored if the mother did not receive antenatal steroids. All scores were 
collated to obtain a composite risk index score on a Likert scale of 10 - the higher the score, the 
poorer the presumed neonatal health 470.  
 
3.4.3 Imaging acquisition and preprocessing  
 
Human infant diffusion MRI (dMRI) was acquired without sedation and during natural sleep or 
when the subject was resting quietly following institutional neonatal guidelines 492. Full-term 
infants were scanned within the first four days of birth. To match the expected developmental stage 
of the full-term infants, preterm infants were scanned at or near-term equivalent age (35-43 weeks 
postmenstrual age). All scans were acquired using a 3-T Siemens TIM Trio System (Erlangen, 
Germany), using an infant-specific, quadrature head coil (Advanced Imaging Research, Cleveland, 
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OH, USA). Anatomical T1W with repetition time (TR) 1550 ms, inversion time (TI) 1100 ms, 
echo time (TE) 3.05 ms, flip angle 15°, 1 × 1 × 1.25 mm3 voxels; and T2W sequences, sagittal, 
magnetization-prepared rapid gradient echo sequence [TR 8210 ms, TE 161 ms, 1 × 1 × 1 
mm3] voxels were obtained. Then, a diffusion-weighted image (DWI) [TR 13300 ms, TE 112 ms, 
1266 Hz/Px bandwidth, 128 mm field of view, 1.2 × 1.2 × 1.2 mm3 voxels], with 27-48 b-directions 
and amplitudes ranging 0-1200 s/mm2 was obtained.  
 
3.4.4 Diffusion tensor imaging  
 
Diffusion weighted image (DWI) data was processed using FSL tools493,494 and corrected for eddy 
current distortions using Eddy495 susceptibility induced distortions using ApplyTopup495 and 
motion corrected using FLIRT496,497. The diffusion signal attenuation curve was modeled as a 
mono-exponential function plus a constant, and diffusion parameters were estimated using 
Bayesian Probability theory498. FA, AD, RD and MD and Principal Eigen Vector maps were 
generated with DSI studio(http://dsi-studio.labsolver.org).  
 
3.4.5 Diffusion basis spectrum imaging  
 
DWI data were processed using FSL tools 493,494 and corrected for eddy current distortions 
using Eddy 495, susceptibility induced distortions using ApplyTopup 495, and motion corrected 
using FLIRT 496,497. The CC, bilateral posterior limbs of the internal capsules, designated as CST, 
and bilateral OPRA were selected a priori as our regions of interest (ROIs) as they have been 
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shown to demonstrate improvement in dMRI indices following hydrocephalus treatment and relate 
to PHH-related neuropsychological outcomes 272,284,452,499. For each subject, ROIs were manually 
segmented on native diffusion parametric maps by three experienced reviewers (Fig. 1), with high 
mean inter-rater reliabilities (range .70-.99). Each ROI was segmented on three contiguous axial 
slices to minimize through-slice partial volume averaging using Analyze 10.0 software 
(AnalyzeDirect, Inc., Overland Park, KS, USA).  
 
The preprocessed 27-48 directional DWI images were analyzed via the DBSI pipeline 307,310 
in MatLab® (MathWorks, Natick, MA, USA). As demonstrated in Equation 1, the DBSI model is 
a sum of the multiple anisotropic diffusion tensors (first term) and a spectrum of isotropic diffusion 















(𝑘 = 1,2,3, … ).												[1] 
 
Here bk is the kth diffusion gradient; Sk/S0 is the acquired diffusion weighted signal at direction of 
bk normalized to non-diffusion-weighted signal; NAniso is the number of anisotropic tensors to be 
determined; fik is the angle between the diffusion gradient bk and the principal direction of the ith 
anisotropic tensor;	9𝑏!
→
9 is b-value of the kth diffusion gradient; l||i and l^i are the axial and radial 
diffusivity of the ith anisotropic tensor under the assumption of cylindrical symmetry; fi is the 
signal-intensity-fraction (non-diffusion-weighted) of the ith anisotropic tensor; a, b are low and 
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high diffusivity limits of the isotropic diffusion spectrum; f(D) is the spectrum of signal-intensity-
fraction (non-diffusion-weighted) at all possible isotropic diffusivity D. 
 
A priori division of isotropic components was established using an isotropic apparent diffusion 
coefficient (ADC) cutoff of ≤0.3 µm2/ms representing restricted diffusion; ADC values between 
0.3-2.5 µm2/ms representing hindered diffusion; and ADC ≥2.5 µm2/ms representing free 
diffusion. Following DBSI analysis, ROI-specific metrics were obtained via voxel-based 
computations. DBSI metrics included: fiber specific FA (fiber FA, FFA), AD (fiber AD, FAD), 
and RD (fiber RD, FRD); axonal density (fiber fraction, FF); and non-fiber related restricted 
fraction (RF), and non-restricted fraction (NRF).  
 
3.4.6 Ventricular size Measurements 
 
All ventricular size measurements were taken by two independent expert raters on axial T2W image 
using the frontal-occipital horn ratio approach20, which sums the distance between the widest 
lateral walls of the frontal and occipital horns, divided by twice the widest biparietal diameter at 
the level of the foramen of Monro. Reproducibility of FRONTAL-OCCIPITAL HORN RATIO 
measures was established across groups using measurements made by two independent raters, with 
inter-rater comparisons demonstrating a high degree of agreement (intraclass correlation 
coefficient=.91; p<.001).  
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3.4.7 Human Postmortem Brains Immunohistochemistry 
 
Autopsy specimens from preterm neonates were obtained from the St. Louis Children’s Hospital 
(SLCH) at the Washington University School of Medicine, St. Louis, Missouri, USA. The relative 
age of these patients was estimated from the time of expected fertilization and recorded as 
Estimated Gestational Age (EGA). Brain specimens were dissected from regions of the frontal 
cortex containing the corpus callosum. Formalin-fixed tissues were paraffin-embedded, and 15 µm 
sections were immunostained with H&E to assess cellular structure, edema and cellularity, 
synaptophysin to assess axonal integrity and GFAP (1:300, catalog #7260, Abcam) to assess 
astrocytes. To examine associations between PVWM and the subjacent ventricular (VZ) and 
subventricular (SVZ) zones, the VZ/SVZ regions of adjacent slides were stained with H&E to 
assess cytoarchitecture, double-label immunostained with 4’6-diamidino-2-phenylindole (DAPI) 
(#D1306 Thermo Fisher Scientific) and GFAP to assess immature ependymal cells and reactive 
astrocytes, and with DAPI and Iba1 (1:100, #PA5-18039, Invitrogen) as a surrogate for microglia- 
and macrophage-associated products. All slides were examined with fluorescence microscopy 
using Nanozoomer-XR (Hamamatsu Photonics). Qualitative comparisons were confirmed by with 
a neuropathologist. Percent VZ disruption was quantified as the cumulative length of the disrupted 
ependymal regions as a factor of the entire length of VZ available on the same slide.  
 
3.4.8 Statistical analysis  
 
Statistical analyses were performed with R version 3.5.0 (The R Foundation, Vienna, Austria)500 
and SAS version 9.4 (The SAS institute, Cary, NC). Normality of data was assessed with the 
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Shapiro-Wilk test, which determined the use of non-parametric methods for all data analyses. 
Descriptive statistics of clinical factors including gestational age at birth, postmenstrual age at 
MRI scan, birth weight and clinical risk index scores 470, as well as measured factors, including 
frontal-occipital horn ratio and dMRI measures in the LVP, FOHP, CC, CST and OPRA were 
obtained. Kruskal-Wallis one-way ANOVA was used to determine between groups differences. 
Wilcoxon signed rank test was used to perform family-wise comparisons, and all resulting p-values 
were corrected with Benjamini-Hochberg adjustment. Correlations between ventricular size and 
dMRI measures were examined using Spearman’s rank-order correlations because the patient 
groups correspond with disease severity (ordinal ranking). To examine group differences in dMRI 
measures between the LVP and FOHP, a linear mixed effect model with a random patient intercept 
was fit to each measure. Specifications of the model included a main effect of region (LVP and 
FOHP), group (FT, VPT, HG-IVH and PHH) and region-by-group interactions with Bonferroni 
correction. Given the reported effect of age on dMRI measures 238, postmenstrual age at scan was 
set as a covariate in the linear model. Where Mauchly’s test of sphericity was violated, 
Greenhouse-Geisser correction was used to adjust degrees of freedom for the averaged tests of 
significance. Similarly, FT, VPT, IVH, PHH groups were compared for all DBSI measures with 
Kruskal-Wallis test, followed by Wilcoxon Rank-Sum tests when Kruskal-Wallis was statistically 
significant. frontal-occipital horn ratio was compared to DBSI scalars for non-linear association 
with Spearman’s rank correlation test. Bonferroni-corrected p value <.050 was considered 
statistically significant. Statistically significant results were further subjected to an ANCOVA 
where number of voxels, number of diffusion directions, and laterality were set as covariates to 
limit any potential confounding effects of those factors on the results. 
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4 Chapter 4: N-cadherin cleavage mediates VZ disruption in PHH and PIH 
 
Adapted from: 
1. Castaneyra-Ruiz L, Morales DM, McAllister JP, Brody SL, Isaacs AM, Strahle JM, Dahiya 
SM, and Limbrick DD. Blood Exposure Causes Ventricular Zone Disruption and Glial 
Activation In Vitro. J Neuropathol Exp Neurol 2018. 77: 803-813 
2. Castaneyra-Ruiz, L., Morales, D. M., McAllister, J. P., Brody, S. L., Isaacs, A. M. and 
Limbrick DD. Preterm Intraventricular Hemorrhage In Vitro: Modeling the Cytopathology 
of the Ventricular Zone. Fluids and Barriers of CNS 2020. FBCN-D-20-00029R2. 
(Accepted) 
 
4.1 Introduction  
 
In the previous chapters, we identified key biological processes central to the pathophysiology of 
PIH and PHH in humans. In CSF, we observed transcriptomic and proteomic evidence of 
neuroinflammation and ependymal barrier damage in the context of VZ and SVZ disruption. We 
confirmed those findings in human brain parenchyma in vivo and ex vivo utilizing dMRI and 
immunohistochemistry, respectively. We also related VZ/SVZ/ependymal disruptions and 
neuroinflammation to PVWM injury. While our findings to date provide insights on relating 
neuroinflammation and brain injury, we have not yet probed the pathogenesis of PIH and PHH. 
Strong evidence demonstrates that proteins of adherens junctions help to form and preserve the 
ependymal barrier. Of the four classical cadherins, neural cadherin (N-cadherin) is the most highly 
expressed in the ependymal layer. In addition to mediating cell-cell adhesion, N-cadherins 
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stimulate CDC42, which mediates apical-basal polarity of neuroepithelial cells and ciliogenesis 
during VZ/SVZ differentiation and ependymal barrier formation. Like other cadherins, N-cadherin 
is susceptible to disruption by metalloproteases. Specifically, our collaborators228,501,502 and several 
others503-507 have shown that the metalloprotease ADAM10 mediates inflammation and cleaves 
cadherins to regulate several epithelial cell pathologies including the lung and liver injury in S. 
aureus sepsis, and in cancer. Therefore, we hypothesized that ADAM10-mediated cleavage of N-
cadherin is associated with VZ disruption, and pharmacological inhibition of ADAM10 will 
ameliorate this disruption and preserve ependymal integrity. We developed a novel in vitro 
ependymal cell culture model of IVH and ventriculitis to characterize the effect of blood and 
pathogens on N-cadherin during VZ differentiation while modulating ADAM10 activity.  
 
4.2 Results  
 
4.2.1 Characterization of in vitro VZ differentiation to mature ependymal cells  
 
I describe details of our cell culture model in the Methods section. Briefly, in P0/P4 mice, we 
harvested VZ cells from the perimeter of the lateral ventricles and modulated their proliferation 
and differentiation in media. First, characterized normal ependymogenesis in our in vitro model to 
establish a baseline for future comparisons and to determine the precise timing for inoculating the 
cells with blood or pathogens. To evaluate differentiation, we immunolabeled cells against the cilia 
marker βIV-tubulin, which allowed us to discriminate between multiciliated, monociliated, and 
nonciliated VZ cells. To determine the stage of ependymal cells maturation, we used the glial 
marker GFAP. Ependymal cells exhibit GFAP-positive attributes in early stages and become 
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GFAP-negative with maturation.197,508-510 This approach permitted identification of six different 
cell types: 1) cells not expressing GFAP or βIV-tubulin, 2) cells expressing GFAP but not βIV-
tubulin, 3) monociliated βIV-tubulin cells not expressing GFAP, 4) monociliated βIV-tubulin cells 
expressing GFAP, 5) multiciliated βIV-tubulin cells expressing GFAP, and 6) multiciliated βIV-
tubulin cells not expressing GFAP. At this stage, we measured successful VZ differentiation by 
the number and quality of multiciliated ependymal cells (mature ependyma) (Figure 41). 
 
Multiciliated ependymal cells developed from monociliated cells in a time-dependent fashion, 
comprising 3.73 ± 4.29%, 23.01 ± 7.56%, and 52.29 ± 11.07% (p < 0.001) of all viable cells at 3, 
5, and 7 days after addition of differentiation media. Overall, the total number of cells changed 
very little at the same time points (day 3: 42.80 ± 7.64, day 5: 42.78 ± 8.61, day 7: 44.31 ± 6.87) 
after the initiation of differentiation. This observation indicates that cells were changing from 
progenitor-like VZ cells to those that are typically found in the well-differentiated ependyma. 
Double-labeling was performed against βIV-tubulin and GFAP took place at days 5 and 7, when 
a significant number of VZ cells had differentiated to ependymal cells. We found no significant 
increase in the percentage of GFAP-negative cells from among all multiciliated cells (day 5; 29.45 
± 18.84, day 7; 35.37 ± 33.77). At both time points, over 60% of the ependymal cells remained in 
a premature stage (still expressing GFAP). In addition, the total number of GFAP-positive cells 
did not change over time (day 5: 72.78 ± 9.42, day 7: 73.61 ± 12.47) (Figure 39). 
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Figure 39:  Differentiation of VZ cells in vitro.  
Differentiation of VZ cells in vitro. Representative images of VZ cells at different stages of 
differentiation and maturation. (A) VZ cells undergo differentiation into multiciliated ependymal 
cells from day 3 to day 7, as identified by cilia marker βIV tubulin. (B) Quantification of 
percentage of multiciliated ependymal cells during differentiation. Data represent means of the 
percentage of ciliated cells from two experiments with at least n=3 wells at days 3, 5 and 7, 
respectively. (C) Expression of GFAP (green) in cultures of multiciliated ependymal cells 
identified by βIV tubulin (red) at days 5 and 7. (D) Detail of double-labeling of GFAP and βIV 
tubulin showing a mixed population of cells, including those not expressing GFAP or βIV tubulin 
(1), expressing GFAP only (2), GFAP-negative monociliated cells (3), GFAP positive 
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monociliated cells (4), GFAP-positive multiciliated cells (5) and GFAP-negative multiciliated 
cells (6). Scale bars = 50 μm in A and C; 10 μm in D.  
 
4.2.2 N-cadherin mediates cell-cell adhesion mediates in VZ development 
 
 The plasma membranes of all VZ cells contained N-cadherin-based adherens junctions. This 
phenomenon probably contributed to the characteristic polygonal shape that occurred regardless 
of whether the ependymal cells were less (day 5) or more (day 7) differentiated. Interestingly, the 
ratio of N-cadherin to total number of cells (N-cadherin expression) initially declined from day 5 
to day 6 (2.93 ± 2.41 vs. 2.11 ± 2.03, respectively; p>0.05). However, levels stabilized by day 7 
(2.22 ± 1.87). This observation suggests a possible heightened requirement for this cell junction 
protein during early stages of normal differentiation. Double-labeling with GFAP and N-cadherin 
showed that the polygonal shape existed independent of GFAP expression, indicating that GFAP 
may not affect N-cadherin expression. The glial projections of the GFAP-positive cells did not 
express N-cadherin. (Figure 40) 
 
Figure 40: Cell-cell junction and astrocytic expression of differentiating of VZ cells in vitro.  
Representative images of VZ cells at different stages of differentiation and maturation. (A) N-
cadherin-based cell-cell junctions, with characteristic membrane marker localization and 
polygonal morphology at day 5 and 7. (B) Expression of N-cadherin (red) and GFAP (green) 
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showing that the glial projections do not colocalize with cell-cell junctions (arrowheads) (B). Scale 
bars = 50 μm. 
 
4.2.3 Effective dose and time of blood administration required to elicit VZ disruption 
 
VZ cultures were used to assess whether blood exposure elicits neuroepithelial and ependymal cell 
loss and to determine the effective timing and dosage of blood needed to elicit the pathology. At 
day 5 of differentiation, we exposed VZ cultures to syngeneic blood, and evaluated treatment 
effects over time. Pilot experiments using 25 (2.5%), 30 (3%) and 40 µL (4%) determined the 
amount of blood needed for this model. After three hours of 40-µL treatment, the number of total 
cells and N-cadherin expression obviously decreased, preventing observations on the 
cytopathology of IVH beyond this time. Treatment with 25 or 30 µL of blood permitted long-term 
experiments because the model offered a sufficient and reliable number of VZ cells even after 48 
h, similar to the human condition. (Figure 41)  
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Figure 41: Time- and dose-dependent response of blood exposure to VZ cells in vitro.  
(A) Three hours of 40 µL of syngeneic blood treatment dramatically decreased the number of total 
cells and N-cadherin expression, precluding observations of IVH cytopathology beyond this time. 
(B) Treatment with 25 or 30 µL of blood permitted long-term experiments because the model 
offered a sufficient and reliable number of VZ cells even after 48 h, similar to the human condition. 
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4.2.4 Blood disrupts VZ cytoarchitecture and differentiation in a time-dependent manner 
 
Based on findings from our dose- and time-response experiments, we used 30 µL of blood 
treatment for the remainder of the experiments. To characterize VZ disruption, we evaluated the 
total number of cells, the percentage of ependymal cells and programmed cell death over time. 
After 3 hours of phosphate buffered saline (PBS) control or blood treatment, we found no 
differences in the total number of VZ DAPI-positive cells per 0.0225 mm2 (38.62± 11.47 vs. 
42.78± 8.614). However, we observed a significant reduction of total VZ cells after 24 hours 
(41.45± 5.62 vs. 32.08± 10.68 p<0.05) and after 48 hours (44.31± 6.87 vs. 26.94± 7.50 p<0.001) 
of blood exposure. A similar effect occurred in multiciliated cells, as shown by changes in βIV-
tubulin signal. We observed was no change in multiciliated cells after three hours of treatment, but 
we noted a decrease after 24 hours (control 31.07 ± 7.78 vs. IVH  11.84 ± 7.86 p<0.001) and after 
48 hours (control: 52.29 ± 11.07 vs. IVH: 14.65 ± 8.49 p<0.001). We then calculated the 
percentage of total cell loss (loss of DAPI-positive cells) after blood exposure and compared this 
value with the percentage of ependymal cell diminution (diminution of multiciliated βIV-tubulin-
positive cells) at three, 24 and 48 hours of blood treatment. After three hours, we observed 
essentially no discrepancy between total cell loss and ependymal cell diminution (-2.92 ± 28.72 vs 
-8.60 ± 24.84, respectively). However, after 24 hours, the ependymal cell diminution was twice as 
high as total cell loss (-59.68% ± 25.10 vs. -27.12% ± 21.94, respectively; p<0.05) and even greater 
after 48 hours (-85.16% ± 9.15 vs. -36.90% ± 23.98, respectively; p<0.001). These results 
demonstrated that the ependymal cell loss exceeded total cell loss, suggesting that cell loss does 
not solely control the decrease of the multiciliated ependymal cells after blood treatment. Indeed, 
other factors, such as alterations in neuroepithelial cell/ependymal cell differentiation may 
contribute to the diminution in ependymal cells following blood exposure (Figure 42).  
 137 
Interestingly, immunohistochemistry against active caspase 3, a marker of apoptosis, showed no 
change in caspase 3-positive cells at the same time points (control vs. blood at 3 h: 2.93 ± 0.70 vs. 
3.39 ± 2.63; at 24 h: 3.72 ± 0.42 vs. 2.50 ± 2.80; at 48 h: 3.19 ± 1.00 vs. 1.823 ± 1.16). These 
results suggest that programmed cell death did not affect cell loss following blood exposure 
(Figures 41 and Figure 42). 
 
Figure 42: Time-dependent effect of blood in VZ cell cultures.  
After 5 days of differentiation, samples were analyzed at 3, 24, and 48 h of control (Cont) or blood 
exposure. (A & C) Controls exhibit normal differentiation from NSC to ependymal cells with 
significant increases in the percentage of βIV-tubulin multiciliated cells (C). (B) Blood exposure 
significantly reduces both the total number of cells (DAPI-positive cells/0.0225 mm2) and (C) the 
percentage of multiciliated cells at 24 h and 48 h. * p<0.05; **p<0.01; *** p<0.001. (D) Double 
labeling with active caspase 3 (green) and βIV-tubulin (red) showed no difference in the number 
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of apoptotic cells. (E) Blood exposure-dependent proportional change of total cells vs. ependymal 
cells (EC). EC decrease was twice as high after 24 h and even greater after 48 h than the cell loss, 
showing a significant discrepancy between total cell loss and the lack of EC. * p<0.05; *** 
p<0.001. Data represent means of the percentage of ciliated cells from two experiments with at 
least n=6 wells at 3, 24, and 48 h, respectively. Scale bars = 50 μm in all panels. 
 
4.2.5 VZ disruption occurs in the setting of cell-cell adherens junction damage 
 
To gain insights into the contributing factors in VZ disruption following blood exposure, the 
integrity of the cell-cell junctions was examined with N-cadherin expression as a surrogate 
measure. N-cadherin expression was quantified as a ratio of the number of N-cadherin positive 
cells to total number of cells. After three hours of blood exposure, we found no changes in N-
cadherin expression (control: 2.29 ± 2.40 vs. blood: 2.76 ± 2.37). After 24 hours, the N-cadherin 
signal profile became fragmented, with loss of the typical lattice-like cell membrane expression 
and appearance of abnormal subcellular cytosolic depositions. However, the total amount of N-
cadherin was not significantly different when immunodensity ratios were quantified (control: 2.11 
± 2.03 vs. blood: 2.06 ± 2.10). After 48 hours, the abnormal deposition and fragmentation persisted 
along with significant loss of N-cadherin signal (control: 2.21 ± 1.87, blood: 1.12 ± 1.07; p<0.05; 
Figure 42 A to C). Western blots confirmed significant reduction of N-cadherin signal by 
measuring the N-cadherin/GAPDH ratio (median of control: 0.47 ± 0.17 vs. blood: 0.22 ± 0.03; 
p<0.05) after 48 hours of blood treatment. (Figure 43) 
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Figure 43: Time-dependent effect of blood in N-cadherin expression in the VZ.  
(A) Representative VZ cultures after 48 hours of control (left) or blood exposure (right). Compared 
to the prominent expression of N-cadherin (red) at the cell membrane in controls (arrows), N-
cadherin expression was weaker and cytoplasmically dislocated after blood exposure (asterisk). 
(B) High magnification of VZ N-cadherin labeling in which 3 hours after exposure to blood, no 
changes were found in the expression of N-cadherin (red). However, after 24 h of treatment, the 
expression of N-cadherin fragmented, with loss of the lattice-like configuration. After 48 hours, 
there was fragmentation, dislocation from the cell membrane, and loss of N-cadherin expression. 
(C) Quantification and comparison of N-cadherin expression between control and blood exposure, 
normalized by the total number of cells. There was a significant decrease in N-cadherin expression 
after 48 h of blood treatment (p<0.05). Data represent means of the immunodensity/cells from two 
experiments with at least n=6 wells at 3, 24, and 48 h, respectively (C) and protein levels (N-
cadherin/GAPDH) by western blot (* p<0.05). (D) Data were analyzed from two experiments with 
n=4 per condition. Scale bars = 50 μm in all A panels and 10 μm in all B panels.  
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4.2.6 Reactive astrocytosis (neuroinflammation) occur with VZ disruption  
 
We also used GFAP immunolabeling to investigate astroglial differentiation following blood 
exposure. The percentage of non-ciliated GFAP-positive cells did not change after 3 hours 
(control: 49.44 ± 12.96 vs. blood: 45.94 ± 16.33) or 24 hours (control: 47.16 ± 17.33 vs. blood: 
59.94 ± 13.53) but increased significantly after 48 hours of blood treatment (control: 47.10 ± 13.21 
vs. blood: 79.63 ± 11.81; p<0.05). GFAP-expressing cells also demonstrated morphological 
changes from 3 to 48 hours of blood exposure. In particular, GFAP-positive cells exhibited branch-
like projections and a larger GFAP-positive cytoskeleton; at 48 hours, the GFAP-positive 
processes appeared elongated, consistent with reactive astrocyte morphology. Treating cells with 
blood for 48 hours increased the GFAP/GAPDH ratio as measured by western blot (median of 




Figure 44: Glial activation in the VZ.  
(A) Representative VZ culture immunostained for GFAP (arrowheads) after 48 h of blood 
treatment. (B) High-resolution images of cells double-labeled with βIV-tubulin and GFAP 
antibodies after 3, 24, and 48 h of blood treatment vs. control. After 48 h treatment, most GFAP-
positive cells exhibited numerous long, thin projections (arrowhead) typical of reactive astrocytes. 
(C) Quantification of non-ciliated GFAP-positive cells. After 48 h treatment, the mean number of 
cells expressing GFAP increased significantly (***, p<0.001). Data represent means from two 
experiments with at least n=6 wells at 3, 24, and 48 h, respectively (D) GFAP protein levels 
quantified by western blot and normalized to GAPDH showing increased levels of GFAP after 48 
h of blood treatment (*, p<0.05; the filled circle is an outlier). Data were analyzed from three 
experiments with n=4 per condition. Scale bars = 50 μm in all A panels and 10 μm in all B panels. 
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4.2.7 ADAM10 inhibition abrogates N-cadherin cleavage and VZ disruption 
 
Under physiological conditions, ADAM10 cleaves N-cadherin, yielding a soluble isoform of N-
cadherin.511 In multiple organ systems, regulation of ADAM10 activity512-514 causes pathological 
shedding of cadherins, resulting in loss of adherens junctions, damage to epithelium, or disruption 
of endothelium.228,505,515. Importantly, the ADAM10 inhibitor GI254023X protects against 
epithelial disruption.516 To examine the role of ADAM10 modulation in IVH, we treated VZ cell 
cultures with either blood alone or blood+GI254023X (20 μM, Catalog #260264-93-5, Sigma-
Aldrich, St. Louis, MO). Treatment of blood elicited similar findings as before, including 
significantly decreased N-cadherin expression compared to DMSO vehicle-treated cells. However, 
the addition of GI254023X partially preserved N-cadherin expression. Accounting for number of 
cells, N-cadherin expression did not change between inhibitor-treated and vehicle-treated cells, 
both of which showed higher expression than the blood-treated cells (Figure 45) 
 
Figure 45: Effect of ADAM10 modulation on blood treated VZ cells.  
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A significant decrease in N-cadherin expression is observed in blood-treated VZ cells after 48 
hours when compared to DMSO (vehicle)-treated cells. Addition of the ADAM10 inhibitor 
GI254023X preserved N-cadherin expression similarly to DMSO-treated cells. 
 
4.2.8 Bacterial toxin causes VZ disruption that can be modulated by ADAM10  
 
To determine if N-cadherin-mediated VZ disruption and astrogliosis contribute to PIH 
pathogenesis and to examine the effects of ADAM10 modulation on VZ cytopathology in 
ventriculitis, we treated VZ cell cultures with ⍺-hemolysin. ⍺-hemolysin, the most cytotoxic 
pathogen secreted by Staphylococcous aureus, commonly causes hydrocephalus-related 
infections. In addition, mounting evidence suggests that ADAM10 carries a selective epitope 
activated by ⍺-hemolysin during systemic S. aureus infection. This epitope activation leads to 
cadherin cleavage and epithelial barrier disruption.512-514,516 Therefore, following differentiation, 
we separated equivalent numbers of wells containing VZ cell-mounted coverslips into three 
groups. Treatments included DMSO, 15 µg/mL of α-hemolysin, or 15 µg/mL of α-
hemolysin+GI254023X. We cultured the cells for a total of 3.5 hours following suspension. 
Treatment with α-hemolysin severely reduced N-cadherin expression. In addition, GI254023X 
treatment preserved N-cadherin structure, similar to DMSO. (Figure 46) 
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Figure 46: Effect of ADAM10 modulation on toxin treated VZ cells. 
Compared to the VZ cells of controls (A & D) treated with DMSO, those treated with (B & E) α-
hemolysin was associated with severely reduced N-cadherin expression and higher GFAP signal. 
However, addition of (C & F) GI254023X to α-hemolysin-treated cells was associated with 
preserved N-cadherin structure. (Right panel) The box and whisker plot demonstrate the relative 
intensity of N-cadherin as a ratio of the total number of cells per well was lowest with the addition 
of α-hemolysin when compared to control DMSO-treated cells. Addition of GI254023X in the 
setting of α-hemolysin preserved the relative N-cadherin intensity, to levels similar to that of 
controls. *** p<0.001. 
 
4.3 Discussion  
 
4.3.1 Summary of findings 
 
In summary, we showed that exposing VZ cells to blood or a bacterial toxin triggers a time-
dependent chain of events starting with the dislocation of N-cadherin. This dislocation impairs 
differentiation and induces loss of ependymal cells, culminating in reactive astrocytosis (Figure 
49). The findings provide a mechanistic basis for PIH and PHH pathogenesis in support of our 
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findings from previous chapters. Furthermore, results from existing literature on human and animal 
models of hydrocephalus support our findings.171,172,175,176,178,183,197,215,216,223,517,518 
 
Figure 47: Model summarizing the effects of the blood on the VZ.  
During maturation, neural stem cells (NSC) with adherens junctions transform into multiciliated 
ependymal cells (EC). Blood exposure produces a time-dependent chain of events starting with 
the dislocation of cell junctions (N-cadherin) from the cell membrane into the cytoplasm and loss 
of multiciliated cells. Subsequently, glial activation occurs, as evidenced by astrocytes with 
numerous processes. In vivo observations suggest that glial activation occurs at the site of VZ 
disruption.  
 
4.3.2 The in vitro model mimics normal human VZ differentiation 
 
Our murine in vitro model recapitulated the normal VZ cell differentiation that occurs across 
species. In rats, differentiation of the dorsolateral wall of the lateral ventricle takes place 
postnatally. At postnatal day one, the VZ comprises approximately 70% neural stem cells, 23% 
non-ciliated cells and 7% multiciliated ependymal cells. Neural stem cells then differentiate into 
multiciliated ependymal cells. However, the percentage of non-ciliated cells remains constant.518 
A similar pattern of postnatal ependymal maturation occurs in mice.519 In humans, ependymal cell 
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maturation occurs earlier in intrauterine life, and multiciliated ependymal cells appear in the 
dorsolateral wall from 23-40 gestational weeks.197,518,520 To model the clinical timeline of VZ 
development as closely as possible, we performed our experiments during the stage of 
differentiation between in vitro days five and seven, when the cultured cells progressed from 
approximately 20% to 55% multiciliated ependymal cells. During this time, the VZ also exhibited 
preterm human-like features such as the presence of undifferentiated monociliated cells with or 
without expression of GFAP, immature multiciliated ependymal cells expressing GFAP (~65% of 
all ependymal cells), and mature ependymal cells not expressing GFAP (~35%). The presence of 
monocilia characterizes neural stem cells123, and GFAP marks astrocytes and immature ependymal 
cells. Thus, monociliated cells failing to express GFAP may belong to another lineage of stem 
cells not committed to microglia. 
 
4.3.3 N-cadherin cleavage underlies the cell-cell junction pathology in VZ disruption 
 
Cell junction pathobiology may mediate VZ disruption in clinical and experimental 
hydrocephalus.171,175,176,216-220,521 In areas of VZ disruption, N-cadherin localizes to the cytoplasm 
rather than binding to the cell membrane.518 Furthermore, many genetic alterations directly or 
indirectly affecting cell junction stability associate with VZ disruption and 
hydrocephalus.174,183,216,522,523 The blood component lysophosphatidic acid (LPA) also alters cell 
junctions, disrupts VZ cytoarchitecture, and produces hydrocephalus.215,223 These authors noted 
VZ disruptions in both the lateral ventricles and the cerebral aqueduct and therefore suggested that 
aqueductal stenosis produced ventriculomegaly in their rodent model. Our in vitro IVH model 
corroborates these well-known cell junction alterations; we observed dislocation of N-cadherin 
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after 24 hours of blood treatment and significantly decreased expression of N-cadherin after 48 
hours of treatment. Adherens junctions mediate VZ cell attachment. Therefore, impairment of 
these junctions results in detachment and loss of those cells. Because cell junctions appear 
fundamental to the genesis of cytopathology in many forms of hydrocephalus, modulators of those 
molecules such as metalloproteases should play a role in the etiology of PIH and PHH.  
 
4.3.4 ADAM10 Inhibition abrogates N-cadherin cleavage and VZ disruption 
 
ADAM10 cleaves more than 40 transmembrane proteins in the extracellular region,524 most of 
which are cell adhesion proteins including L1-CAM,525 E-cadherin, and N-cadherin (reviewed in 
526). ADAM10 activation disrupts lung epithelial cells in mice,228 presenting a pattern of cadherin 
alteration similar to what we observed in our in vitro model. Interestingly, our group previously 
reported that many of the proteins cleaved by ADAM10 such as amyloid precursor protein and 
L1-CAM show increased levels in the CSF of both congenital hydrocephalus and PHH.246,249,527,528 
In our model, exposure of VZ cells to the ADAM10 agonist α-hemolysin enhanced the activity of 
ADAM10 and triggered VZ disruption by cleaving N-cadherin. Perhaps more importantly, we 
prevented VZ disruption after both α-hemolysin and blood induction by using the ADAM10 
inhibitor GI254023X. These observations support the potential for this inhibitor, or perhaps other 
metalloprotease inhibitors, to have important direct therapeutic implications. However, future 
studies need to rigorously examine pharmacological inhibition of ADAM10 as a potential 
therapeutic strategy for preventing the development of PIH and PHH. 
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4.3.5 Reactive astrocytosis (neuroinflammation) occurs at the site of VZ disruption 
 
The in vitro model also resulted in fewer total VZ cells after 24 hours of treatment with blood or 
bacterial toxin, possibly due to loss of adherens junctions. Interestingly, we observed fewer 
multiciliated cells at 24 and 48 hours, suggesting that those cells may be more affected by this 
detachment. However, the percentage of VZ cells lost was not proportional to the percentage of 
ependymal cell diminution. We found that ependymal cells decrease twice as much as observed 
cell loss, indicating that factors other than cell loss contribute to ependymal cell absence. Also, 
impaired ependymal cell differentiation appears to take place, probably due to the aforementioned 
blood- or pathogen-dependent N-cadherin effects. This observation is consistent with the findings 
reported by Muniz-Talavera and Schmidt (2017)529 where mutant mice lacking the junctional 
cadherin complex regulator (Jhy) showed protracted ependymal cell differentiation and developed 
hydrocephalus. In both human and animal cases, VZ disruption relates to glial activation by 
possibly forming a new layer to specifically repair the disrupted area.133,171,517 Our experimental 
model corroborates this theory by displaying a significant increase in the number of GFAP-positive 
cells at 48 hours and by exhibiting multiple projections reminiscent of a reactive astroglial 
response. This glial response occurred 24 hours after disruption of N-cadherin, and we detected 
loss of multiciliated cells, indicating that this reaction may respond to cell junction impairment 
and VZ cell loss. These alterations seem to promote neural stem cell differentiation into reactive 
astrocytes, even though these stem cells originally committed to an ependymal cell fate. This 
altered program of VZ differentiation also explains the discrepancy between cell loss and 
ependymal cell differentiation. Glial activation, especially the addition of branched processes, 
influences the overall decrease of N-cadherin levels found after 48 hours of blood treatment 
because glial projections do not express this junction protein.  
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4.4 Materials and Methods 
 
4.4.1 Animals and surgery 
 
All animal procedures were approved by the Institutional Animal Care and Use Committee 
(IACUC) of the Washington University School of Medicine. C57BL/6 mice at P0 to P4 were used. 
Each pup was exposed to wet ice for approximately 2 minutes until circulatory arrest, then 
sacrificed by removing the head and gently stripping the scalp. The brain was removed through a 
combination of a lateral incision from the foramen magnum toward the external auditory canal (~3 
mm) and a superficial sagittal incision from the foramen magnum all the way through the midline; 
incisions were made using Metzenbaum scissors. The frontal and parietal bones were then 
removed with curved surgical forceps. The brain was then deposited in a Petri dish with ice cold 
Hank’s Balanced Salt Solution (HBSS), 1% PSA. Under a stereomicroscope, both hemispheres, 
the brainstem, and the olfactory bulbs were dissected by cutting in the midline using a single edge 
razor blade. The medial hemispheric side was positioned superiorly; using ultrafine forceps, one 
tip was introduced into the lateral ventricle in an anteroposterior direction all the way through the 
ventricle until reaching the parahippocampal gyrus. The opposite tip of the forceps was kept in a 
ventral position and closed completely leaving the hippocampus and the thalamus over the forceps 
and the lateral wall underneath. With a single twist of the wrist, the hippocampus and thalamus 
were removed from the lateral wall. The meninges were then stripped off.  
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4.4.2 Ventricular zone cell cultures 
  
Cells were dissociated with an enzymatic digestion solution (17 µL of Papain #37A17241, 
Worthington, Lakewood, NJ; 15 µL of DNAse, #EN0521, Thermo Fisher Scientific, Waltham, 
MA; and 288 µg of L-Cysteine, #C7352, Sigma, Saint Louis, MO in 1 mL of DMEM (Dulbecco's 
Modified Eagle Medium)/Glutamax) per brain for 1 h. Dissociated VZ cells were plated into 25 
cm2 flasks and grown in proliferation media composed of DMEM/Glutamax supplemented with 
10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S) at 37 °C to select for 
ependymal cells as described by Delgehyr et al. (2015). Half of the media was replaced the 
following day. After the cultures were confluent (~4 days), the flasks were shaken at 250 rpm 
overnight at room temperature to remove weakly attached cells, which were mainly differentiated 
neurons. The remaining cells were rinsed with Ca2+/Mg2+-free PBS and incubated for 5 minutes at 
37 °C with 1 mL of trypsin-EDTA (ethylenediaminetetraacetic acid) to detach them from the flask. 
These cells were resuspended in proliferation media and re-plated onto 12 mm diameter round 
glass coverslips in 24-well plates. The cell suspension (20 µL of 2x106 cells/mL) was carefully 
placed onto the coverslip and incubated for 1 h, allowing the cells to adhere at high density, after 
which 1 mL of the proliferation media was added to each well. The following day, 
DMEM/Glutamax supplemented with 1% P/S (differentiation media) was used for continued 




4.4.3 Alpha hemolysin and whole blood induction 
 
Five days after differentiation was initiated, the VZ cells were submerged in either non-heparinized 
whole blood (collected using orbital sinus puncture530 on animals within the same colony) or, 
alternatively, in α-hemolysin. All samples were held at 4 °C for less than 5 minutes. Cells on 
coverslips were treated with 25, 30, or 40 µL of blood or 15 µg/mL α-hemolysin with or without 
the ADAM10 inhibitor GI254023X (#260264-93-5, Sigma-Aldrich, St. Louis, MO) for a total of 
3, 24, or 48 h in the pilot dose-response experiment. This experimental group was compared to 
control coverslips that were submerged in PBS under similar conditions. Subsequently, time-
related experiments were performed comparing exposure of cells to 30 µL of PBS, blood, or α-
hemolysin for 3, 24, or 48 h. 
 
4.4.4 Immunohistochemistry and cellular imaging 
  
At 3, 24, and 48 h after treatment, the coverslips were washed three times with PBS and fixed with 
4% paraformaldehyde (PFA) in PBS for 7 minutes. After washing again in PBS, the cells were 
permeabilized with 5% bovine serum albumin (BSA) in PBS and 1% Triton X-100 for 1 h; 
subsequently the cells were incubated for 2 h with antibodies diluted in PBS supplemented with 
0.1% Triton X-100. Antibodies and dilutions included: N-cadherin (#180224, Thermo Fisher 
Scientific, Waltham, MA), 1:25; GFAP (#7260, Abcam, Cambridge, MA), 1:300; βIV tubulin 
(#11315, Abcam, Cambridge, MA), 1:100; and active caspase-3 (#AF835, Novus Biologicals, 
Littleton, CO), 1:100. After rinsing three times with PBS, the coverslips were incubated for 1 h 
with the appropriate secondary antibody and diluted in PBS supplemented with 0.1% Triton X-
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100. Secondary antibodies included goat anti-mouse Alexa fluor 488 (#A11001, Thermo Fisher 
Scientific, Waltham, MA), goat anti-rabbit Alexa fluor 488 (#A11034, Invitrogen, Carlsbad, CA) 
at 1:300 or goat anti-mouse Alexa fluor 555 (#AQ21422, Thermo Fisher Scientific, Waltham, MA) 
at 1:300. Lastly, the cells were stained with DAPI at 1:5000 in PBS (#D1306, Thermo Fisher 
Scientific, Waltham, MA) for 5 minutes to label cell nuclei. Images of immunostained tissue were 
obtained using Pascal confocal microscopy at 20X (0.50 Zeiss, Oberkochen, Germany) and 63X 
(1.4 Zeiss, Oberkochen, Germany). Leveraging the National Institute of Health’s ImageJ software, 
we created an in-house script that quantified cell variations (total cells, number of cells expressing 
specific proteins, and immunodensity) in areas of 0.0225mm2. (Supplementary Figure 6). 
 
Supplementary Figure 6. ImageJ quantification of VZ cells of interest  
Representative image (screenshot) of in-house script (A) incorporated into ImageJ for the 
quantification of cells of interest. By selecting an area of 0.0225mm2 (A), the cells of interest, in 
this case DAPI-positive (blue) cells are recognized (B). Cells in focus within the same plane are 
automatically selected (C), demarcated (yellow circles), and quantified. Quantification measures 
include total number of cells expressing the proteins of interest and their mean immunodensity. 
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4.4.5 Western Blot 
 
After 48 h of treatment, the cells were rinsed with PBS and then treated with 50 µL of 
radioimmunoprecipitation assay (RIPA) buffer (#R0278 Sigma, Saint Louis, MO) to homogenize 
the cultures. Proteins were denatured in lithium dodecyl sulfate (LDS) sample buffer (NP0007, 
Invitrogen, Carlsbad, CA) and reduced using β-mercaptoethanol (#M7154, Sigma, Saint Louis, 
MO). After heating at 95 °C for 5 minutes, each 30 μL sample was run on an SDS-PAGE gel (4-
12% polyacrylamide) (#NP0321, Invitrogen, Carlsbad, CA) for 1 h at 120 V in SDS running buffer 
(#NP0001, Novex, Carlsbad, CA). The proteins were then blotted onto a nitrocellulose membrane 
(#LC2006, Novex, Carlsbad, CA) at 170 mA for 2.5 h in 15% methanol transfer buffer (#NP0006, 
Novex, Carlsbad, CA). After blocking for 1 h in Tris buffered saline (TBS) with 5% powdered 
milk, samples were incubated with primary antibodies in TBS and 0.1% Tween (TBST) at 4 °C 
overnight. Primary antibodies and dilutions were GFAP (#7260, Abcam, Cambridge, MA), 
1:1000; N-cadherin (#180224, Thermo Fisher Scientific, Waltham) 1:50, and GAPDH (#2118S, 
Cell Signaling Technology, Danvers), 1:500. Detection was performed by enhanced 
chemiluminescence (#7003, Cell Signaling Technology, Danvers, MA) after 1 h of incubation with 
horseradish peroxidase-conjugated anti-rabbit (#70742, Cell Signaling Technology, Danvers, 
MA), 1:10,000 or anti-mouse (#SC-2005, Santa Cruz Biotechnology, Dallas, TX), 1:5,000. 
Western blot images were taken with the molecular imager ChemidocTM XRS+ using Image LabTM 





4.4.6 Statistical analysis 
 
One-way ANOVA followed by the Tukey post-hoc test or the Student’s t-test were used for 
parametric data and a Mann-Whitney U test was used for non-parametric data. Results were 
considered statistically significant if p < 0.05. Data are presented as group medians (non-
parametric) or means ± SD (parametric) and were considered statistically significant at p < 0.05. 




5 Chapter 5: Development of in vivo models of PIH and PHH  
 
Adapted from:  
1. McAllister JP, Castaneyra Ruiz L, Morales D, Isaacs AM, Ge X, Hartman A, Crevecoeur 
T, Brown J, Engelbach J, Talcott M, Baksh B, Garbow J, Bayly P, Limbrick DD. 
Development of a Novel Model of Intraventricular Hemorrhage and Post-Hemorrhagic 
Hydrocephalus in Infant Ferrets. (In preparation) 
2. Isaacs AM, Castaneyra Ruiz L, McAllister JP, Wu Y, Hamilton M, Yang R, Morales D, 
Dunn J, Limbrick DD. Intraventricular Injection of Gram-Positive Bacterial Toxin as a 
Mouse Model of Post-infectious Hydrocephalus. (In preparation) 
 
5.1 Introduction  
 
While cell cultures are ideal for testing disease mechanisms and manipulating biological processes 
in a controlled fashion, they are not able to provide a complete physiological environment of an 
intact organism. Therefore, we anticipate our future work beyond this thesis will require the use 
of in vivo animal models, not only to establish the mechanisms we have identified in vivo but also 
as a foundation for preclinical drug studies and easier translation into FDA–approved clinical 
trials. Our primary objective was to create animal models of PHH and PIH that mimic the human 
disease characterized by VZ disruption, impairment of neural stem cells differentiation, ependymal 
denudation, and neuroinflammation occurring in the setting of IVH or infection.  
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For PIH, we developed a mouse model because their small size, relatively cheaper cost, ease of 
handling, and availability of transgenics make them more feasible for a disease with very limited 
information on previous experimental models. On the other hand, PHH has many existing 
experimental models including mice531,532, rats372,533-536, rabbits384,537-540, cats541, dogs378,542-548, 
sheep378,542-548, and piglets379,380,549,550. Nevertheless, we developed a novel ferret model to 
circumvent some of the major limitations of the existing models. Unlike the lissencephalic cerebral 
cortex of rodents, ferrets have a gyrencephalic brain that is similar to a human brain, providing 
investigators with access to very early stages of neural development551. Particularly important for 
the investigation of preterm IVH, ferret brain maturation at birth is equivalent to the human brain 
during the early second trimester552. Their smaller size in comparison to other USDA-covered 
species makes them relatively easier to handle and cost-effective.  
 
5.2 Results  
 




Thirty-two ferret kits (ages 14-21 days old) were included in this study. Five intact controls did 
not undergo any surgery. Stereotactic intraventricular injection was performed in 4 sham PBS 
induction controls, 13 autologous blood inductions, and 10 syngeneic lysed blood inductions. 
Variations in age of induction, which occurred due to logistical challenges, were factored into 
future analyses.  (Table 9) 
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Table 9. Summary of ferrets used in the development of an animal model of PHH 


















































































F3 29 NA F22 48 Bilateral F19 44 Bilateral F38 28 Bilateral 
F4 121 NA F23 48 Bilateral F20 44 Bilateral F39 28 Bilateral 
F8 7 NA F24 48 Bilateral F21 44 Bilateral F40 28 Bilateral 
F17 44 NA F25 48 Bilateral F26 6 Unilateral F42 28 Bilateral 
F35 54 NA 
   
F27 23 Bilateral F43 28 Bilateral       
F28 52 Unilateral F44 28 Bilateral       
F29 52 Unilateral F45 28 Bilateral       
F30 52 Unilateral F63 22 Bilateral       
F31 35 Unilateral F64 22 Bilateral       
F32 35 Bilateral F66 22 Bilateral       
F33 35 Unilateral 
   
      
F34 35 Bilateral 
   
      
F36 28 Unilateral 
   
* Calculated post-induction age based on induction at 20 days of age. 
 
5.2.1.2 Neurological Status and Health 
 
None of the ferret kits developed post-operative neurological deficits or signs of discomfort. Jills 
consistently provided normal maternal care and nourishment. Early in the study, one jill removed 
the skin sutures within an hour after surgery; this experience prompted us to carefully place single, 
interrupted subcuticular sutures and to cover the incision with skin glue. Subsequently, no incisions 
were opened by the jill in the remaining cases. Except for the expiration of one kit at the end of an 
MRI scan, probably from a thermoregulatory impairment, all kits recovered well after 





The extent of ventriculomegaly was variable within and among induction groups, with a clear trend 
toward more frequent and more severe ventricular enlargement occurring in kits that received 
syngeneic lysed blood compared to those receiving autologous blood. The volume of syngeneic 
lysed blood injected into each lateral ventricle (150-250 μL) was considerably higher than the 
amount of autologous blood delivered (10-50 μL). The pattern of ventriculomegaly was quite 
consistent, with much greater enlargement of the occipital and temporal horns of the lateral 
ventricles compared to the frontal horns. Often ventriculomegaly was asymmetric even though 
equal volumes of blood were usually injected into both frontal horns. Unilateral injections rarely 
produced bilateral ventriculomegaly (Figure 48). 
 
Figure 48. Ventricular enlargement in ferret a model of PHH 
(A) Representative T2-weighted coronal MRI images illustrating ventricular size in an intact 
control (animal F035) and (B) following bilateral intraventricular injection of syngeneic blood 
(animal F050). Selected images are viewed with the animals’ left corresponding to the reader’s 
TH 
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left, arranged from anterior (left) to posterior (right) in each row and aligned at approximately the 
same coronal plane. Note the extremely small size of the frontal (FH) and temporal (TH) horns of 
the lateral ventricles in the control ferret (A). Following blood injections (in this case, 9 days), the 
occipital (OH) and temporal (TH) horns of the lateral ventricles expanded dramatically, and a CSF 
flow void (hypointense signal) was apparent in the cerebral aqueduct (CA). The needle trajectory 
for injecting blood is drawn with a dashed line in (B). (C) Line plot depicting the progression of 
mean body weights for each experimental group up to 25 days post-induction. All groups followed 
similar growth curves, although the PBS-injected sham controls were lighter (non-significantly), 
probably because they were selected for less traumatic procedures due to their lower initial 
weights. (D) Bar plot depicting ventricular volumes for the controls (intact and sham) and blood-
induced (autologous and syngeneic) groups. While the ventricular volume of the blood injected 
group was much greater than the control group, the difference was not statistically significant due 
to large within-group variation. 
 
5.2.1.4 VZ disruption and glial activation (neuroinflammation)  
 
Histological and immunohistochemical methods confirmed the patterns of ventriculomegaly 
detected with MRI and, importantly, revealed VZ disruption neuroinflammation. The pattern of 
VZ disruption was quite similar to our observations in preterm humans with IVH and PHH197 and 
with in vitro studies of maturing ependymal cells318, namely loss of ciliated ependyma, eruption 
of VZ cells into the lateral ventricle, loss or spatial rearrangement of N-cadherin adherens 
junctions, and the appearance of reactive astrocytes in the areas of VZ disruption. These 
impairments, found as early as nine days following blood induction, were found throughout the 
lateral ventricle, but seemed more frequent and prominent in the occipital and temporal horns 
where the ventricular enlargement was greatest. It is important to note that the pattern of 
cytopathology we observed occurred in all animals that had been injected with blood regardless of 
the extent of ventriculomegaly (Figure 49).  
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Figure 49:  Immunohistochemistry in a ferret model of PHH 
Representative photomicrographs comparing astrocyte (GFAP), ependymal cell cilia (βIV 
tubulin), adherens junction (N-cadherin) proteins, and a known modulator of N-cadherin 
(ADAM10) in the temporal horn (LVt) of PBS-injected control (A,C,C’,E,E’) and blood injected 
IVH (B,D,D’,F,F’) ferrets. (A & B) In H&E-stained sections, the monolayer of ependymal cells 
(Ep) is much thinner in IVH and contains a prominent area of disruption (*). (C/C’&D/D’) Viewed 
at low (C & D) and high (C’ & D’) magnification, IVH is associated with a conspicuous reduction 
in βIV tubulin-positive cilia, and the disrupted area contains numerous reactive GFAP-positive 
astrocytes. (E/E’ & F/F’) Likewise, in IVH there is a reduction in N-cadherin-positive (Ncad) 
adherens junctions and a conspicuous increase in ADAM10 immunostaining. Taken together, 
these results demonstrate that ventricular zone disruption and reactive astrocytosis are associated 
with IVH, even in mild forms of ventriculomegaly. (G) Box and whisker plots of the mean 
immunodensity of N-cadherin and ADAM10 in the ventricular wall of control and IVH/PHH 
ferrets. The decrease in N-cadherin expression and the increase in ADAM10 expression are both 
statistically significant, suggesting a causative role for ADAM10 in the ependymal disruption that 
occurs in PHH. Additional abbreviations: CP – choroid plexus; GFAP – glial fibrillary acidic 
protein. 
 
Lateral to the VZ/SVZ, the PVWM contained many more GFAP-positive astrocytes compared to 
controls, and most of these cells had the classical appearance of reactive astrocytes, suggesting 
neuroinflammation in the setting of VZ/SVZ disruption in the blood-treated group (Figure 50). 
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Figure 50. Reactive astrocytosis in a ferret mode of PHH 
Representative histological and immunohistochemical images (of increasing magnification from 
A-C) comparing VZ and periventricular white matter region cytology in control and blood-injected 
ferrets. GFAP-positive reactive astrocytes cluster at the areas of ependymal denudation. LV- 
lateral ventricle 
 
5.2.1.5 Diffusion Basis Spectrum Imaging of ferrets 
 
The brains of 13 age- and weight-matched female ferrets, including 7 blood-injected (IVH/PHH 
group) and 6 PBS-injected (Control group), underwent ex-vivo DBSI scans following sacrifice at 
~50 days old. The corpus callosum (CC) and bilateral anterior limbs (ALIC) and posterior limbs 
(PLIC) of internal capsules were demarcated as regions of interest (ROIs). DBSI measures were 
extracted from the ROIs. The IVH/PHH group exhibited a 50% proportional increase in non-
restricted fractions within the PVWM compared to controls (p=0.001) reflecting PVWM edema. 
However, 68% of this change was due to an increase in the hindered fraction (p<0.0004), implying 
that there was a component of increased cellularity in the PVWM, which would suggest 
inflammation. The proportional increases in non-restricted and hindered fractions in the CC were 
96% (p=0.002) and 120% (p=0.0006), respectively, and 49% (p=0.0006) and 51% (p=0.0005) in 
the ALIC, respectively. There was no significant change in the PLIC. Assessing intrinsic PVWM 
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injury, the CC and ALIC appear to sustain the most impact from PHH. This is evident as their 
respective fiber density proportionally decreased by 7% (p=0.007) and 10% (p=0.03). In addition 
to axonal fiber loss, the ALIC also demonstrated evidence of axonal injury by a decrease in axial 
diffusivity of 8% (p=0.008) when compared to controls. While similar trends were observed in the 
PLIC, none were statistically significant. (Figure 51) 
 
Figure 51. Periventricular white matter dMRI characteristics in a ferret model of PHH 
Proportional change in mean Diffusion Basis Spectrum Imaging (DBSI) of intraventricular 
hemorrhage and posthemorrhagic hydrocephalic (IVH/PHH) from control ferrets in three white 
matter tracts: corpus callosum (CC) and bilateral anterior limbs (ALIC) and posterior limbs (PLIC) 
of the internal capsules. In the CC and ALIC, there was an approximately 50-90% increase in the 
non-restricted fraction, reflecting PVWM edema in the IVH/PHH group. At the same time, there 
was over a 100% increase in the hindered fraction, reflecting increased cellularity, typically as a 
result of inflammation, contributed to the edema. No significant changes were observed in the 
PLIC. ★ p< 0.05. Abbreviations: MA – mean diffusivity, FA – fractional anisotropy, AD – axial 




5.2.2 Mouse model of PIH 
 
5.2.2.1 Neurological status and health 
 
Of 23 mice, 14 underwent bilateral intraventricular injection of ⍺-hemolysin (⍺-hemolysin group) 
and 9 received PBS (Control group). There was no difference in pre-induction weights between 
groups (p=0.66). There was a steep learning curve during the development of the model, as there 
was no existing literature to guide the concentration and volume of ⍺-hemolysin that would yield 
the desired endpoint (hydrocephalus). Injection of 25 µL/ventricle in the first cohort (5 controls 
and 5 ⍺-hemolysin) had unacceptably high mortality (80-90%), with the ⍺-hemolysin-injected 
mice dying within hours of surgery. The majority of control mice in that cohort died within 24-48 
hours of injection, suggesting there was also a volume effect, perhaps causing delayed intracranial 
hypertension, hydrocephalus, and death. Therefore, the volume was reduced for subsequent 
injections. Further volume response trials showed that injections of 2-2.5 µL/ventricle was ideal, 
as they did not cause any issues in the control mice. Additionally, ⍺-hemolysin injection at that 




For dose response trials, three concentrations of 𝜶-hemolysin were tested: low (27.4 µg/mL), 
medium (54.8 µg/mL), and high (91.3µg/ml) doses.  Likely due to technical reasons, early (<48h) 
mortality rates in the low and high dose were similar (~15%), whereas mice in the medium dose 
had no change in mortality. Neuroimaging was obtained 7 days after surgery. Approximately 50% 
of mice developed hydrocephalus to varying severity of ventriculomegaly. However, there were 
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no significant differences in ventricle size between the animals receiving different doses of ⍺-
hemolysin (p=0.403). The mice receiving medium and high doses mice did demonstrate significant 
white matter T2W hyperintensity suggestive of inflammation/edema (Figure 52). 
 
Figure 52. Ventricular enlargement in a mouse model of PIH  
Representative T2W coronal images of mice undergoing bilateral intraventricular injection of PBS 
(control) and low (27.4 µg/mL), medium (54.8 µg/mL), or high (91.3µg/ml) doses of α-hemolysin 
at 2.5 µL/ventricle. Note the Hamilton syringe needle tract on the left (red dotted arrow). All α	-
hemolysin-injected mice developed hydrocephalus as compared to the ventricular size of the 
controls. However, there was significant white matter hyperintensity observed in the medium and 
high dose mice in comparison to the hypointense signal seen in the low dose and control mice 
(blue solid arrow). 
 
5.2.2.3 VZ disruption and reactive gliosis (neuroinflammation) 
 
Immunohistochemistry confirmed the pathology detected with MRI, revealing ependymal 
denudation and astrogliosis (neuroinflammation). The pattern of ependymal disruption 
recapitulated our observations in preterm humans, in in vitro studies of maturing ependymal cells 
in both the blood and ⍺-hemolysin-treated cells, and in our ferret model of IVH/PHH. These 
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findings provide further evidence that ependymal disruption and neuroinflammation are an 
underlying pathophysiology that is common to PIH and PHH (Figure 53). 
 
Figure 53:  Immunohistochemistry in a mouse model of PIH  
Representative photomicrographs comparing astrocyte (GFAP) and ependymal cell cilia (βIV 
tubulin) in (A-C) non-disrupted and (D-F) disrupted regions of mice injected with intraventricular 
α	-hemolysin. Cell nuclei are stained with DAPI. Viewed at low (A & D), medium (B & E), and 
high (C & E) magnification, the disrupted regions showed a conspicuous reduction in βIV tubulin-
positive cilia and contained numerous reactive GFAP-positive astrocytes. These results 
demonstrate that ventricular zone disruption and reactive astrocytosis are associated with PIH. 
GFAP – glial fibrillary acidic protein. 
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5.3 Discussion  
 
5.3.1 Prevalence and time course of ventriculomegaly in PIH and PHH models  
 
Our observations indicate that the progression of PHH and PIH begin with periventricular edema 
followed by expansion of the lateral ventricles. In the mouse PIH model, animals that were scanned 
within 24 hours of surgery demonstrated diffuse white matter hyperintense T2W signal suggestive 
of edema. However, those that made it to 7 days to be scanned had developed much larger 
ventricles compared to their initial perioperative scans. In the PHH ferret model, ventriculomegaly 
typically occurred 10-15 days post-induction. Occasionally, ventriculomegaly occurred abruptly 
and severely within 7-10 days post-induction. The frequency of ventriculomegaly in both the PIH 
and PHH models was approximately 30% to 50%, which is similar to those reported in other 
species 379,553,554 and quite consistent with the incidence of PIH and PHH in human neonates who 
develop sepsis or IVH11,38,44,240,555. Thus, both the mice and ferret models appear to mimic the 
clinical occurrence of PIH and PHH. This feature also raises the pertinent and unanswered question 
of why some humans and animals do not develop ventriculomegaly after neonatal sepsis or IVH. 
 
5.3.2 Cytopathology  
 
Ependymal disruption in both models were characterized by ependymal cell denudation, loss of 
motile cilia, and accumulation of reactive astrocytes, possibly in the same location as ependymal 
alterations. In the ferret model, we also observed lost or spatial translocation of N-cadherin from 
the cell membrane to the cytoplasm in addition to lost or misdirected radial glial cells. These 
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features are consistent with those observed in human preterm infants182,197,556,557 and rabbits558,559 
with IVH/PHH as well as rodents with congenital hydrocephalus182,183,560. Furthermore, a glial 
response similar to reactive astrocytosis occurred in the ependyma and the PVWM. This finding 
matches a growing line of evidence from in vitro and in vivo models of IVH/PHH, as well as the 
observations from ferret kits receiving intracisternal injections of kaolin to induce obstructive 
hydrocephalus561.   
 
5.3.3 Surgical and Methodological Considerations  
 
Several important lessons were learned during the development of the animal models. For the 
mouse model, the main issues we encountered, which were later overcome, were related to finding 
the optimal dose and volume to achieve ventriculomegaly without acute death. There remains the 
limitation of bypassing the normal routes of human infection that lead to PHH when the 
intraventricular route is used. Future work will include inducing PHH via systemic infection. 
 
In the ferret model, a considerable volume of injected blood was required in order to promote 
ventriculomegaly. Autologous blood, which could only be obtained in limited quantities from the 
tail, seldom exceeded 25 μL/injection and the subsequent ventricular volumes in these preparations 
were lower than when larger volumes of blood were injected. In order to obtain a sufficient 
quantity of injectable blood, syngeneic cardiac samples had to be collected from a ferret littermate. 
These preparations delivered 150-250 μL/injection and produced much larger ventricles. It should 
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be noted that Whitehall and colleagues ultimately employed a second intraventricular injection of 
blood with a raised hematocrit in order to increase their yield of rats with ventriculomegaly.562  
 
The ferret model does not feature an expandable skull. Even though the sagittal and coronal sutures 
appeared flexible during the injection surgery at 20 days of age, none of the kits demonstrated an 
enlarged skull, even those with relatively severe ventriculomegaly. To our knowledge, there are 
no reports on when the cranial sutures of the ferret ossify, but it may be that the sutures close 
within a few days of our injections, prior to when intracranial pressure may increase. The lack of 
an expandable skull and the prevalence of mild-moderate ventriculomegaly in this model are 
important, especially because other models in infant-juvenile rats, cats, and rabbits do present with 
a remarkably expansive skull and open anterior fontanelle.  
 
A complete stereotaxic atlas of the adult or developing ferret is not available. As a result, we had 
to rely on measurements and trajectories planned from MRI scans and gross brain dissections. In 
addition, the short snout and relatively flat face of the infant ferret required a nose cone for 
anesthesia, which interfered with the standard bite bar used in commercial stereotaxic frames. 
Furthermore, the external auditory meatus of a 20-day-old ferret kit is still closed. We attempted 
to carefully secure the animal in the usual stereotaxic planes with the ear bars directed toward the 
openings of the external auditory meatuses and the dorsum of the skull perfectly horizontal, but 
positioning can still be variable. Further studies with short-term post-induction neuroimaging are 
still needed to determine the accuracy of intraventricular injections.  
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None of the ferret kits, regardless of the severity of ventriculomegaly or the amount of blood 
injected, developed detectable neurological deficits. This feature of the model may be 
advantageous for long-term studies, but it appears that functional outcome assessments will have 
to rely on more stringent behavioral, cognitive, and neurological tests. Such tests are not 
impossible; however, as di Curzio et al. have demonstrated, quantitative open field tests can be 
performed on ferret kits from 10 to 44 days old563. Depending on the outcome measures to be used 
(e.g., advanced MRI), studies with the infant ferret IVH/PHH model can become quite expensive. 
Because a ferret is a covered species by the USDA and Institutional Animal Care and Use 
Committees, purchase from purpose-bred vendors, domestic and local transportation costs, and 




This study has several limitations. As stated previously, the modest yield of, and relatively low 
variability in ventriculomegaly in both models contributed to the low sample sizes, making it 
difficult to draw firm predictions on the severity of hydrocephalus and to accumulate cohort sizes 
amenable to statistics. The mice used in this model were older so we could assess the ventricular 
zone as their ependyma had already developed. However, we used older mice in order to be able 
to obtain neuroimaging as the small brains of immature rodents create difficulties for high-
resolution neuroimaging86,564. Ongoing experiments are utilizing P0/P1 mice for intraventricular 
injections. We also recognize that an intraventricular injection approach bypasses the typical 
systemic route of infection; however, as first steps we had to ensure adequate ventriculitis was 
achieved, which can be further advanced to include systemic inoculation. The absence of an 
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expandable skull in the ferret may require inductions in younger kits; it may also indicate that 




5.4.1 Ferret model of IVH and PHH 
 
5.4.1.1 Subjects  
 
Ferrets were delivered to the Washington University School of Medicine animal facility as a litter 
of one jill and 4-6 kits when the kits were 12-14 days old. Following a 5-8-day quarantine period, 
kits underwent a pre-induction baseline MRI 2-3 days prior to receiving intraventricular injections 
to mimic IVH. Autologous blood or syngeneic blood obtained from an age-matched littermate was 
used to induce IVH. Controls received intraventricular injections of sterile saline or phosphate 
buffered saline (PBS) or no injections to serve as intact controls. All of the induction and control 
procedures were conducted when the kits were 14-21 days old; these times were chosen to match 
the age during which most premature humans present with IVH240,552,565. Post-induction MRI scans 
were performed to document the development of ventriculomegaly, indicative of PHH. To 
conclude each study, kits were euthanized with an overdose of Fatal Plus (sodium pentobarbital 
95%, ketamine 5%; IM), and the brains were fixed by cardiac perfusion of 4% paraformaldehyde 
in PBS. All procedures were conducted in accordance with National Institutes of Health Guide for 
the Care and Use of Laboratory Animals and approved by the Washington University in St. Louis 
Institutional Animal Care and Use Committee (IACUC protocol #2015005). 
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5.4.1.2 Induction of IVH and PHH  
 
Initially, IVH/PHH was induced in infant ferrets by unilateral or bilateral intraventricular 
injections of heparinized autologous blood obtained from the tail vein of the animal. This method 
was modified from procedures described previously by Whitelaw et al379,562. Approximately 20-
150 μL of autologous blood, depending on each animal, was obtained from the tail using a 22-
gauge hypodermic needle and drawn into sterile heparinized 70 μL glass capillary tubes. These 
blood samples were kept on ice for about 10 minutes to allow heparin to be mixed with the blood; 
this step proved to be critical to prevent blood clotting and obstruction in the microliter syringe. 
About 20-50 μL of the sample was drawn into a sterile Hamilton 50 or 100 μL syringe, which was 
then mounted on a stereotactic carrier for intraventricular injection.  
 
In order to mimic larger hemorrhages (i.e., IVH grades III and IV566, unilateral or bilateral 
intraventricular injections of syngeneic lysed blood were employed. Syngeneic blood was obtained 
from an anesthetized, age-matched littermate by cardiac puncture using routine methods. This 
approach yielded approximately 500-5,000 μL of blood, which was sufficient for induction of 4-5 
littermates. The blood samples were placed immediately in 1.5 mL heparinized tubes and frozen 
in liquid nitrogen. As needed, samples were lysed by 3 subsequent thaw-freeze cycles before being 
drawn into a sterile 1.0 mL syringe for intraventricular injection into each animal. 
 
For all intraventricular injections, the following procedures were performed using sterile 
technique. Kits were anesthetized with 1-4% isoflurane vapor in 100% oxygen. Heart rate and 
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oxygen saturation were monitored by pulse oximetry using a probe clipped to a rear paw. 
Respiratory rate was monitored by manual observation, and body temperature was monitored with 
a rectal probe. Kits were placed on a heating pad in the prone position and the head stabilized in a 
stereotaxic frame. Blunt ear bars were placed against the external auditory meatus because the ear 
canal was not patent at this age. The mouth was secured to a standard bite bar onto which the 
anesthesia nose cone was taped. Because maintaining body temperature in ferret kits at this age is 
very important for survival, towels were placed over the animal to keep it warm. The skin on the 
dorsal neck and skull were alternately swabbed three times each with Betadine and 70% alcohol 
to obtain sterility. The surgical field was covered with sterile drapes and a small hole cut in the 
outermost drape for access to the dorsum of the skull. A small skin incision was made over the 
dorsum of the skull and the skin retracted to expose bregma and the coronal suture. Based on 
measurements taken from pre-induction MRIs and prior gross morphology dissections, stereotaxic 
coordinates were set at 1.0-1.5 mm lateral to bregma, 2.0-3.0 mm anterior to bregma, and 5.5-
6.5mm deep to the pial surface to target the frontal horn of the lateral ventricle. A small (~1.0 mm 
diameter) burr hole was drilled in the skull. After bone and dura mater bleeding had been controlled 
with saline flushes, bone wax and Gelfoam, the syringe was loaded with PBS, saline or blood and 
advanced into the brain to the approximate depth. Initially this depth was 5.0 mm from the skull 
surface, subsequently 10.0 mm proved to be more accurate. After a 30-second equilibration period, 
the induction agent was injected slowly into each lateral ventricle. In general, the complete 
injection process consisted of short (about 10 second) injections of about 5.0 μL of sample 
followed by equilibration intervals of about 20 seconds. After the final injection, the needle was 
left in place for about 30 seconds and then withdrawn. When bilateral injections were performed, 
the same needle was used, having been pre-loaded with a sufficient amount of induction agent, 
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and the same injection procedure repeated on the opposite side. The skin incision was closed with 
absorbable suture using subcutaneous suturing techniques after surrounding tissue had been 
infiltrated with a mixture of Lidocaine-Marcaine (2.0 mg/kg). The wound area was cleaned with 
sterile saline and minimal amounts of skin glue applied to the incision to prevent the jill from 
opening the incision. Post-operative analgesia and infection control were initiated with 
Buprenorphine (0.01-0.03 mg/kg IM) and Cephalexin (10mg/kg SC). Isoflurane inhalation (but 
not oxygen) was discontinued and the animal allowed to recover; once sternal and reactive, the kit 
was returned to its litter.  
 
Following surgery all kits were weighed daily and monitored for signs of neurological deficits 
(ataxia, alertness, reflexes), general health (dehydration, lethargy), and discomfort (vocalization, 
stiff hair).  
 
5.4.1.3 Ferret Neuroimaging 
 
5.4.1.3.1 In vivo 
 
Anatomic MRI techniques, performed sequentially during the same setting or individually during 
separate sessions, were used to determine gross morphological changes in the brain, especially 
volumetric increases in the cerebral ventricles and the location of blood deposits and needle tracks. 
Imaging was performed pre-induction or post-induction (5-75 days, depending on the experiment) 
on an Agilent/Varian 4.7T small animal MR scanner equipped with a DirectDriveTM console 
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(Santa Clara, CA), built around an Oxford Instruments (Oxford, United Kingdom) horizontal 
magnet with a 40-cm clear bore diameter. MRI images were collected with a custom-built actively 
decoupled transmit (volume, 9-cm inner diameter) and receive (surface, 3.3, 3.8 or 4.5 cm outer 
diameter, depending on ferret head size) coil pair. 
 
Ferrets were anesthetized with isoflurane/oxygen mixture (3-4% isoflurane) in an induction 
chamber. When all reflexes had been abolished, the head of the ferret was placed in the prone 
position and secured in a custom-built head-holder with a C-clamp on the head and a pallet bar. A 
custom-built nose cone was taped in place for delivery of 1-3% Isoflurane for maintenance of 
anesthesia during the scan. Isoflurane excavation was accomplished by a silicone suction tubing 
placed next to the animal's head. The eyes were moistened with ophthalmic ointment. The ferret 
body was placed prone onto a padded heating bed that circled warm water through a water pump 
(Isotemp® 2100). A pulse oximeter (Nonin® 7500) secured to the ferret paw was used to monitor 
heart rate and oxygen saturation during MRI scan. Ferret respiratory rate (a pillow attached to 
animal abdomen) and body temperature (rectal probe) were monitored and heat-compensated with 
a MR-compatible small animal monitoring & gating system (SA Instruments, Inc.). Total 
preparation time was about 15-30 minutes. All monitored physiological parameters were recorded 
every 15 minutes until the animal had been recovered and had assumed a sternal posture. The in 
vivo MRI scans required 60-150 minutes, depending on the MRI sequences obtained. While 




For anatomical sequences, depending on brain size, 24-30 slices of T2-weighted transaxial images 
were collected with a 2D fast spin-echo (fsems) sequence with an echo train length (ETL) of 8, 
Kzero = 8, TR 3 S, effective TE 96-112 ms; matrix size 256 x 256 and field of view (FOV) 48 x 
48 to 60 x 60 mm2 (depending on ferret brain size) with a slice thickness 1.0 mm. Total data 
collection time for four averages was 6 minutes 48 seconds. The T2-weighted images were loaded 
into MatLab (MathWorks®) and converted into NIfTI (.nii) format with zero-padding to a matrix 
size of 512 x 512 as anatomic images. These T2-weighted images were used for ventricular volume 
segmentation with ITK-SNAP.  
 
5.4.1.3.2 Ex-vivo DBSI 
 
To limit cost, the explanted brains of a subset of age and weight matched ferrets (n=13) sacrificed 
at approximately 50 days old underwent DBSI to assess their PVWM integrity. The brains were 
placed in a 35mL syringe tube in 4% PFA then scanned ex vivo in an Agilent® 4.7 Tesla magnet 
with a solenoid coil. T2-weighted images, along with a multi-echo spin-echo diffusion weighted 
sequence in 99 diffusion directions (TR 3000 ms, TE 60 ms, Matrix = 192 x 192, b-value max = 
3000 s/mm2) was acquired for a total scan time of 14 hours per animal. The raw data files were 
converted to NIfTI and registered to a single subject space.  
 
All datasets were processed with our in-house DBSI pipeline described above. Two anisotropic 
components were used to model primary and secondary direction of fibers within imaged voxels. 
 176 
For division of the isotropic components, 2.0 µm2/ms and higher ADC was chosen to represent 
free diffusion, 0.6-2.0 µm2/ms hindered diffusion, and 0.6 µm2/ms and less for restricted diffusion.  
 
ROIs of the white matter tracts we examined were drawn on de-noised T2W coronal images by 
two independent blinded operators. The ventricles on de-noised T2W coronal slices were marked 
as ROIs for ventricular volumetric assessment. PVWM ROIs were identified in coronal slices. The 
genu – the anterior end of the corpus callosum was demarcated medial to the frontal lobes and the 
anterior horns of the lateral ventricles, behind and below the cingulate gyrus. The internal capsule 
was demarcated as a white matter structure that begins at the level of the thalamus, resting between 
the caudate nucleus and the thalamus, connected to cortical white matter. Thus, in the same slice 
as the genu, the anterior limb of internal capsule was identified. The most posterior end of the 
corpus callosum the splenium was identified coming through the mid-region of the coronal slice. 
The position was determined in the second to last slice in which the corpus callosum still existed, 
knowing that fibers continued all the way through the structure still. Positioned between the 
splenium and genu, the posterior limb of internal capsule was identified using the same guidelines 
as the anterior limb, being sure to exclude the crus cerebri (cerebral peduncle). Rostrally, the crus 
cerebri was observed as a bright, dense bundle of white nerve fibers emerging from the ventral 
cerebral cortex.  
 
All PVWM and ventricular volume ROIs were delineated using ITK-SNAP (open source software, 
www.itk-snap.org). After delineation, the voxel intensity values of all ROIs were extracted and 
analyzed. 
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5.4.1.4 Sacrifice and Neurocytology 
 
Routine histology and immunohistochemistry (IHC) of PFA-fixed brains collected at sacrifice 
were used to characterize cytology and cytoarchitecture, as described previously197. Each brain 
was blocked in the coronal plane and embedded in paraffin following routine methods. Coronal 
sections were cut serially at a thickness of 10 μm, collected into staining groups in which sections 
were mounted onto glass slides at intervals of approximately 100 μm and stained with Hematoxylin 
and Eosin (H&E). For routine immunohistochemistry, primary antibodies directed against cilia 
(βIV tubulin 1:100; catalog #11315, Abcam), immature ependymal cells and astrocytes (glial 
fibrillary acidic protein, GFAP; 1:300; catalog #7260, Abcam), microglia (ionized calcium binding 
adaptor molecule 1, Iba1; 1:100, catalog #PA5-27436, Thermo Fisher Scientific), and adherens 
junctions (N-cadherin, Ncad; 1:25; catalog #180224, Thermo Fisher Scientific), were employed. 
Secondary antibodies included goat anti-rabbit Alexa Fluor 488 (1:300; #A11034, Thermo Fisher 
Scientific) and goat anti-mouse Alexa Fluor 555 (1:300; #AQ21422, Thermo Fisher Scientific). 
Finally, the tissue was treated with 4’6-diamidino-2-phenylindole (DAPI 405, 1:5000; #D1306 
Thermo Fisher Scientific) to label all cell nuclei. Sections were analyzed by light microscopy and 
multiple fluorescence confocal microscopy. Quantification of immunohistochemistry was 
performed with our in-house script that quantified cell variations (total cells, number of cells 
expressing specific proteins, and immunodensity) per slide (Supplementary Figure 6). Relative 




5.4.1.5 Statistical analysis  
 
All statistical analyses were performed using in-house Python v2.7 and R package v3.4.1 scripts. 
Parameter map (PM) intensity values inside PVWM ROIs and ventricular volumes were analyzed 
with Shapiro-Wilk test for normality. Paired and non-paired t-tests and non-parametric measures 
(Wilcoxon signed rank tests) were used for between group comparisons as determined by tests of 
normality. Correlations between PVWM and ventricular volumes were analyzed between and 
within groups.  
 
5.4.2 Mouse Model of Ventriculitis and PIH 
 
5.4.2.1 Subjects and Experimental Design 
 
Mice were delivered to the University of Calgary animal facility as a litter of 12 pups. Following 
a 5-day quarantine period, pups underwent intraventricular injections to mimic ventriculitis and 
PIH. ⍺-hemolysin (Medimmune, Mountain View, CA) provided by our collaborator was used. 
Controls received intraventricular injections of saline. Post-induction MRI scans were performed 
to document the development of ventriculomegaly, indicative of PHH. All procedures were 
approved by the Calgary University Institutional Animal Care and Use Committee (IACUC 
protocol #AC17-0151). Throughout the study, mice were monitored daily for neurological and 
general health status until the time of euthanasia. In addition to routine assessments of alertness, 
locomotion, hydration, pain, anxiety, and infection, special attention was focused on signs and 




Mice were anesthetized with isoflurane 2−4% via inhalation through a nose cone. Their head was 
secured in a stereotactic head frame in the prone position. A surgical plane of anesthesia was 
obtained, as determined by multiple clinical signs such as limb withdrawal following paw pressure 
and any response to painful stimuli. Buprenorphine hydrochloride (0.05 mg/kg) was administered 
subcutaneously with a 27-gauge needle to maximize animal comfort during recovery. Strict aseptic 
techniques were followed at all times during surgery. The skin on the dorsal neck and skull was 
alternately swabbed three times each with Betadine and 70% alcohol to obtain sterility. The 
surgical field was covered with sterile drapes, sterile instruments and materials were used, and 
sterile surgical gloves were worn at all times.  
 
A small skin incision was made over the dorsum of the skull and the skin retracted to expose 
bregma. A small (~1mm diameter) burr hole was drilled in the skull 1.0 mm lateral to bregma and 
0.5 mm posterior to the coronal suture. After bone bleeding had been controlled with saline flushes 
or bone wax, the stereotactic frame was positioned to its coordinates for the frontal horn of the 
lateral ventricle. A Hamilton 30-gauge needle connected to a 5-µL gas-tight glass syringe 
(Hamilton, Reno, NV, USA) that was loaded with different concentrations and volumes of ⍺-
hemolysin in saline (27.4 µg/ml, 2.5 µl each side; 54.8 µg/ml, 2.5 µl each side; 91.3 µg/ml, 2 µl 
each side; 68.5 µg/ml, 2 µl each side) was lowered to the predetermined depth so that the tip will 
be located in the frontal horn of the lateral ventricle. The drug was then dispensed into the ventricle. 
After a 1-minute equilibration period, the needle was withdrawn slowly, and any leaking CSF 
stopped with a piece of bone wax. The similar process was performed on the opposite hemisphere. 
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The incision was closed with absorbable suture, the wound was cleaned, and the animal was 
allowed to recover prior to return to its cage. The induction procedure took ~30 minutes skin-to-




Imaging was undertaken 7 days post-injection or sooner if the mouse showed signs of humane 
endpoint. Imaging was performed on a Bruker BioSpin 9.4T MRI using a helium cooled cryocoil, 
which is a dual channeled surface coil. Anatomical scans were obtained as T2W RARE sequences 
(Matrix = 256 x 256, FOV =1.92 x 1.92 cm, slice thickness = 0.5 mm, TE = 30 ms, TR= 4000 ms,) 
to determine morphological changes in the brain, especially volumetric increases in the cerebral 
ventricles. Animals were anesthetized with isoflurane (2-4%) while in an induction chamber and 
then through a nose cone while positioned in the MRI scanner. After the animal was sufficiently 
anesthetized, the animal’s eyes were moistened by the application of ophthalmic ointment to 
further reduce the amount of drying to the eyes. The animal was placed into the scanner headfirst 
for imaging in prone position while lying on a bed of pillows with a heart rate and respiration 
monitor. Core temperature (36°C) was controlled using regulated air flow and a feedback to a 
rectal probe. Respiration was monitored and maintained by adjustments in anesthesia.  
 
The total time in the MRI lasted 30-45 minutes after which the animal was removed from the MRI 
and monitored until the anesthetic has worn off and normal movements had returned. While 
recovering from anesthetic, the mouse was placed on a heating pad to keep body temperature as 
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close to normal as possible. After normal movement has been restored, the animal was returned to 




To conclude each study, mice were euthanized with an overdose of Sodium Pentobarbital (200 
mg/kg). After all reflexes had been abolished, the pleural cavity was opened surgically, and a 
transcardial perfusion was performed with PBS. The extracted brains were cryopreserved in 
Optimal cutting temperature (OCT) compound prior to storage in -80 °C freezer. 
Immunohistochemistry of coronal sections of the cryofixed brains were performed with primary 
antibodies directed against cilia (βIV tubulin 1:100; catalog #11315, Abcam), and immature 
ependymal cells and astrocytes (GFAP; 1:300; catalog #7260, Abcam). Secondary antibodies 
included goat anti-rabbit Alexa Fluor 488 (1:300; #A11034, Thermo Fisher Scientific) and goat 
anti-mouse Alexa Fluor 555 (1:300; #AQ21422, Thermo Fisher Scientific). The tissues were 
treated with DAPI (405, 1:5000; #D1306 Thermo Fisher Scientific) to label all cell nuclei. Sections 
were analyzed by light microscopy and multiple fluorescence confocal microscopy. However, 




6 Chapter 6: Discussion of dissertation  
 
6.1.1 Leveraging a translational neuroscience approach to PIH and PHH 
 
In the past decade alone, over 11,000 hydrocephalus-related research articles have been published, 
accounting for one third of all papers published on the subject since 1860. In this extensive volume 
of data are many useful ideas that could potentially change the landscape of the field. However, 
there seems to be a dichotomy of the domains of hydrocephalus research, i.e. experimental versus 
clinical, and only a few studies have endeavored to merge the two approaches into a translational 
framework87,102. In addition, the majority of studies tend to focus on a single variant of 
hydrocephalus366,567-569, and those combining two or more forms of hydrocephalus are uncommon. 
Since the 1990s, “Translational Neuroscience” has gained widespread recognition, facilitating 
critical advances in many neurological conditions570. In addition to bridging the gap between 
fundamental neurosciences (typically in experimental models) and human brain function, the 
scope of translational neuroscience has widened to include multi-disciplinary consortiums, the 
design and implementation of new technologies and the development of diagnostic, prognostic, 
treatment and monitoring strategies570,571.  
 
The studies presented in this dissertation epitomizes the use of translational neuroscience 
principles to further hydrocephalus research. Rather than focusing on a single disease, two similar 
variants of hydrocephalus (PIH and PHH) were examined together as sharing a common 
pathophysiology.  In addition, all experiments were performed within a cross-disciplinary, multi-
institutional and international consortium including samples and expert representations from North 
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America and Sub-Saharan Africa. Furthermore, not only did we examine different anatomical 
regions of the brain including the VZ, SVZ and PVWM, as well as CSF physiology, we defined 
PIH and PHH with in-depth granularity by characterizing their pathophysiology at the gene, 
protein and cellular levels. We also developed and/or implemented several novel experimental 
approaches, including dMRI segmentation of the VZ/SVZ, DBSI, proteogeonomics and in vitro 
cell cultures to understand the pathophysiology and underlying mechanisms of PIH and PHH. 
Finally, we developed animal models that mimic the human disease and our findings, and are 
amenable to the modulation of physiological processes to further understand the pathophysiology 
of PIH and PHH, and perhaps more importantly, for utilization by animal trials that can be 
transitioned into human clinical trials for PIH and PHH therapy.  
 
6.1.2 A unifying pathophysiological mechanism for PIH and PHH 
 
With a long-term goal of improving the care of infants affected by PIH and PHH, and identifying 
strategies to prevent both conditions, the objective of this dissertation was to define the common 
and unique pathways underlying the pathophysiology of PIH and PHH. With proteogenomics, we 
established that both conditions are associated with the differential expression of genes involved 
in neuroinflammation and brain-CSF barrier cell-cell junction structure in CSF. While the 
neuroinflammation was predominantly innate, there was overlap with the adaptive immune system 
through complement activation.  
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Assessment of the ventricular perimeter of human infants with dMRI confirmed that, in the setting 
of neuroinflammation, PIH and PHH are associated with microstructural disruptions of the neural 
stem cell rich VZ/SVZ regions. The most aberrant dMRI measures were found in the FOHP 
regions and were attributed to compounding mechanical injury caused by pressures exerted on 
those regions by the expanded ventricles. The neuroinflammation and VZ/SVZ pathology were 
confirmed with neurocytology in humans, ferrets and mice with PIH or PHH.  
 
Utilizing in vitro cell cultures, we identified that the VZ/SVZ disruption was mediated by cleavage 
of adherens junctional proteins (e.g. N-cadherin). N-cadherin cleavage was found to be facilitated 
by activation of metalloproteases (e.g. ADAM10), which led to a reduction in the number of 
VZ/SVZ cells available for differentiation into ependymal cells and neuroglia. In addition, 
differentiation of the remaining cells was also impaired, culminating in a disrupted ependymal 
barrier. Disruption of the VZ/SVZ and ependymal barrier was associated with injury to the 
subjacent PVWM, in which axonal injury, reduced axonal fibers, increased cellularity and edema, 
neuroinflammation, and myelin disruption of myelinated axons were observed in human and ferret 
dMRI and immunohistochemistry.  
 
Together, these findings confirm our central hypothesis and provide verifiable evidence to posit 
the following regarding PIH and PHH: 1) the antecedent events of hemorrhage and infection and 
the hydrocephalus activate neuroinflammation cascades that, while physiologically necessary, 
inadvertently cause ependymal injury; 2) these events occur in the setting of alterations in gene-
activated pathways of host immune-responses and also during a stage of active differentiation of 
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VZ/SVZ neural stem cells, making neuroinflammation-related VZ/SVZ disruption central to the 
pathogenesis of PIH and PHH; 3) VZ/SVZ disruption is mediated by ADAM10 cleavage of N-
cadherin-based cell-cell junctions, leading to denudation of the ependymal barrier, which 
compromises the brain-CSF barrier critical for CSF homeostasis; 4) PVWM injury occurs when 
the brain-CSF barrier is damaged, which has been previously related to neurodevelopmental 
deficits in affected infants, and even later in adult life;  5) pharmacologic modulation of ADAM10 
represents a viable therapeutic approach to mitigating the deleterious pathogenesis of PIH and 
PHH. (Figure 54) 
 
Figure 54: A proposed unifying pathophysiological mechanism for PIH and PHH  
The ventricular zone (VZ) and subventricular (SVZ) zones are the main neurogenic niche for brain 
development. During fetal development, neuroepithelial cells in the VZ/SVZ migrate to 
differentiate into cortical neurons, astroglia and ependymal cells, utilizing radial glial cells. During 
this critical period, a systemic infection or intraventricular hemorrhage (1) may elicit a host-
immune response and activation of metalloproteases (e.g., ADAM10) (2), which in turn cleave 
adherens junction molecules (e.g., N-cadherin) (3), leading to disruption of the brain-CSF 
ependymal barrier (4). Together, the VZ/SVZ and ependymal disruption lead to impairment of 
CSF dynamics (5), and the juxtaposed periventricular white matter to injury from persistent 
neuroinflammation and CSF-laden toxins. Inhibition of ADAM10 abrogates the N-cadherin 
mediated VZ/SVZ disruption in cell cultures. (Modified after Rodriguez et. al.172 and Gao et. 
al.572). 
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6.1.3 Neuroinflammation is central to PIH and PHH pathophysiology 
 
Neuroinflammation has long been associated with the pathogenesis of infection-related 
hydrocephalus. Earlier reports described inflammation-mediated granular ependymitis and 
scarring of CSF pathways as the cause of infectious hydrocephalus573-576. Similar mechanisms of 
host immune responses have been implicated in the pathogenesis of PHH following IVH242,577 and 
congenital hydrodrocephalus.145,207,242 Indeed, reactive astrocytosis has been demonstrated 
repeatedly in both congenital and acquired models of hydrocephalus, and has been further shown 
to increase with the progression of hydrocephalus. Additionally, there is evidence to suggest that 
in many forms of hydrocephalus, neuroinflammation has widespread deleterious effects on brain 
function, including disturbances in oxidative metabolism, neurotransmission, periventricular cell-
cell junctional interaction, brain-CSF barriers, iron transport mechanisms, and choroid plexus 
function.84,145,169,182,197,212,318,336,382,578-580 Bearing in mind the effects of neuroinflammation across 
many variants of hydrocephalus, we elected to use non-hemorrhagic non-infectious hydrocephalic 
infants as controls in order to detect molecular mechanisms that were more specific to PIH and 
PHH. 
 
Neuroinflammation can be mediated through many different pathways. The TLR system, 
especially the TLR4 ligand for lipopolysaccharides (LPS), is perhaps the best understood. It 
involves LPS binding to the lymphocyte antigen 96 which then triggers dimerization of TLR4 to 
enhance cytokine and chemokine production downstream. TLR4 can also be activated by blood 
products.581 In a rat model, Karimy et al. demonstrated that TLR4-mediated activation of SPAK-
NKCC1 led to hypersecretion of CSF by the choroid plexus epithelium, leading to 
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hydrocephalus.145 While the TLR immune system pathway is commonly implicated in 
hydrocephalus,145,198,336,582 the JAK-STAT pathway is considered the most efficient form of innate 
immunity, especially to intracellular pathogens.201,202 In fact, protein mutations in the JAK-STAT 
pathway have been implicated in poor inflammation mediation.201,202 For example, impaired JAK 
function in severe combined immunodeficiency is associated with susceptibility to infections due 
to the absence of natural killer (NK) cells, B cells or T cells.583,584 In our PIH and PHH human 
cohorts, JAK-STAT-dependent processes predominated, likely because all the infants were less 
than 3 months of age and had not had the antigenic exposure required to mount a detectable 
humoral response.  
 
The proteogenomics experiments validated our previous findings from immunometric assays 
confirming that activation of the immune system in PIH and PHH increases cytokine and 
chemokine production207. In addition, there was differential expression of products involved in the 
innate immune system-related metabolism such as iron depletion and generation of reactive 
oxidative species (ROS). During an acute infection585 or IVH586,587, there is a high rate of oxidative 
metabolism and response to ROS such as hydrogen peroxide, superoxide radicals and nitric oxide. 
ROS activation typically triggers cascades of cellular excitotoxicity targeted toward the blood-
brain barrier (BBB), which secondarily results in brain injury that impairs brain oxygenation, 
leading to cerebral vascular dysfunction and ischemia.588 The role of BBB disruption in CNS 
infections and IVH have been broadly studied. In sepsis, the BBB acts as a nexus for integrating 
signals of the brain and periphery and permits extravasation of microbes and infection-related 
mediators into the CNS (reviewed in 589-591). In IVH, BBB abnormalities identified as decreased 
pericyte laminin, which is critical for maintaining their tight junctions 592,593 and type IV collagen 
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that provide structural support for the capillaries 594 have been reported. However, it is unclear 
whether the BBB abnormalities in hemorrhage or infections are triggers of hydrocephalus as there 
are many inconsistencies in the literature on the role of BBB in hydrocephalus pathophysiology 
39,595,596. Nevertheless, our finding of abundant expression of neutrophil-generated ROS in PIH 
and PHH infants raises important questions as to whether BBB disruption contributes to the 
sustained (chronic) inflammatory milieu in PIH and PHH even months after the initial infection or 
hemorrhage, when the CSF samples were collected.  
 
6.1.4 Role of modulating neuroinflammation pathways to mitigate PIH and PHH 
 
From CSF to neural stem cell organization, ependymal barrier structure and PVWM, across 
human, mice and ferret species, and at both the gene and protein levels, our results consistently 
supported host-immune response as being central to PIH and PHH pathophysiology. However, it 
would be premature to suggest that our findings support the general use of anti-inflammatory or 
immunosuppressive agents during neonatal sepsis or IVH to mitigate the risk of developing 
hydrocephalus. For one, it remains unclear whether neuroinflammation drives the development of 
PIH and PHH or vice versa. Moreover, the time course and permanence of neuroinflammation-
mediated brain injury have yet to be elucidated187. In experimental models, non-specific 
modulation of immune response has yielded variable results. For example, minocycline, a 
tetracycline antibiotic that has many undefined effects but has been shown to inhibit microglial 
cells has been explored. In the H-Tx rat model of congenital hydrocephalus, intraperitoneal 
administration of minocycline significantly reduced the numbers of astrocytes and microglia and 
increased cortical mantle thickness 94,96. It is important to note that minocycline has many side 
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effects including tooth discoloration in children and long-term severe osteoporosis; which may 
limit its translation to clinical use88.  
 
The use of steroids remains a controversial topic in perinatal medicine, and in particular, in 
neonatal sepsis and IVH597-600. There have been many attempts to use corticosteroids in treating 
infants with acute bacterial meningitis, and despite a few notable exceptions such as Hemophilus 
influenza and pneumococcal meningitis, there have been many failures, some with devastating 
outcomes601-609.  In experimental models, corticosteroids and glucocorticoids have been used for 
decades with variable benefit in hydrocephalus88. For example, intravenous administration of 
dexamethasone in kaolin-induced hydrocephalic dogs yielded a 40 % reduction in CSF flow. 
However, the effect, was short-lived, lasting for approximately six hours. 610,611. 
 
Neuroinflammation tends to involve several biological pathways, each of which encompasses 
scores of mediators that are also involved in other related processes. As such, while it may not be 
advisable to broadly modulate upstream ligands of neuroinflammation such as TLRs or JAK 
receptors, specific mediators (e.g., TGF-β1) may be targeted to minimize inadvertent effects on 
the patient’s physiology. A few decades ago, it was reported that compared to controls, the CSF 
of preterm IVH infants expressed relatively higher levels of TGF-β1, which is released from 
platelets at sites of blood clotting to regulate fibroblasts proliferation612. This line of work 
prompted several experimental studies to explore specific targeting of TGF-β1 as a potential 
therapy for hydrocephalus. In experimental models, transgenic mice with TGF-β1 overexpression 
613,614, and wild type mice who were injected with TGF-β1 into the subarachnoid compartment 
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both had hydrocephalus615,616. Perhaps more importantly, the induced hydrocephalus mice could 
be remediated with intraventricular infusion TGF-β1 antagonists617. In addition, Botfield et al. 
showed that in kaolin-induced hydrocephalic rats with, treatment with decorin, a TGF-β1 binding 
proteoglycan, at the time of Kaolin injection was associated with reduced inflammation and 
fibrosis in the subarachnoid compartment and prevention of hydrocephalus 89. Other studies have 
also shown that decorin has the therapeutic potential to decrease ventricle size and PVWM 
microstructural damage, as well as cognitive outcome in rats90,92. While the experimental work on 
TGF-β1 modularion is exciting, none of these studies have translated to humans. Another good 
example of specific targeting is the recent work of Karimy et al145. In a rat model of PHH, Karimy 
et al showed that IVH causes a TLR4 and NF-κB dependent inflammatory response in choroid 
plexus epithelium, which was associated with an approximately three-fold increase in CSF 
secretion and hydrocephalus. It was found then that the SPAK gene, which binds, phosphorylates, 
and stimulates the NKCC1 co-transporter at the choroid plexus epithelium apical membrane was 
responsible for TLR4-dependent choroid plexus CSF hypersecretion. To that effect, genetic 
depletion of TLR4 or SPAK, as well as antagonism of TLR4-NF-κB signaling or the SPAK-
NKCC1 co-transporter complex all led to normalized CSF secretion rates145. Future studies are 
needed to explore these specific targets in humans. 
   
Our human proteogenomic work does point to novel intervention pathways and supports that 
selective and targeted modulation of certain aspects of immune response pathways may be a more 
successful approach in the prevention of hydrocephalus.For example, in addition to pro-
inflammatory immune factors, we found a differential expression of IL-4 and IL-13, which 
generally have anti-inflammatory effects. IL-4 and IL-13 can share a common receptor618-620 and 
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typically work synergistically to decrease inflammation by counteracting the activity of pro-
inflammatory cytokines such as  IL-12.621,622  IL-4 and IL-13 are also considered neuroprotective 
as they can induce death of microglial cells that mediate neuronal damage623-625. As a caution, Park 
and colleagues reported that, in experimental models, IL-4 and IL-13 potentiate oxidative stress-
related injury to hippocampal neurons.626,627 Thus, one hypothesis is that the balance of IL-12 and 
IL-4/IL-13 within the CSF contributes to the risk of PIH, suggesting that their targeted modulation 
may be a potential therapeutic target. Further studies are needed to examine the role of 
cytokine/chemokine modulators as potential adjunctive treatment targets to regulate the immune 
response during such infections and IVH in an effort to reduce the chance of developing 
hydrocephalus.  
 
It is also critical emphasize that inflammation itself, at least in the acute phase of CNS injury, is a 
physiologically helpful process for appropriately responding to and clearing microbes and toxins. 
Since there are no set thresholds, it is challenging to define an inappropriate inflammatory response 
and the point at which modulation would do more benefit than detriment. Time course and levels 
of inflammatory markers in biological samples could be helpful, but more research is needed to 
identify robust biomarkers and obtain normative data on appropriate levels of response. 
 
6.1.5 Ependymal barrier damage is associated with PVWM injury  
 
As we have consistently demonstrated in the setting of neuroinflammation, disruption of neural 
stem cells in the VZ/SVZ compromises their differentiation into ependymal cells.  While this 
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dissertation focused on the ependyma due to its central role in hydrocephalus pathogenesis, we 
acknowledge that VZ/SVZ disruption also negatively impacts neurogliogenesis via both the radial 
and tangential migration streams572. With regards to ependymogenesis, the ependymal barrier, 
which is responsible for many functions including brain-CSF homeostasis and immune 
response232,233, is defective when the VZ/SVZ differentiation is disrupted, demonstrating regions 
of denudation and heterotopias. As a result, the protective barrier properties of the ependymal layer 
to shield the subjacent PVWM from injurious CSF toxins is compromised. With dMRI and 
immunohistochemistry, we demonstrated ependymal layer microstructural damage was intimately 
related to transependymal CSF migration, and PVWM dysmyelination and axonal loss across 
species.  
 
While VZ/SVZ injury involves the majority of the LVP, we found segmental variations in the 
magnitude of injury. The FOHP regions tend to be more vulnerable than other regions, perhaps 
due to relatively higher pressures exerted on the FOHP by the expanded ventricles. Across the 
lateral ventricle there are regional differences in the cytoarchitecture of the VZ and in the 
organization of neural stem cells within the SVZ.133,197,463 While radial glial cells are sequentially 
replaced by ependymal cells along the LVP during fetal development, the lateral wall of the frontal 
horn is the only region that retains these stem cells into infancy463, which may be associated with 
adverse neurodevelopment when those specific regions are damaged by PHH. Our findings of 
more aberrant VZ/SVZ and ependyma in the FOHP than in the rest of the ventricle are consistent 
with the patterns of injury seen on conventional MRIs of hydrocephalus patients193-195,465, and  
reflect the disproportionate distribution of stress and strain on the FOHP region.466-468 Indeed, 
porohyperelastic finite element anatomical models have showed that, compared to the rest of the 
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lateral ventricle, the FOHP is subjected to increased stress and strain and a 3.5-times increased 
edema468. The disproportionate risk of injury at the FOHP has been attributed to the acute 
anterolateral angles at those regions, which subject them to high ICP- and hydrocephalus-related 
tensile forces466-468. In contrast to the convex shape of the body of the lateral ventricle, the concave 
geometry of the FOHP is associated with expanded extracellular spaces, which makes those 
regions more susceptible to free water accumulation and edema, leading to impairment of arterial 
blood flow, venous stasis, ischemia-induced PVWM injury, dysmyelination, axonal 
disruption.458,466-468,486,487  This segmental difference in VZ/SVZ injury is critical because it begs 
the question as to whether therapeutic strategies should be focused on localized regions at the 
highest risk of injury, and those most populated by neural stem cells that have the capacity to 
regenerate (the FOHP).  
 
In our cohort, ventricular size negatively correlated with the magnitude of VZ/SVZ and PVWM 
injury, suggesting that the expansion of the ventricles likely has a negative effect on ependymal 
and PVWM tissue integrity, speaking to whether ventricular size can be used as a surrogate marker 
for disease severity in PIH and PHH. However, we must note that there is ongoing debate regarding 
ventricular size-PVWM injury correlations, as variable results have been reported in the 
literature.450,628,629 For example, Kulkarni et al. did not find any association between FRONTAL-
OCCIPITAL HORN RATIO and PVWM injury in 23 pediatric patients with treated, stable 
obstructive hydrocephalus629. Our findings are similar to those of Akbari et al.450 and Cauley et 
al.628, who showed significant positive correlations between FRONTAL-OCCIPITAL HORN 
RATIO and dMRI measures. At the very least, we can conclude that our findings and some of the 
existing literature underscore the importance of evaluating the role of ventricular size – a readily 
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modifiable factor – on white matter integrity, brain development and neurodevelopmental 
disability associated with PIH and PHH.  
 
6.1.6 VZ/SVZ differentiation modulation and ependymal barrier and PVWM repair 
 
Given the many downsides of broadly interfering with acute neuroinflammation, the paradigm 
could probably be shifted towards mitigating chronic inflammation, which has an implicated role 
in the perpetuation of brain injury following IVH and CNS infections198. ADAM10 has been 
implicated in some chronic inflammatory diseases such as multiple sclerosis and 
osteoarthritis.630,631  With our cell culture model, we established that ADAM10 activation led to 
cleavage of N-cadherin, which impaired VZ/SVZ differentiation and ependyma cell-cell junction 
adhesion. During systemic infections, ADAM10 dysregulates BBB function through ectodomain 
shedding of barrier proteins such as LRP1, endothelial barrier damage and increased vascular 
permeability632,633, which likely perpetuates chronic inflammation.  As such, there is a growing 
body of evidence involving ADAM10 therapy in the treatment of other conditions.526,633 For 
example, the a-secretase activity of ADAM10 is presently being investigated as a potential 
therapeutic target for limiting Aβ production in Alzheimer’s disease633-635. Administration of 
ADAM10 inhibitors have also been shown to be effective at protecting against lung and liver 
epithelia disruption during staphylococcal infection502,516.  In our experiments, the inhibition of 
ADAM10 enabled us to preserve VZ/SVZ cytoarchitecture in vitro in the setting of blood and 
bacterial toxins inoculation. Therefore, there is potential for ADAM10 as a modifiable, therapeutic 
target for preserving ependymal barrier cytoarchitecture, to limit progression to PIH and PHH 
following an infection or hemorrhage. From a patient management standpoint, ADAM10 cleavage 
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of N-cadherin yields soluble isoforms of N-cadherin,511 which can be detected in the CSF of human 
PHH infants in addition to other ADAM10-related substrates such as L1CAM, NCAM-1, and 
APP.245,247,636 Nevertheless, it must be noted that while the ADAM10/N-cadherin mechanisms we 
tested in this dissertation brings necessary focus, there may be other proteases or important 
pathways involved in the pathophysiology of PIH and PHH. In addition, the effect of hemorrhage 
or infection on choroid plexus physiology, as well as the secretory/absorptive capacity of the 
ependymal layer can be further explored.  
 
In terms of PVWM, Del Bigio et al. demonstrated that in kaolin-induced hydrocephalic rats axonal 
damage was in part mediated by increased levels of proteolytic enzymes mediated by intracellular 
calcium637. This prompted modulation of calcium as therapy in experimental models of 
hydrocephalus. Although rats treated with the calcium channel blocker nimodipine for two weeks 
after hydrocephalus induction did not show a reduction in ventricular size, their corpus callosum 
was relatively thicker and they performed better on motor and cognitive behavior testing when 
compared to untreated hydrocephalic control rats97. In two-week-old ferrets, parenteral injections 
of magnesium sulfate, a calcium competitor, was associated with lethargy and there was no 
evidence for protection against the effects of hydrocephalus at the behavioral, structural, or 
biochemical level364. In addition, administration of magnesium sulfate, with or without nimodipine 
was associated with substantial side effects including dysregulation of systemic arterial blood 
pressure, cerebral perfusion and intracerebral pulse pressure459. Nevertheless, it is worth 
mentioning that there are several experimental therapies geared towards PVWM repair and 
recovery of neurological function. For example, in rat models of PHH, Ballabh and colleagues 
have explored therapies related to epidermal growth factor638, AMPA-Kainate Receptor 
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inhibitors540, hyaluronidase and hyaluronan oligosaccharides639, thyroxine640, bone morphogenetic 
protein641 and cox-2 inhibitors642. On the horizon, there are also other therapeutic strategies for 
hydrocephalus that are focused on reparative or regenerative processes of already disrupted 
ependyma. For example, Rodriguez and colleagues have explored neurosphere transplantation 
therapy for the regeneration of denuded ependyma. Unilateral intraventricular implantation of 
neurospheres obtained from normal HTx rats helped to repair VZ disruption in hydrocephalic 
littermates643. McAllister and colleagues have also utilized Decorin, a proteoglycan capable of 
inhibiting fibrosis in the subarachnoid space, to prevent the development of ventriculomegaly and 
reduce reactive astrogliosis and inflammation in congenital hydrocephalus models89,90. While the 
current non-surgical therapies for hydrocephalus are experimental, they provide a glimmer of hope 
that the progression to PIH and PHH following infection or hemorrhage can be mitigated, the 
outcomes of affected patients can be improved, and that PIH and PHH can eventually be prevented 
by pursuing robust scientific discovery. 
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